BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-655. [PMID: 7165009 DOI: 10.1097/00000421-198212000-00014] [Cited by in Crossref: 6330] [Cited by in F6Publishing: 3112] [Article Influence: 166.6] [Reference Citation Analysis]
Number Citing Articles
1 Nassar AP, Caruso P. ICU physicians are unable to accurately predict length of stay at admission: a prospective study. Int J Qual Health Care 2016;28:99-103. [DOI: 10.1093/intqhc/mzv112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
2 Bengoechea I, Gutiérrez SG, Vrotsou K, Onaindia MJ, Lopez JM. Opioid use at the end of life and survival in a Hospital at Home unit. J Palliat Med 2010;13:1079-83. [PMID: 20799903 DOI: 10.1089/jpm.2010.0031] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
3 Wadler S, Fell S, Haynes H, Katz HJ, Rozenblit A, Kaleya R, Wiernik PH. Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferon. Cancer 1993;71:1726-30. [DOI: 10.1002/1097-0142(19930301)71:5<1726::aid-cncr2820710504>3.0.co;2-m] [Cited by in Crossref: 24] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
4 Etiz D, Erkal HS, Serin M, Küçük B, Hepari A, Elhan AH, Tulunay O, Cakmak A. Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignancies. Oral Oncol 2000;36:116-20. [PMID: 10889930 DOI: 10.1016/s1368-8375(99)00075-5] [Cited by in Crossref: 47] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
5 Loree JM, Kennecke HF, Lee-Ying RM, Goodwin RA, Powell ED, Tang PA, Price Hiller JA, Vickers MM, Cheung WY. Impact of Postoperative Adjuvant Chemotherapy Following Long-course Chemoradiotherapy in Stage II Rectal Cancer. Am J Clin Oncol 2018;41:643-8. [PMID: 27819876 DOI: 10.1097/COC.0000000000000342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ekström M, Bornefalk-Hermansson A. Cardiovascular and antacid treatment and mortality in oxygen-dependent pulmonary fibrosis: A population-based longitudinal study. Respirology 2016;21:705-11. [PMID: 27009834 DOI: 10.1111/resp.12781] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
7 Guo D, Yang L, Yang J, Shi K. Plasma cell-free DNA methylation combined with tumor mutation detection in prognostic prediction of patients with non-small cell lung cancer (NSCLC). Medicine (Baltimore) 2020;99:e20431. [PMID: 32590728 DOI: 10.1097/MD.0000000000020431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chow LW, Yip AY, Loo WT, Toi M. Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer. Cancer Letters 2008;262:232-8. [DOI: 10.1016/j.canlet.2007.12.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
9 Qiao G, Li J, Huang A, Yan Z, Lau WY, Shen F. Artificial neural networking model for the prediction of post-hepatectomy survival of patients with early hepatocellular carcinoma. J Gastroenterol Hepatol. 2014;29:2014-2020. [PMID: 24989634 DOI: 10.1111/jgh.12672] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
10 Yoneda Y, Kunisada T, Naka N, Nishida Y, Kawai A, Morii T, Takeda K, Hasei J, Yamakawa Y, Ozaki T. Favorable outcome after complete resection in elderly soft tissue sarcoma patients: Japanese Musculoskeletal Oncology Group study. European Journal of Surgical Oncology (EJSO) 2014;40:49-54. [DOI: 10.1016/j.ejso.2013.09.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
11 Jiao X, Krasna MJ, Sonett J, Gamliel Z, Suntharalingam M, Doyle A, Greenwald B. Pretreatment surgical lymph node staging predicts results of trimodality therapy in esophageal cancer. European Journal of Cardio-Thoracic Surgery 2001;19:880-6. [DOI: 10.1016/s1010-7940(01)00737-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
12 Mayr R, May M, Martini T, Lodde M, Comploj E, Pycha A, Strobel J, Denzinger S, Otto W, Wieland W, Burger M, Fritsche H. Comorbidity and Performance Indices as Predictors of Cancer-Independent Mortality But Not of Cancer-Specific Mortality After Radical Cystectomy for Urothelial Carcinoma of the Bladder. European Urology 2012;62:662-70. [DOI: 10.1016/j.eururo.2012.03.057] [Cited by in Crossref: 68] [Cited by in F6Publishing: 42] [Article Influence: 7.6] [Reference Citation Analysis]
13 Samonis G, Koutsounaki E, Karageorgopoulos DE, Mitsikostas P, Kalpadaki C, Bozionelou V, Bompolaki I, Sgouros J, Taktikou V, Falagas ME. Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study. Eur J Clin Microbiol Infect Dis 2012;31:1389-98. [DOI: 10.1007/s10096-011-1454-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
14 Russell B, Collins A, Dowling A, Dally M, Gold M, Murphy M, Burchell J, Philip J. Predicting distress among people who care for patients living longer with high-grade malignant glioma. Support Care Cancer 2016;24:43-51. [DOI: 10.1007/s00520-015-2739-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
15 Deitcher SR, Kessler CM, Merli G, Rigas JR, Lyons RM, Fareed J;  ONCENOX Investigators. Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone vs initial enoxaparin followed by warfarin for a 180-day period. Clin Appl Thromb Hemost. 2006;12:389-396. [PMID: 17000884 DOI: 10.1177/1076029606293692] [Cited by in Crossref: 264] [Cited by in F6Publishing: 189] [Article Influence: 17.6] [Reference Citation Analysis]
16 Tang T, Walsh SR, Fanshawe TR, Gillard JH, Sadat U, Varty K, Gaunt ME, Boyle JR. Estimation of physiologic ability and surgical stress (E-PASS) as a predictor of immediate outcome after elective abdominal aortic aneurysm surgery. Am J Surg 2007;194:176-82. [PMID: 17618800 DOI: 10.1016/j.amjsurg.2006.10.032] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
17 Dreicer R, Manola J, Schneider DJ, Schwerkoske JF, George CS, Roth BJ, Wilding G. Phase II trial of gemcitabine and docetaxel in patients with advanced carcinoma of the urothelium: A trial of the Eastern Cooperative Oncology Group. Cancer 2003;97:2743-7. [DOI: 10.1002/cncr.11413] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
18 Biasoli I, Castro N, Delamain M, Silveira T, Farley J, Pinto Simões B, Solza C, Praxedes M, Baiocchi O, Gaiolla R, Franceschi F, Bonamin Sola C, Boquimpani C, Clementino N, Fleury Perini G, Pagnano K, Steffenello G, Tabacof J, de Freitas Colli G, Soares A, de Souza C, Chiattone CS, Raggio Luiz R, Milito C, Morais JC, Spector N. Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients-An analysis from the Brazilian Hodgkin Lymphoma Registry. Int J Cancer 2018;142:883-90. [PMID: 29023692 DOI: 10.1002/ijc.31096] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
19 Pati AK, Parganiha A, Kar A, Soni R, Roy S, Choudhary V. Alterations of the characteristics of the circadian rest-activity rhythm of cancer in-patients. Chronobiol Int 2007;24:1179-97. [PMID: 18075806 DOI: 10.1080/07420520701800868] [Cited by in Crossref: 46] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
20 Mcdonald JC, du Manoir JM, Kevork N, Le LW, Zimmermann C. Advance directives in patients with advanced cancer receiving active treatment: attitudes, prevalence, and barriers. Support Care Cancer 2017;25:523-31. [DOI: 10.1007/s00520-016-3433-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
21 Park SB, Alberti P, Kolb NA, Gewandter JS, Schenone A, Argyriou AA. Overview and critical revision of clinical assessment tools in chemotherapy-induced peripheral neurotoxicity. J Peripher Nerv Syst 2019;24 Suppl 2:S13-25. [PMID: 31647154 DOI: 10.1111/jns.12333] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
22 Suzuki K, Furuse H, Tsuda T, Masaki Y, Okazawa S, Kambara K, Inomata M, Miwa T, Matsui S, Kashii T, Taniguchi H, Hayashi R, Tobe K. Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: A retrospective study. J Int Med Res 2015;43:573-82. [DOI: 10.1177/0300060515579116] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
23 Witte RS, Elson P, Bryan GT, Trump DL. Trimetrexate in advanced renal cell carcinoma: An ECOG Phase II Trial. Invest New Drugs 1992;10:51-4. [DOI: 10.1007/bf01275483] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Saven A, Carrera CJ, Carson DA, Beutler E, Piro LD. 2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia. Leukemia & Lymphoma 2009;5:133-8. [DOI: 10.3109/10428199109103394] [Cited by in Crossref: 81] [Cited by in F6Publishing: 64] [Article Influence: 6.8] [Reference Citation Analysis]
25 Decaudin D, Mounier N, Tilly H, Ribrag V, Ghesquières H, Bouabdallah K, Morschhauser F, Coiffier B, Le Gouill S, Bologna S, Delarue R, Huynh A, Bosly A, Brière J, Gisselbrecht C. 90Y Ibritumomab Tiuxetan (Zevalin) Combined With BEAM (Z -BEAM) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed or Refractory Low-grade CD20-positive B-cell Lymphoma. A GELA Phase II Prospective Study. Clinical Lymphoma Myeloma and Leukemia 2011;11:212-8. [DOI: 10.1016/j.clml.2011.03.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
26 Sekiguchi M, Oda I, Suzuki H, Abe S, Nonaka S, Yoshinaga S, Taniguchi H, Sekine S, Saito Y. Clinical outcomes and prognostic factors in gastric cancer patients aged ≥85 years undergoing endoscopic submucosal dissection. Gastrointest Endosc 2017;85:963-72. [PMID: 27751873 DOI: 10.1016/j.gie.2016.10.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
27 Fang HY, Chao YK, Chang HK, Tseng CK, Liu YH. Survival outcomes of consolidation chemoradiotherapy in esophageal cancer patients who achieve clinical complete response but refuse surgery after neoadjuvant chemoradiotherapy. Dis Esophagus 2017;30:1-8. [PMID: 27878893 DOI: 10.1111/dote.12515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
28 Bhanji RA, Watt KD. Physiologic Reserve Assessment and Application in Clinical and Research Settings in Liver Transplantation. Liver Transpl 2021;27:1041-53. [PMID: 33713382 DOI: 10.1002/lt.26052] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Oba A, Wu YHA, Lieu CH, Meguid C, Colborn KL, Beaty L, Al-Musawi MH, Davis SL, Leal AD, Purcell T, King G, Wooten ES, Fujiwara Y, Goodman KA, Schefter T, Karam SD, Gleisner AL, Ahrendt S, Leong S, Messersmith WA, Schulick RD, Del Chiaro M. Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study. Br J Surg 2021;108:976-82. [PMID: 34155509 DOI: 10.1093/bjs/znab092] [Reference Citation Analysis]
30 Li W, Purdie TG, Taremi M, Fung S, Brade A, Cho BJ, Hope A, Sun A, Jaffray DA, Bezjak A, Bissonnette J. Effect of Immobilization and Performance Status on Intrafraction Motion for Stereotactic Lung Radiotherapy: Analysis of 133 Patients. International Journal of Radiation Oncology*Biology*Physics 2011;81:1568-75. [DOI: 10.1016/j.ijrobp.2010.09.035] [Cited by in Crossref: 63] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
31 Gridelli C, Ardizzoni A, Le Chevalier T, Manegold C, Perrone F, Thatcher N, van Zandwijk N, Di Maio M, Martelli O, De Marinis F. Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel. Annals of Oncology 2004;15:419-26. [DOI: 10.1093/annonc/mdh087] [Cited by in Crossref: 118] [Cited by in F6Publishing: 96] [Article Influence: 6.9] [Reference Citation Analysis]
32 Postlewait LM, Baptiste GG, Ethun CG, Le N, Cardona K, Russell MC, Willingham FF, Kooby DA, Staley CA, Maithel SK. A 15-year experience with gastric neuroendocrine tumors: Does type make a difference? J Surg Oncol. 2016;114:576-580. [PMID: 27393718 DOI: 10.1002/jso.24369] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
33 West MA, Loughney L, Lythgoe D, Barben CP, Sripadam R, Kemp GJ, Grocott MP, Jack S. Effect of prehabilitation on objectively measured physical fitness after neoadjuvant treatment in preoperative rectal cancer patients: a blinded interventional pilot study. Br J Anaesth. 2015;114:244-251. [PMID: 25274049 DOI: 10.1093/bja/aeu318] [Cited by in Crossref: 188] [Cited by in F6Publishing: 144] [Article Influence: 26.9] [Reference Citation Analysis]
34 Kenis C, Decoster L, Bastin J, Bode H, Van Puyvelde K, De Grève J, Conings G, Fagard K, Flamaing J, Milisen K, Lobelle J, Wildiers H. Functional decline in older patients with cancer receiving chemotherapy: A multicenter prospective study. Journal of Geriatric Oncology 2017;8:196-205. [DOI: 10.1016/j.jgo.2017.02.010] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 12.5] [Reference Citation Analysis]
35 Si L, Zhang X, Shin SJ, Fan Y, Lin CC, Kim TM, Dechaphunkul A, Maneechavakajorn J, Wong CS, Ilankumaran P, Lee DY, Gasal E, Li H, Guo J. Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma. Eur J Cancer 2020;135:31-8. [PMID: 32534242 DOI: 10.1016/j.ejca.2020.04.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Peoples H, Nissen N, Brandt Å, la Cour K. Belonging and quality of life as perceived by people with advanced cancer who live at home. Journal of Occupational Science 2018;25:200-13. [DOI: 10.1080/14427591.2017.1384932] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
37 Bridgewater JA, Nelstrop AE, Rustin GJ, Gore ME, McGuire WP, Hoskins WJ. Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel. J Clin Oncol 1999;17:501-8. [PMID: 10080591 DOI: 10.1200/JCO.1999.17.2.501] [Cited by in Crossref: 86] [Cited by in F6Publishing: 12] [Article Influence: 3.9] [Reference Citation Analysis]
38 Cormio C, Caporale F, Spatuzzi R, Lagattolla F, Lisi A, Graziano G. Psychosocial distress in oncology: using the distress thermometer for assessing risk classes. Support Care Cancer 2019;27:4115-21. [DOI: 10.1007/s00520-019-04694-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
39 Tamburini N, Maniscalco P, Mazzara S, Maietti E, Santini A, Calia N, Stefanelli A, Frassoldati A, Santi I, Rinaldi R, Nigim F, Righi R, Pedrazzi S, Cavallesco G. Multidisciplinary management improves survival at 1 year after surgical treatment for non-small-cell lung cancer: a propensity score-matched study. Eur J Cardiothorac Surg 2018;53:1199-204. [PMID: 29293943 DOI: 10.1093/ejcts/ezx464] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
40 Oshiro Y, Takeda Y, Hirano S, Ito H, Aruga T. Role of radiotherapy for local control of asymptomatic adrenal metastasis from lung cancer. Am J Clin Oncol. 2011;34:249-253. [PMID: 20498589 DOI: 10.1097/coc.0b013e3181dbb727] [Cited by in Crossref: 50] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
41 Loree JM, Mulder KE, Ghosh S, Spratlin JL. CAPOX Associated With Toxicities of Higher Grade but Improved Disease-Free Survival When Compared With FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer. Clinical Colorectal Cancer 2014;13:172-7. [DOI: 10.1016/j.clcc.2014.01.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
42 Lee K, Oh EG, Kim S, Kim S. Symptom experiences and health‐related quality of life among non‐small cell lung cancer patients participating in clinical trials. J Clin Nurs 2019;28:2111-23. [DOI: 10.1111/jocn.14803] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
43 Wiltshire KL, Ward IG, Swallow C, Oza AM, Cummings B, Pond GR, Catton P, Kim J, Ringash J, Wong CS. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival. Int J Radiat Oncol Biol Phys. 2006;64:709-716. [PMID: 16242252 DOI: 10.1016/j.ijrobp.2005.08.012] [Cited by in Crossref: 79] [Cited by in F6Publishing: 56] [Article Influence: 4.9] [Reference Citation Analysis]
44 Saven A, Burian C, Adusumalli J, Koziol JA. Filgrastim for Cladribine-Induced Neutropenic Fever in Patients With Hairy Cell Leukemia. Blood 1999;93:2471-7. [DOI: 10.1182/blood.v93.8.2471] [Cited by in Crossref: 40] [Article Influence: 1.8] [Reference Citation Analysis]
45 Tan WJ, Lin W, Sultana R, Foo FJ, Tang CL, Chew MH. A prognostic score predicting survival following emergency surgery in patients with metastatic colorectal cancer. ANZ J Surg 2021. [PMID: 34374482 DOI: 10.1111/ans.17065] [Reference Citation Analysis]
46 Robak, Błoński, Kasznicki, Konopka, Ceglarek, Dmoszyńska, Soroka-wojtaszko, Skotnicki, Nowak, Dwilewicz-trojaczek, Tomaszewska, Hellmann, Lewandowski, Kuliczkowski, Potoczek, Zdziarska, Hansz, Kroll, Komarnicki, Hołowiecki, Grieb. Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients: Cladribine with or without Prednisone in CLL. British Journal of Haematology 2000;108:357-68. [DOI: 10.1046/j.1365-2141.2000.01850.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
47 Saunthararajah Y, Molokie R, Saraf S, Sidhwani S, Gowhari M, Vara S, Lavelle D, DeSimone J. Clinical effectiveness of decitabine in severe sickle cell disease. Br J Haematol 2008;141:126-9. [PMID: 18324975 DOI: 10.1111/j.1365-2141.2008.07027.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
48 Ohmachi K, Ando K, Ogura M, Uchida T, Itoh K, Kubota N, Ishizawa K, Yamamoto J, Watanabe T, Uike N, Choi I, Terui Y, Usuki K, Nagai H, Uoshima N, Tobinai K; The Japanese Bendamustine Lymphoma Study Group. Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma. Cancer Science 2010;101:2059-64. [DOI: 10.1111/j.1349-7006.2010.01635.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
49 Içli F, Karaoguz H, Akbulut H, Dinçol D, Demirkazik A, Çay F. Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer. J Surg Oncol 1997;64:318-23. [DOI: 10.1002/(sici)1096-9098(199704)64:4<318::aid-jso13>3.0.co;2-z] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
50 Su Y, Huang J, Wang S, Unger JM, Arias-Fuenzalida J, Shi Y, Li J, Gao Y, Shi W, Wang X, Peng R, Xu F, An X, Xue C, Xia W, Hong R, Zhong Y, Lin Y, Huang H, Zhang A, Zhang L, Cai L, Zhang J, Yuan Z. The Effects of Ganglioside-Monosialic Acid in Taxane-Induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized Trial. J Natl Cancer Inst. 2020;112:55-62. [PMID: 31093677 DOI: 10.1093/jnci/djz086] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
51 Murakami J, Ueda K, Sano F, Hayashi M, Nishimoto A, Hamano K. Pulmonary emphysema and tumor microenvironment in primary lung cancer. Journal of Surgical Research 2016;200:690-7. [DOI: 10.1016/j.jss.2015.09.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
52 Cardi M, Sammartino P, Framarino ML, Biacchi D, Cortesi E, Sibio S, Accarpio F, Luciani C, Palazzo A, di Giorgio A. Treatment of peritoneal carcinomatosis from breast cancer by maximal cytoreduction and HIPEC: a preliminary report on 5 cases. Breast 2013;22:845-9. [PMID: 23523180 DOI: 10.1016/j.breast.2013.02.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
53 Drilon A, Clark JW, Weiss J, Ou SI, Camidge DR, Solomon BJ, Otterson GA, Villaruz LC, Riely GJ, Heist RS, Awad MM, Shapiro GI, Satouchi M, Hida T, Hayashi H, Murphy DA, Wang SC, Li S, Usari T, Wilner KD, Paik PK. Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration. Nat Med 2020;26:47-51. [DOI: 10.1038/s41591-019-0716-8] [Cited by in Crossref: 99] [Cited by in F6Publishing: 81] [Article Influence: 99.0] [Reference Citation Analysis]
54 Ravanelli M, Agazzi GM, Ganeshan B, Roca E, Tononcelli E, Bettoni V, Caprioli A, Borghesi A, Berruti A, Maroldi R, Farina D. CT texture analysis as predictive factor in metastatic lung adenocarcinoma treated with tyrosine kinase inhibitors (TKIs). Eur J Radiol 2018;109:130-5. [PMID: 30527295 DOI: 10.1016/j.ejrad.2018.10.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
55 Toffart AC, Duruisseaux M, Brichon PY, Pirvu A, Villa J, Selek L, Guillem P, Dumas I, Ferrer L, Levra MG, Moro-Sibilot D. Operation and Chemotherapy: Prognostic Factors for Lung Cancer With One Synchronous Metastasis. Ann Thorac Surg 2018;105:957-65. [PMID: 29397931 DOI: 10.1016/j.athoracsur.2017.10.040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
56 Baldotto CS, Cronemberger EH, de Biasi P, Zamboni M, Sousa A, Zukin M, Small IA, Ferreira CG. Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy? Support Care Cancer 2012;20:2721-7. [DOI: 10.1007/s00520-012-1392-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
57 Patel A, Tiwari A, Biswas B, Chand Sharma M, Vishnubhatla S, Bakhshi S. Clinical Predictors and Prognostic Model for Pediatric Lymphoblastic Lymphoma Treated With Uniform BFM90 Protocol: A Single-Center Experience of 65 Patients From Asia. Clinical Lymphoma Myeloma and Leukemia 2019;19:e291-8. [DOI: 10.1016/j.clml.2019.01.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
58 Gómez-bernal A, Cruz JJ, García-palomo A, Arizcun A, Pujol E, Diz P, Martín G, Fonseca E, Sánchez P, Rodríguez C, Barco ED, López Y. Biweekly Docetaxel and Vinorelbine in Anthracycline-Resistant Metastatic Breast Cancer: A Multicenter Phase II Study. American Journal of Clinical Oncology 2003;26:127-31. [DOI: 10.1097/00000421-200304000-00005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
59 Demura S, Kato S, Shinmura K, Yokogawa N, Shimizu T, Handa M, Annen R, Kobayashi M, Yamada Y, Murakami H, Kawahara N, Tomita K, Tsuchiya H. Perioperative complications of total en bloc spondylectomy for spinal tumours. Bone Joint J 2021;103-B:976-83. [PMID: 33934644 DOI: 10.1302/0301-620X.103B5.BJJ-2020-1777.R1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Lasalvia-prisco E, Vázquez J, Golomar W, Larrañaga J, Garcia-giralt E, Cucchi S, Lasalvia-galante E. Advanced breast cancer: anti-progressive immunotherapy using a thermostable autologous hemoderivative. Breast Cancer Res Treat 2006;100:149-60. [DOI: 10.1007/s10549-006-9235-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
61 Han JH, Kim DG, Chung H, Kim C, Park C, Chung YS, Paek SH, Yoo M, Kim B, Jung H. Radiosurgery for brain metastasis from advanced gastric cancer. Acta Neurochir 2010;152:605-10. [DOI: 10.1007/s00701-009-0554-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
62 Pallis AG, Voutsina A, Kentepozidis N, Giassas S, Papakotoulas P, Agelaki S, Tryfonidis K, Kotsakis A, Vamvakas L, Vardakis N, Georgoulias V. A phase II trial of erlotinib as front-line treatment in clinically selected patients with non-small-cell lung cancer. Clin Lung Cancer 2012;13:129-35. [PMID: 22000696 DOI: 10.1016/j.cllc.2011.08.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
63 Spira D, Fenchel M, Lauer UM, Claussen CD, Gregor M, Bitzer M, Horger M. Comparison of different tumor response criteria in patients with hepatocellular carcinoma after systemic therapy with the multikinase inhibitor sorafenib. Acad Radiol 2011;18:89-96. [PMID: 20926315 DOI: 10.1016/j.acra.2010.08.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
64 Braud A, Asselain B, Scholl S, De La Rochefordière A, Palangie T, Dieras V, Pierga J, Dorval T, Jouve M, Beuzeboc P, Pouillart P. Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse? European Journal of Cancer 1999;35:392-7. [DOI: 10.1016/s0959-8049(98)00393-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
65 Advani R, Lum BL, Fisher GA, Halsey J, Chin DL, Jacobs CD, Sikic BI. A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance. Ann Oncol 2005;16:1968-73. [PMID: 16126736 DOI: 10.1093/annonc/mdi396] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
66 Wirz S, Wittmann M, Schenk M, Schroeck A, Schaefer N, Mueller M, Standop J, Kloecker N, Nadstawek J. Gastrointestinal symptoms under opioid therapy: A prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine. European Journal of Pain 2009;13:737-43. [DOI: 10.1016/j.ejpain.2008.09.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
67 Tjaden C, Hassenpflug M, Hinz U, Klaiber U, Klauss M, Büchler MW, Hackert T. Outcome and prognosis after pancreatectomy in patients with solid pseudopapillary neoplasms. Pancreatology 2019;19:699-709. [PMID: 31227367 DOI: 10.1016/j.pan.2019.06.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
68 Le Scodan R, Mornex F, Girard N, Mercier C, Valette P, Ychou M, Bibeau F, Roy P, Scoazec J, Partensky C. Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review. Annals of Oncology 2009;20:1387-96. [DOI: 10.1093/annonc/mdp015] [Cited by in Crossref: 69] [Cited by in F6Publishing: 55] [Article Influence: 5.8] [Reference Citation Analysis]
69 Di Matteo FM, Saccomandi P, Martino M, Pandolfi M, Pizzicannella M, Balassone V, Schena E, Pacella CM, Silvestri S, Costamagna G. Feasibility of EUS-guided Nd:YAG laser ablation of unresectable pancreatic adenocarcinoma. Gastrointestinal Endoscopy 2018;88:168-174.e1. [DOI: 10.1016/j.gie.2018.02.007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
70 Zhai T, van Dijk LV, Huang B, Lin Z, Ribeiro CO, Brouwer CL, Oosting SF, Halmos GB, Witjes MJ, Langendijk JA, Steenbakkers RJ, Sijtsema NM. Improving the prediction of overall survival for head and neck cancer patients using image biomarkers in combination with clinical parameters. Radiotherapy and Oncology 2017;124:256-62. [DOI: 10.1016/j.radonc.2017.07.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
71 Akgun M, Meral M, Onbas O, Araz O, Koplay M, Aslan S, Mirici A. Comparison of clinical characteristics and outcomes of patients with COPD exacerbation with or without venous thromboembolism. Respiration 2006;73:428-33. [PMID: 16636527 DOI: 10.1159/000092952] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
72 Oyaga-iriarte E, Insausti A, Sayar O, Aldaz A. Population pharmacokinetic model of irinotecan and its metabolites in patients with metastatic colorectal cancer. Eur J Clin Pharmacol 2019;75:529-42. [DOI: 10.1007/s00228-018-02609-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Sakoda Y, Ikegame S, Ikeda-Harada C, Takakura K, Kumazoe H, Wakamatsu K, Nakanishi Y, Kawasaki M. Retrospective analysis of nursing and healthcare-associated pneumonia: analysis of adverse prognostic factors and validity of the selection criteria. Respir Investig 2014;52:114-20. [PMID: 24636267 DOI: 10.1016/j.resinv.2013.08.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
74 Jochems A, Deist TM, van Soest J, Eble M, Bulens P, Coucke P, Dries W, Lambin P, Dekker A. Distributed learning: Developing a predictive model based on data from multiple hospitals without data leaving the hospital – A real life proof of concept. Radiotherapy and Oncology 2016;121:459-67. [DOI: 10.1016/j.radonc.2016.10.002] [Cited by in Crossref: 85] [Cited by in F6Publishing: 47] [Article Influence: 17.0] [Reference Citation Analysis]
75 Massa E, Astara G, Madeddu C, Dessì M, Loi C, Lepori S, Mantovani G. Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: comparison between elderly and non-elderly patient response. Crit Rev Oncol Hematol. 2009;70:83-91. [PMID: 18723369 DOI: 10.1016/j.critrevonc.2008.07.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
76 Hess G, Rule S, Jurczak W, Jerkeman M, Santucci Silva R, Rusconi C, Caballero D, Joao C, Witzens-harig M, Bence-bruckler I, Cho S, Zhou W, Goldberg JD, Trambitas C, Enny C, Vermeulen J, Traina S, Chiou C, Diels J, Dreyling M. Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus. Leukemia & Lymphoma 2017;58:2824-32. [DOI: 10.1080/10428194.2017.1326034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
77 Kawakita D, Hosono S, Ito H, Oze I, Watanabe M, Hanai N, Hasegawa Y, Tajima K, Murakami S, Tanaka H, Matsuo K. Impact of smoking status on clinical outcome in oral cavity cancer patients. Oral Oncol 2012;48:186-91. [PMID: 21996543 DOI: 10.1016/j.oraloncology.2011.09.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
78 Zinzani P, Lauria F, Rondelli D, Benfenati D, Raspadori D, Bocchia M, Bendandi M, Gozzetti A, Tura S, Zaja F, Fanin R, Russo D, Galieni P. Fludarabine: An active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma. Annals of Oncology 1993;4:575-8. [DOI: 10.1093/oxfordjournals.annonc.a058591] [Cited by in Crossref: 76] [Cited by in F6Publishing: 61] [Article Influence: 2.7] [Reference Citation Analysis]
79 Pera M, Gallego R, Montagut C, Martín-richard M, Iglesias M, Conill C, Reig A, Balagué C, Pétriz L, Momblan D, Bellmunt J, Maurel J. Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer. Annals of Oncology 2012;23:664-70. [DOI: 10.1093/annonc/mdr291] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
80 Hernádi Z, Juhász B, Póka R, Lampé LG. Randomised trial comparing combinations of cyclophosphamide and cisplatin without or with doxorubicin or 4'-epi-doxorubicin in the treatment of advanced ovarian cancer. Int J Gynaecol Obstet 1988;27:199-204. [PMID: 2903085 DOI: 10.1016/0020-7292(88)90008-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
81 Ciftci TT, Unal E, Azizova A, Ayyildiz VA, Akinci D, Akhan O. Renal Cystic Echinococcosis: Long-Term Outcomes of Percutaneous Treatment. J Vasc Interv Radiol 2021;32:890-895.e2. [PMID: 33727151 DOI: 10.1016/j.jvir.2021.03.519] [Reference Citation Analysis]
82 Fetterly GJ, Owen JS, Stuyckens K, Passarell JA, Zannikos P, Soto-matos A, Izquierdo MA, Perez-ruixo JJ. Semimechanistic pharmacokinetic/pharmacodynamic model for hepatoprotective effect of dexamethasone on transient transaminitis after trabectedin (ET-743) treatment. Cancer Chemother Pharmacol 2008;62:135-47. [DOI: 10.1007/s00280-007-0583-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
83 Gow CH, Hsieh MS, Wu SG, Shih JY. A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population. Lung Cancer 2017;103:82-9. [PMID: 28024701 DOI: 10.1016/j.lungcan.2016.12.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
84 Sadetsky N, Chuo CY, Davidoff AJ. Development and evaluation of a proxy for baseline ECOG PS in advanced non-small cell lung cancer, bladder cancer, and melanoma: An electronic health record study. Pharmacoepidemiol Drug Saf 2021;30:1233-41. [PMID: 34145696 DOI: 10.1002/pds.5309] [Reference Citation Analysis]
85 Keränen I, Kylänpää L, Udd M, Louhimo J, Lepistö A, Halttunen J, Kokkola A. Gastric outlet obstruction in gastric cancer: a comparison of three palliative methods. J Surg Oncol. 2013;108:537-541. [PMID: 24590674 DOI: 10.1002/jso.23442] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
86 Holyoake DLP, Warren DR, Hurt C, Aznar M, Partridge M, Mukherjee S, Hawkins MA. Stomach Dose-Volume Predicts Acute Gastrointestinal Toxicity in Chemoradiotherapy for Locally Advanced Pancreatic Cancer. Clin Oncol (R Coll Radiol) 2018;30:418-26. [PMID: 29602584 DOI: 10.1016/j.clon.2018.02.067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
87 Saito J, Nakai Y, Saijo Y, Nukiwa T, Koinumaru S, Matsuura Y, Aso N, Yamane Y, Tsukamoto T, Sayama T, Nakabayashi T. A phase II trial of oral UFT plus cisplatin (CDDP) in patients with non-small cell lung cancer (NSCLC). Lung Cancer 2001;31:285-93. [DOI: 10.1016/s0169-5002(00)00183-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
88 Nagamatsu H, Hiraki M, Mizukami N, Yoshida H, Iwamoto H, Sumie S, Torimura T, Sata M. Intra-arterial therapy with cisplatin suspension in lipiodol and 5-fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis. Aliment Pharmacol Ther. 2010;32:543-550. [PMID: 20500734 DOI: 10.1111/j.1365-2036.2010.04379.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
89 Baratti D, Kusamura S, Martinetti A, Seregni E, Oliva DG, Laterza B, Deraco M. Circulating CA125 in patients with peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol. 2007;14:500-508. [PMID: 17151789 DOI: 10.1245/s10434-006-9192-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
90 Wolfort SF, Dellon AL. Peripheral neuropathy in HIV patients: Treatment by decompression of peripheral nerves. Microsurgery 2012;32:31-4. [DOI: 10.1002/micr.20938] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
91 Gupta PK, Gupta H, Natarajan B, Shetty S, Smith RB, Lindau R, Fang X, Lydiatt WM. Postoperative respiratory failure after thyroid and parathyroid surgery: Analysis of national surgical quality improvement program. Head Neck 2012;34:321-7. [DOI: 10.1002/hed.21723] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
92 Xu WL, Shen HL, Ao ZF, Chen BA, Xia W, Gao F, Zhang YN. Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia. Leuk Res 2006;30:407-13. [PMID: 16219352 DOI: 10.1016/j.leukres.2005.08.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
93 Jeon HJ, Shim EJ, Shin YW, Oh DY, Im SA, Heo DS, Hahm BJ. Discrepancies in performance status scores as determined by cancer patients and oncologists: are they influenced by depression? Gen Hosp Psychiatry 2007;29:555-61. [PMID: 18022049 DOI: 10.1016/j.genhosppsych.2007.08.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
94 Soldath P, Binderup T, Kjær A, Federspiel B, Langer SW, Knigge U, Petersen RH. Long-term survival and recurrence after resection of bronchopulmonary carcinoids: A single-center cohort study of 236 patients. Lung Cancer 2021;156:109-16. [PMID: 33940543 DOI: 10.1016/j.lungcan.2021.04.010] [Reference Citation Analysis]
95 Jespersen E, Winther SB, Minet LR, Möller S, Pfeiffer P. Frailty screening for predicting rapid functional decline, rapid progressive disease, and shorter overall survival in older patients with gastrointestinal cancer receiving palliative chemotherapy - a prospective, clinical study. J Geriatr Oncol 2021;12:578-84. [PMID: 33830020 DOI: 10.1016/j.jgo.2020.10.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
96 Alva AS, Tallman CT, He C, Hussain MH, Hafez K, Montie JE, Smith DC, Weizer AZ, Wood D, Lee CT. Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer: A multidisciplinary approach. Cancer 2012;118:44-53. [DOI: 10.1002/cncr.26240] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
97 Spetz A, Henriksson R, Salander P. A specialist nurse as a resource for family members to patients with brain tumors: an action research study. Cancer Nurs 2008;31:E18-26. [PMID: 18600107 DOI: 10.1097/01.NCC.0000305741.18711.8f] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
98 Hannon B, Swami N, Pope A, Rodin G, Dougherty E, Mak E, Banerjee S, Bryson J, Ridley J, Zimmermann C. The oncology palliative care clinic at the Princess Margaret Cancer Centre: an early intervention model for patients with advanced cancer. Support Care Cancer 2015;23:1073-80. [DOI: 10.1007/s00520-014-2460-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
99 Tyc VL, Klosky JL, Kronenberg M, de Armendi AJ, Merchant TE. Children's Distress in Anticipation of Radiation Therapy Procedures. Children's Health Care 2002;31:11-27. [DOI: 10.1207/s15326888chc3101_2] [Cited by in Crossref: 16] [Article Influence: 0.8] [Reference Citation Analysis]
100 Latenstein AEJ, Mackay TM, Creemers GJ, van Eijck CHJ, de Groot JWB, Haj Mohammad N, Homs MYV, van Laarhoven HWM, Molenaar IQ, Ten Tije BJ, de Vos-Geelen J, Besselink MG, van der Geest LGM, Wilmink JW; Dutch Pancreatic Cancer Group. Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis. Acta Oncol 2020;59:705-12. [PMID: 32056483 DOI: 10.1080/0284186X.2020.1725241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Cesari M, Cerullo F, Zamboni V, Di Palma R, Scambia G, Balducci L, Antonelli Incalzi R, Vellas B, Gambassi G. Functional Status and Mortality in Older Women With Gynecological Cancer. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2013;68:1129-33. [DOI: 10.1093/gerona/glt073] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 6.4] [Reference Citation Analysis]
102 Tada Y, Matsubara M, Kawada S, Ishida M, Wada M, Wada T, Onishi H. Psychiatric disorders in cancer patients at a university hospital in Japan: descriptive analysis of 765 psychiatric referrals. Jpn J Clin Oncol 2012;42:183-8. [PMID: 22259217 DOI: 10.1093/jjco/hyr200] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
103 Bassan R, Buelli M, Viero P, Minotti C, Barbui T. The management of acute myelogenous leukemia in the elderly: ten-year experience in 118 patients. Hematol Oncol 1992;10:251-60. [PMID: 1493909 DOI: 10.1002/hon.2900100503] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
104 Yang M, Xu W, Liu T, Yang X, Wang P, Wu S, Wei H, Zhao J, Yang C, Xiao J. Development and Validation of a Novel Survival Prediction Model in Patients With Spinal Metastasis From Non-small Cell Lung Cancer. Spine (Phila Pa 1976) 2019;44:246-57. [PMID: 30059487 DOI: 10.1097/BRS.0000000000002816] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
105 Lin JW, Chang ML, Hsu CW, Chen YC, Liang KH, Huang YH, Lin CC, Yeh CT. Acute exacerbation of hepatitis C in hepatocellular carcinoma patients receiving chemotherapy. J Med Virol 2017;89:153-60. [PMID: 27273118 DOI: 10.1002/jmv.24595] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
106 Murakami M, Kuroda Y, Nakajima T, Okamoto Y, Mizowaki T, Kusumi F, Hajiro K, Nishimura S, Matsusue S, Takeda H. Comparison between chemoradiation protocol intended for organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma. Int J Radiat Oncol Biol Phys. 1999;45:277-284. [PMID: 10487546 DOI: 10.1016/s0360-3016(99)00171-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
107 Gmür A, Kolly P, Knöpfli M, Dufour J. FACT-Hep increases the accuracy of survival prediction in HCC patients when added to ECOG Performance Status. Liver Int 2018;38:1468-74. [DOI: 10.1111/liv.13711] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
108 Mol L, Ottevanger PB, Koopman M, Punt CJ. The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients. Eur J Cancer 2016;66:138-43. [PMID: 27573427 DOI: 10.1016/j.ejca.2016.07.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
109 Presant C, Scolaro M, Kennedy P, Blayney D, Flanagan B, Lisak J, Presant J. Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma. The Lancet 1993;341:1242-3. [DOI: 10.1016/0140-6736(93)91147-e] [Cited by in Crossref: 75] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
110 Stevens CSM, Lemon B, Lockwood GA, Waldron JN, Bezjak A, Ringash J. The development and validation of a quality-of-life questionnaire for head and neck cancer patients with enteral feeding tubes: the QOL-EF. Support Care Cancer 2011;19:1175-82. [DOI: 10.1007/s00520-010-0934-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
111 King MT. A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res 2011;11:171-84. [PMID: 21476819 DOI: 10.1586/erp.11.9] [Cited by in Crossref: 315] [Cited by in F6Publishing: 253] [Article Influence: 31.5] [Reference Citation Analysis]
112 Devriese LA, Koch KM, Mergui-roelvink M, Matthys GM, Ma WW, Robidoux A, Stephenson JJ, Chu QSC, Orford KW, Cartee L, Botbyl J, Arya N, Schellens JHM. Effects of low-fat and high-fat meals on steady-state pharmacokinetics of lapatinib in patients with advanced solid tumours. Invest New Drugs 2014;32:481-8. [DOI: 10.1007/s10637-013-0055-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
113 Ferreira CPDC, Ribeiro MA, Szutan LA. Overall survival predictors in hepatocellular carcinoma patients treated with sorafenib. Rev Assoc Med Bras (1992) 2020;66:275-83. [PMID: 32520145 DOI: 10.1590/1806-9282.66.3.275] [Reference Citation Analysis]
114 Nourissat A, Vasson M, Merrouche Y, Bouteloup C, Goutte M, Mille D, Jacquin J, Collard O, Michaud P, Chauvin F. Relationship between nutritional status and quality of life in patients with cancer. European Journal of Cancer 2008;44:1238-42. [DOI: 10.1016/j.ejca.2008.04.006] [Cited by in Crossref: 72] [Cited by in F6Publishing: 55] [Article Influence: 5.5] [Reference Citation Analysis]
115 Dagher J, Dugay F, Rioux-leclercq N, Verhoest G, Oger E, Bensalah K, Cabillic F, Jouan F, Kammerer-jacquet S, Fergelot P, Vigneau C, Arlot-bonnemains Y, Belaud-rotureau M. Cytoplasmic PAR-3 protein expression is associated with adverse prognostic factors in clear cell renal cell carcinoma and independently impacts survival. Human Pathology 2014;45:1639-46. [DOI: 10.1016/j.humpath.2014.03.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
116 Pal R, Varma S, Ahluwalia J, Prakash G. Antiphospholipid Antibodies Are Not Associated with Clinical Parameters or Prognostic Outcomes in Patients with Non-Hodgkin's Lymphoma. Hamostaseologie 2020;40:662-70. [PMID: 32932545 DOI: 10.1055/a-1223-3367] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Gordon LI, Andersen J, Colgan J, Glick J, Resnick GD, O'connell M, Cassileth PA. Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study. Cancer 1995;75:865-73. [DOI: 10.1002/1097-0142(19950201)75:3<865::aid-cncr2820750319>3.0.co;2-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
118 Furata T, Tabuchi A, Adachi Y, Mizumatsu S, Tamesa N, Ichikawa T, Tamiya T, Matsumoto K, Ohmoto T. Primary brain tumors in children under age 3 years. Brain Tumor Pathol 1998;15:7-12. [DOI: 10.1007/bf02482094] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
119 Yam C, Landsburg DJ, Nead KT, Lin X, Mato AR, Svoboda J, Loren AW, Frey NV, Stadtmauer EA, Porter DL, Schuster SJ, Nasta SD. Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas: Autologous SCT in CR1 May not Extend PFS in Patients with PTCL. Am J Hematol 2016;91:672-6. [DOI: 10.1002/ajh.24372] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
120 Wadler S, Yeap B, Vogl S, Carbone P. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: Initial and long term results—Eastern Cooperative Oncology Group study E2878. Cancer 1996;77:733-42. [DOI: 10.1002/(sici)1097-0142(19960215)77:4<733::aid-cncr20>3.0.co;2-0] [Cited by in Crossref: 20] [Article Influence: 0.8] [Reference Citation Analysis]
121 Thomas PA, Couderc AL, Boulate D, Greillier L, Charvet A, Brioude G, Trousse D, D'Journo XB, Barlesi F, Loundou A. Early-stage non-small cell lung cancer beyond life expectancy: Still not too old for surgery? Lung Cancer 2021;152:86-93. [PMID: 33360807 DOI: 10.1016/j.lungcan.2020.12.009] [Reference Citation Analysis]
122 Oermann EK, Kress MS, Collins BT, Collins SP, Morris D, Ahalt SC, Ewend MG. Predicting Survival in Patients With Brain Metastases Treated With Radiosurgery Using Artificial Neural Networks. Neurosurgery 2013;72:944-52. [DOI: 10.1227/neu.0b013e31828ea04b] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
123 Lassen K, Nymo LS, Kørner H, Thon K, Grindstein T, Wasmuth HH, Moger T, Bjørnbeth BA, Norderval S, Eriksen MT, Viste A. The New National Registry for Gastrointestinal Surgery in Norway: NoRGast. Scand J Surg 2018;107:201-7. [DOI: 10.1177/1457496918766697] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
124 Jayson GC, Zweit J, Jackson A, Mulatero C, Julyan P, Ranson M, Broughton L, Wagstaff J, Hakannson L, Groenewegen G. Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies. J Natl Cancer Inst. 2002;94:1484-1493. [PMID: 12359857 DOI: 10.1093/jnci/94.19.1484] [Cited by in Crossref: 203] [Cited by in F6Publishing: 150] [Article Influence: 10.7] [Reference Citation Analysis]
125 D'Agostino G, del Campo J, Mellado B, Izquierdo MA, Minarik T, Cirri L, Marini L, Perez-Gracia JL, Scambia G. A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer. Int J Gynecol Cancer 2006;16:71-6. [PMID: 16445613 DOI: 10.1111/j.1525-1438.2006.00276.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
126 McCormack L, Hany TI, Hübner M, Petrowsky H, Mullhaupt B, Knuth A, Stenner F, Clavien PA. How useful is PET/CT imaging in the management of post-transplant lymphoproliferative disease after liver transplantation? Am J Transplant. 2006;6:1731-1736. [PMID: 16827878 DOI: 10.1111/j.1600-6143.2006.01358.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
127 Katsuragi S, Tanaka H, Hasegawa J, Kanayama N, Nakata M, Murakoshi T, Osato K, Nakamura M, Tanaka K, Sekizawa A, Ishiwata I, Yamamoto Y, Wakasa T, Takeuchi M, Yoshimatsu J, Ikeda T. Analysis of preventability of malignancy-related maternal death from the nationwide registration system of maternal deaths in Japan. J Matern Fetal Neonatal Med 2021;34:432-8. [PMID: 30999803 DOI: 10.1080/14767058.2019.1609930] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
128 Chira C, Jacob J, Derhem N, Bollet MA, Campana F, Marchand V, Pierga J, Fourquet A, Kirova YM. Preliminary experience of whole-brain radiation therapy (WBRT) in breast cancer patients with brain metastases previously treated with bevacizumab-based chemotherapy. J Neurooncol 2011;105:401-8. [DOI: 10.1007/s11060-011-0607-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
129 Kang TW, Lim HK, Lee MW, Kim YS, Rhim H, Lee WJ, Paik YH, Kim MJ, Ahn JH. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study. Radiology. 2016;280:300-312. [PMID: 26824711 DOI: 10.1148/radiol.2016151243] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 9.2] [Reference Citation Analysis]
130 Shanafelt T. Treatment of older patients with chronic lymphocytic leukemia: key questions and current answers. Hematology 2013;2013:158-67. [DOI: 10.1182/asheducation-2013.1.158] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
131 Nagai H, Ogura M, Kusumoto S, Takahashi N, Yamaguchi M, Takayama N, Kinoshita T, Motoji T, Ohyashiki K, Kosugi H, Matsuda S, Ohnishi K, Omachi K, Hotta T. Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma. Eur J Haematol 2011;86:117-23. [PMID: 21070370 DOI: 10.1111/j.1600-0609.2010.01552.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
132 Mathias SD, Crosby RD, Qian Y, Jiang Q, Dansey R, Chung K. Estimating Minimally Important Differences for the Worst Pain Rating of the Brief Pain Inventory–Short Form. The Journal of Supportive Oncology 2011;9:72-8. [DOI: 10.1016/j.suponc.2010.12.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
133 Ciuleanu T, Bazin I, Lungulescu D, Miron L, Bondarenko I, Deptala A, Rodriguez-Torres M, Giantonio B, Fox NL, Wissel P, Egger J, Ding M, Kalyani RN, Humphreys R, Gribbin M, Sun W. A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma. Ann Oncol. 2016;27:680-687. [PMID: 26802147 DOI: 10.1093/annonc/mdw004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
134 Tengberg LT, Cihoric M, Foss NB, Bay-Nielsen M, Gögenur I, Henriksen R, Jensen TK, Tolstrup MB, Nielsen LB. Complications after emergency laparotomy beyond the immediate postoperative period - a retrospective, observational cohort study of 1139 patients. Anaesthesia 2017;72:309-16. [PMID: 27809332 DOI: 10.1111/anae.13721] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 7.2] [Reference Citation Analysis]
135 Kozyrakis D, Kratiras Z, Soukias G, Chatzistamou S, Zarkadas A, Perikleous S, Kateris D, Katsaros I, Skriapas K, Karagiannis D. Clinical Outcome and Prognostic Factors of Sepsis, Septic Shock and Prolonged Hospitalization, of Patients Presented with Acute Obstructive Pyelonephritis. Journal of Endourology 2020;34:516-22. [DOI: 10.1089/end.2019.0801] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
136 Escalón MP, Liu NS, Yang Y, Hess M, Walker PL, Smith TL, Dang NH. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: The M. D. Anderson Cancer Center experience. Cancer 2005;103:2091-8. [DOI: 10.1002/cncr.20999] [Cited by in Crossref: 171] [Cited by in F6Publishing: 127] [Article Influence: 10.7] [Reference Citation Analysis]
137 Bulitta JB, Zhao P, Arnold RD, Kessler DR, Daifuku R, Pratt J, Luciano G, Hanauske A, Gelderblom H, Awada A, Jusko WJ. Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients. Cancer Chemother Pharmacol 2009;63:1049-63. [DOI: 10.1007/s00280-008-0827-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
138 Mattiucci GC, Morganti AG, Valentini V, Ippolito E, Alfieri S, Antinori A, Crucitti A, D'Agostino GR, Di Lullo L, Luzi S, Mantini G, Smaniotto D, Doglietto GB, Cellini N. External beam radiotherapy plus 24-hour continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long-term results of a phase II study. Int J Radiat Oncol Biol Phys 2010;76:831-8. [PMID: 19427747 DOI: 10.1016/j.ijrobp.2009.02.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
139 Yin JY, Han LF, Huang Q, Xu XJ, Zhou HH, Liu ZQ. ABCC1 polymorphism Arg723Gln (2168G> A) is associated with lung cancer susceptibility in a Chinese population. Clin Exp Pharmacol Physiol 2011;38:632-7. [PMID: 21736601 DOI: 10.1111/j.1440-1681.2011.05571.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
140 Quaglino P, Fierro MT, Rossotto GL, Savoia P, Bernengo MG. Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy. Br J Dermatol 2004;150:327-36. [PMID: 14996105 DOI: 10.1111/j.1365-2133.2004.05712.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
141 Zhang H, Seikaly H, Nguyen NT, Abele JT, Dziegielewski PT, Harris JR, O'Connell DA. Validation of metabolic tumor volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery. Oral Oncol 2016;57:6-14. [PMID: 27208838 DOI: 10.1016/j.oraloncology.2016.03.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
142 Chang SC, Chang CY, Chang SJ, Yuan MK, Lai YC, Liu YC, Chen CY, Kuo LC, Yu CJ. Gefitinib-related interstitial lung disease in Taiwanese patients with non-small-cell lung cancer. Clin Lung Cancer 2013;14:55-61. [PMID: 22607779 DOI: 10.1016/j.cllc.2012.03.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
143 Oliva EN, Alati C, Santini V, Poloni A, Molteni A, Niscola P, Salvi F, Sanpaolo G, Balleari E, Germing U, Fenaux P, Stamatoullas A, Palumbo GA, Salutari P, Impera S, Avanzini P, Cortelezzi A, Liberati AM, Carluccio P, Buccisano F, Voso MT, Mancini S, Kulasekararaj A, Morabito F, Bocchia M, Cufari P, Spiriti MAA, Santacaterina I, D'errigo MG, Bova I, Zini G, Latagliata R. Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial. The Lancet Haematology 2017;4:e127-36. [DOI: 10.1016/s2352-3026(17)30012-1] [Cited by in Crossref: 76] [Cited by in F6Publishing: 25] [Article Influence: 19.0] [Reference Citation Analysis]
144 Taylor AC, Maddirela D, White SB. Role of Radioembolization for Biliary Tract and Primary Liver Cancer. Surgical Oncology Clinics of North America 2019;28:731-43. [DOI: 10.1016/j.soc.2019.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
145 Eldeib HK, Abbassi MM, Hussein MM, Salem SE, Sabry NA. The Effect of Telephone-Based Follow-Up on Adherence, Efficacy, and Toxicity of Oral Capecitabine-Based Chemotherapy. Telemedicine and e-Health 2019;25:462-70. [DOI: 10.1089/tmj.2018.0077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
146 Metzger ML, Stewart CF, Freeman BB 3rd, Billups CA, Hoffer FA, Wu J, Coppes MJ, Grant R, Chintagumpala M, Mullen EA, Alvarado C, Daw NC, Dome JS. Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study. J Clin Oncol 2007;25:3130-6. [PMID: 17634492 DOI: 10.1200/JCO.2007.10.9298] [Cited by in Crossref: 48] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
147 Ishikawa S, Kato J, Kuriyama M, Takemoto K, Uraoka T, Takaki A, Yagi T, Sakaguchi K. Feasibility and findings of colonoscopy for living-donor liver transplant candidates. J Clin Gastroenterol 2009;43:69-74. [PMID: 18724252 DOI: 10.1097/MCG.0b013e3181571bf7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
148 Sheppard JP, Prashant GN, Chen CHJ, Peeters S, Lagman C, Ong V, Udawatta M, Duong C, Nguyen T, Romiyo P, Gaonkar B, Yong WH, Kaprealian TB, Tenn S, Lee P, Yang I. Timing of adjuvant radiation therapy and survival outcomes after surgical resection of intracranial non-small cell lung cancer metastases. Clin Neurol Neurosurg 2019;183:105389. [PMID: 31280101 DOI: 10.1016/j.clineuro.2019.105389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
149 Sung JH, Brown MC, Perez-Cosio A, Pratt L, Houad J, Liang M, Gill G, Moradian S, Liu G, Howell D. Acceptability and accuracy of patient-reported outcome measures (PROMs) for surveillance of breathlessness in routine lung cancer care: A mixed-method study. Lung Cancer 2020;147:1-11. [PMID: 32634651 DOI: 10.1016/j.lungcan.2020.06.028] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Ashley S, Shanks JH, Oliveira P, Lucky M, Parnham A, Lau M, Sangar V. Human Papilloma Virus (HPV) status may impact treatment outcomes in patients with pre-cancerous penile lesions (an eUROGEN Study). Int J Impot Res 2021;33:620-6. [DOI: 10.1038/s41443-020-0327-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
151 Miyake H, Hara I, Sakai I, Harada K, Inoue T, Eto H, Takechi Y, Fujisawa M. Clinical outcome of combined immunotherapy with low-dose interleukin-2 and interferon-α for Japanese patients with metastatic renal cell carcinoma who had undergone radical nephrectomy: a preliminary report. Int J Clin Oncol 2005;10:338-41. [DOI: 10.1007/s10147-005-0515-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
152 Haga Y, Ikejiri K, Wada Y, Takahashi T, Ikenaga M, Akiyama N, Koike S, Koseki M, Saitoh T. A multicenter prospective study of surgical audit systems. Ann Surg 2011;253:194-201. [PMID: 21233616 DOI: 10.1097/SLA.0b013e3181f66199] [Cited by in Crossref: 36] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
153 Amano K, Maeda I, Ishiki H, Miura T, Hatano Y, Tsukuura H, Taniyama T, Matsumoto Y, Matsuda Y, Kohara H, Morita T, Mori M, Inoue S, Yokomichi N, Imai K, Yamauchi T, Naito AS, Uneno Y, Yoshioka A, Hiramoto S, Kikuchi A, Hori T, Funaki H, Tanaka K, Suzuki K, Kamei T, Azuma Y, Uno T, Miyamoto J, Katayama H, Kashiwagi H, Matsumoto E, Oya K, Yamaguchi T, Okamura T, Hashimoto H, Kosugi S, Ikuta N, Matsumoto Y, Ohmori T, Nakai T, Ikee T, Unoki Y, Kitade K, Koito S, Ishibashi N, Ehara M, Kuwahara K, Ueno S, Nakashima S, Ishiyama Y, Sakashita A, Matsunuma R, Takatsu H, Yamaguchi T, Ito S, Terabayashi T, Nakagawa J, Yamagiwa T, Inoue A, Yamaguchi T, Miyashita M, Yoshida S, Hiratsuka Y, Tagami K, Watanabe H, Odagiri T, Ito T, Ikenaga M, Shimizu K, Hayakawa A, Kamura R, Okoshi T, Nishi T, Kosugi K, Shibata Y, Hisanaga T, Higashibata T, Yabuki R, Hagiwara S, Shimokawa M, Miyake S, Nozato J, Iriyama T, Kaneishi K, Baba M, Okizaki A, Watanabe YS, Uehara Y, Satomi E, Nishijima K, Shimoinaba J, Nakahori R, Hirohashi T, Hamano J, Kawashima N, Kawaguchi T, Uchida M, Sato K, Matsuda Y, Tsuneto S, Maeda S, Kizawa Y, Otani H. Effects of enteral nutrition and parenteral nutrition on survival in patients with advanced cancer cachexia: Analysis of a multicenter prospective cohort study. Clinical Nutrition 2021;40:1168-75. [DOI: 10.1016/j.clnu.2020.07.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
154 Reif K, de Vries U, Petermann F, Görres S. A patient education program is effective in reducing cancer-related fatigue: a multi-centre randomised two-group waiting-list controlled intervention trial. Eur J Oncol Nurs 2013;17:204-13. [PMID: 22898654 DOI: 10.1016/j.ejon.2012.07.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
155 Brunelli A, Salati M, Refai M, Xiumé F, Rocco G, Sabbatini A. Risk-adjusted econometric model to estimate postoperative costs: An additional instrument for monitoring performance after major lung resection. The Journal of Thoracic and Cardiovascular Surgery 2007;134:624-9. [DOI: 10.1016/j.jtcvs.2007.03.057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
156 van Hulsteijn LT, Niemeijer ND, Dekkers OM, Corssmit EP. (131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis. Clin Endocrinol (Oxf). 2014;80:487-501. [PMID: 24118038 DOI: 10.1111/cen.12341] [Cited by in Crossref: 87] [Cited by in F6Publishing: 59] [Article Influence: 10.9] [Reference Citation Analysis]
157 Manning AM, Casper KA, Peter KS, Wilson KM, Mark JR, Collar RM. Can Predictive Modeling Identify Head and Neck Oncology Patients at Risk for Readmission? Otolaryngol Head Neck Surg 2018;159:669-74. [DOI: 10.1177/0194599818775938] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
158 Revenig LM, Canter DJ, Taylor MD, Tai C, Sweeney JF, Sarmiento JM, Kooby DA, Maithel SK, Master VA, Ogan K. Too Frail for Surgery? Initial Results of a Large Multidisciplinary Prospective Study Examining Preoperative Variables Predictive of Poor Surgical Outcomes. Journal of the American College of Surgeons 2013;217:665-670.e1. [DOI: 10.1016/j.jamcollsurg.2013.06.012] [Cited by in Crossref: 195] [Cited by in F6Publishing: 140] [Article Influence: 24.4] [Reference Citation Analysis]
159 van Meer S, de Man RA, Coenraad MJ, Sprengers D, van Nieuwkerk KM, Klümpen HJ, Jansen PL, IJzermans JN, van Oijen MG, Siersema PD. Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the Netherlands. J Hepatol. 2015;63:1156-1163. [PMID: 26100498 DOI: 10.1016/j.jhep.2015.06.012] [Cited by in Crossref: 76] [Cited by in F6Publishing: 59] [Article Influence: 12.7] [Reference Citation Analysis]
160 Sequist LV, Besse B, Lynch TJ, Miller VA, Wong KK, Gitlitz B, Eaton K, Zacharchuk C, Freyman A, Powell C. Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2010;28:3076-3083. [PMID: 20479403 DOI: 10.1200/jco.2009.27.9414] [Cited by in Crossref: 292] [Cited by in F6Publishing: 124] [Article Influence: 26.5] [Reference Citation Analysis]
161 Roos FC, Hampel C, Thüroff JW. Renal cancer surgery in the elderly: . Current Opinion in Urology 2009;19:459-64. [DOI: 10.1097/mou.0b013e32832f0c7d] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
162 Wang Z, Yan C, Zhang Z, Zhang C, Hu H, Tu W, Kirwan J, Mendenhall WM. Impact of Salivary Gland Dosimetry on Post-IMRT Recovery of Saliva Output and Xerostomia Grade for Head-and-Neck Cancer Patients Treated With or Without Contralateral Submandibular Gland Sparing: A Longitudinal Study. International Journal of Radiation Oncology*Biology*Physics 2011;81:1479-87. [DOI: 10.1016/j.ijrobp.2010.07.1990] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
163 Rossi CR, Foletto M, Di Filippo F, Vaglini M, Anza' M, Azzarelli A, Pilati P, Mocellin S, Lise M. Soft tissue limb sarcomas: Italian clinical trials with hyperthermic antiblastic perfusion. Cancer 1999;86:1742-9. [DOI: 10.1002/(sici)1097-0142(19991101)86:9<1742::aid-cncr16>3.0.co;2-g] [Cited by in Crossref: 68] [Cited by in F6Publishing: 4] [Article Influence: 3.1] [Reference Citation Analysis]
164 Ito T, Hanafusa N, Soneda N, Isoai A, Kobayashi R, Torii N, Kato M. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy against cirrhotic ascites in comparison with malignancy-related ascites. J Gastroenterol Hepatol 2021. [PMID: 34250635 DOI: 10.1111/jgh.15620] [Reference Citation Analysis]
165 Carmona-bayonas A, Font C, Jiménez-fonseca P, Fenoy F, Otero R, Beato C, Plasencia J, Biosca M, Sánchez M, Benegas M, Calvo-temprano D, Varona D, Faez L, Vicente M, de la Haba I, Antonio M, Madridano O, Ramchandani A, Castañón E, Marchena P, Martínez M, Martín M, Marín G, Ayala de la Peña F, Vicente V. On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism. Thrombosis Research 2016;143:76-85. [DOI: 10.1016/j.thromres.2016.05.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
166 Bhatia S, Hanna N, Ansari R, Pletcher W, Einhorn L, Ng E, Sandler A. A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancer. Lung Cancer 2002;38:73-7. [PMID: 12367796 DOI: 10.1016/s0169-5002(02)00145-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
167 Galli G, Triulzi T, Proto C, Signorelli D, Imbimbo M, Poggi M, Fucà G, Ganzinelli M, Vitali M, Palmieri D, Tessari A, de Braud F, Garassino MC, Colombo MP, Lo Russo G. Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer. Lung Cancer 2019;132:72-8. [DOI: 10.1016/j.lungcan.2019.04.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
168 Weiden PL, Breitz HB, Press O, Appelbaum JW, Bryan JK, Gaffigan S, Stone D, Axworthy D, Fisher D, Reno J. Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL): initial phase I/II study results. Cancer Biother Radiopharm 2000;15:15-29. [PMID: 10740649 DOI: 10.1089/cbr.2000.15.15] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 4.4] [Reference Citation Analysis]
169 Krok JL, Baker TA, Mcmillan SC. Age Differences in the Presence of Pain and Psychological Distress in Younger and Older Cancer Patients: . Journal of Hospice & Palliative Nursing 2013;15:107-13. [DOI: 10.1097/njh.0b013e31826bfb63] [Cited by in Crossref: 20] [Article Influence: 2.5] [Reference Citation Analysis]
170 Rapoport BL, Falkson G. Phase II clinical study of pirarubicin in hormone resistant prostate cancer. Invest New Drugs 1992;10:119-21. [DOI: 10.1007/bf00873129] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
171 Gadisa DA, Assefa M, Wang SH, Yimer G. Toxicity profile of Doxorubicin-Cyclophosphamide and Doxorubicin-Cyclophosphamide followed by Paclitaxel regimen and its associated factors among women with breast cancer in Ethiopia: A prospective cohort study. J Oncol Pharm Pract 2020;26:1912-20. [PMID: 32122234 DOI: 10.1177/1078155220907658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
172 Baser S, Shannon VR, Eapen GA, Jimenez CA, Onn A, Lin E, Morice RC. Smoking Cessation After Diagnosis of Lung Cancer Is Associated With a Beneficial Effect on Performance Status. Chest 2006;130:1784-90. [DOI: 10.1016/s0012-3692(15)50902-1] [Cited by in Crossref: 75] [Article Influence: 5.0] [Reference Citation Analysis]
173 Kim H, Park H, Kim EK. Risk factors for postoperative delirium in patients with colorectal cancer. J Clin Nurs 2021. [PMID: 34096659 DOI: 10.1111/jocn.15894] [Reference Citation Analysis]
174 Rifkin RM, Bell JA, DasMahapatra P, Hoole M, Lowe M, Curran C, Campbell S, Hou P, Romanus D. Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma. Pharmacoecon Open 2020;4:473-83. [PMID: 31605300 DOI: 10.1007/s41669-019-00184-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
175 Gouverneur A, Salvo F, Berdaï D, Moore N, Fourrier-Réglat A, Noize P. Inclusion of elderly or frail patients in randomized controlled trials of targeted therapies for the treatment of metastatic colorectal cancer: A systematic review. J Geriatr Oncol 2018;9:15-23. [PMID: 28844343 DOI: 10.1016/j.jgo.2017.08.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
176 Kampers J, Orjuela-grimm M, Schober T, Schulz TF, Stiefel M, Klein C, Körholz D, Mauz-körholz C, Kreipe H, Beier R, Maecker-kolhoff B. Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules. Leukemia & Lymphoma 2016;58:633-8. [DOI: 10.1080/10428194.2016.1205742] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
177 Giannini EG, Bucci L, Garuti F, Brunacci M, Lenzi B, Valente M, Caturelli E, Cabibbo G, Piscaglia F, Virdone R, Felder M, Ciccarese F, Foschi FG, Sacco R, Svegliati Baroni G, Farinati F, Rapaccini GL, Olivani A, Gasbarrini A, Di Marco M, Morisco F, Zoli M, Masotto A, Borzio F, Benvegnù L, Marra F, Colecchia A, Nardone G, Bernardi M, Trevisani F; for the Italian Liver Cancer (ITA.LI.CA) group. Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice. Hepatology 2018;67:1784-96. [DOI: 10.1002/hep.29668] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 16.3] [Reference Citation Analysis]
178 Hasegawa T, Kondo C, Sato Y, Inaba Y, Yamaura H, Kato M, Murata S, Onoda Y, Kuroda H, Sakao Y, Yatabe Y. Diagnostic Ability of Percutaneous Needle Biopsy Immediately After Radiofrequency Ablation for Malignant Lung Tumors: An Initial Experience. Cardiovasc Intervent Radiol 2016;39:1187-92. [PMID: 26968406 DOI: 10.1007/s00270-016-1324-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
179 Jones S, Stokoe C, Sborov M, Braun M, Ethirajan S, Kutteh L, Pippen J, Patel M, Paul D, Blum JL, Holmes FA, Myron MC, Cantrell J, Hartung NL, Look RM, Di Salle E, Davis JC, Ilegbodu D, Asmar L. The Effect of Tamoxifen or Exemestane on Bone Mineral Density During the First 2 Years of Adjuvant Treatment of Postmenopausal Women with Early Breast Cancer. Clinical Breast Cancer 2008;8:527-32. [DOI: 10.3816/cbc.2008.n.065] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
180 Katamura Y, Aikata H, Kimura Y, Kawaoka T, Takaki S, Waki K, Hiramatsu A, Kawakami Y, Takahashi S, Ishikawa M, Hieda M, Kakizawa H, Chayama K. Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases: Chemotherapy for hepatoma. Journal of Gastroenterology and Hepatology 2010;25:1117-22. [DOI: 10.1111/j.1440-1746.2009.06110.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
181 Ciftciler R, Demiroglu H, Buyukasık Y, Okay M, Aksu S, Sayınalp N, Malkan UY, Haznedaroglu IC, Ozcebe O, Goker H. Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients. Transfus Apher Sci 2018;57:752-5. [PMID: 30249531 DOI: 10.1016/j.transci.2018.09.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
182 Kurzrock R, Goel S, Wheler J, Hong D, Fu S, Rezai K, Morgan-linnell SK, Urien S, Mani S, Chaudhary I, Ghalib MH, Buchbinder A, Lokiec F, Mulcahy M. Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies: Phase 1 Study of EZN-2208. Cancer 2012;118:6144-51. [DOI: 10.1002/cncr.27647] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
183 Bedini AV, Tavecchio L, Milani F, Gramaglia A, Spreafico C, Marchianò A, Ravasi G. Non-resectable Stage IIIa-b lung carcinoma: a Phase II study on continuous infusion of cisplatin and concurrent radiotherapy (plus adjuvant surgery). Lung Cancer 1993;10:73-84. [DOI: 10.1016/0169-5002(93)90311-k] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
184 Pallis A, Wedding U, Lacombe D, Soubeyran P, Wildiers H. Questionnaires and instruments for a multidimensional assessment of the older cancer patient: What clinicians need to know? European Journal of Cancer 2010;46:1019-25. [DOI: 10.1016/j.ejca.2010.01.006] [Cited by in Crossref: 61] [Cited by in F6Publishing: 36] [Article Influence: 5.5] [Reference Citation Analysis]
185 Ohmachi K, Niitsu N, Uchida T, Kim SJ, Ando K, Takahashi N, Takahashi N, Uike N, Eom HS, Chae YS, Terauchi T, Tateishi U, Tatsumi M, Kim WS, Tobinai K, Suh C, Ogura M. Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma. JCO 2013;31:2103-9. [DOI: 10.1200/jco.2012.46.5203] [Cited by in Crossref: 107] [Cited by in F6Publishing: 27] [Article Influence: 13.4] [Reference Citation Analysis]
186 Ball DL, Burmeister BH, Ball DL, Burmeister BH. 3. Radiation therapy. Medical Journal of Australia 1997;166. [DOI: 10.5694/j.1326-5377.1997.tb123325.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
187 Vandecasteele K, Tummers P, Makar A, van Eijkeren M, Delrue L, Denys H, Lambert B, Beerens AS, Van den Broecke R, Lambein K, Fonteyne V, De Meerleer G. Postoperative intensity-modulated arc therapy for cervical and endometrial cancer: a prospective report on toxicity. Int J Radiat Oncol Biol Phys 2012;84:408-14. [PMID: 22377596 DOI: 10.1016/j.ijrobp.2011.12.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
188 Yamada S, Okumura H, Morishita E, Asakura H. Complete hemostasis achieved by factor XIII concentrate administration in a patient with bleeding after teeth extraction as a complication of aplastic anemia and chronic disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2020;31:274-8. [PMID: 32167951 DOI: 10.1097/MBC.0000000000000902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
189 Kujundžić M, Vogl T, Stimac D, Rustemović N, Hsi RA, Roh M, Katičić M, Cuenca R, Lustig R, Wang S. A Phase II safety and effect on time to tumor progression study of intratumoral light infusion technology using talaporfin sodium in patients with metastatic colorectal cancer. J Surg Oncol 2007;96:518-24. [DOI: 10.1002/jso.20832] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
190 Scholz M, Engel C, Loeffler M; the German High Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Model-based design of chemotherapeutic regimens that account for heterogeneity in leucopoenia. Br J Haematol 2006;132:723-35. [DOI: 10.1111/j.1365-2141.2005.05957.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
191 Baratti D, Scivales A, Balestra M, Ponzi P, Di Stasi F, Kusamura S, Laterza B, Deraco M. Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). European Journal of Surgical Oncology (EJSO) 2010;36:463-9. [DOI: 10.1016/j.ejso.2010.03.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
192 Witte RS, Elson P, Stewart JA, Malliard JA, Oken MM, Loehrer PJ. A phase II trial of melphalan or thioguanine in the treatment of patients with advanced renal cell cancer. Urologic Oncology: Seminars and Original Investigations 1996;2:96-8. [DOI: 10.1016/s1078-1439(96)00073-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
193 Asai N, Sakanashi D, Suematsu H, Kato H, Hagihara M, Nishiyama N, Koizumi Y, Yamagishi Y, Mikamo H. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan. J Infect Chemother 2018;24:505-9. [PMID: 29548627 DOI: 10.1016/j.jiac.2018.02.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
194 Fountzilas G, Papadimitriou C, Dafni U, Bafaloukos D, Skarlos D, Moulopoulos LA, Razis E, Kalofonos HP, Aravantinos G, Briassoulis E, Papakostas P, Abela K, Gogas E, Kosmidis P, Pavlidis N, Dimopoulos MA. Dose-Dense Sequential Chemotherapy With Epirubicin and Paclitaxel Versus the Combination, as First-Line Chemotherapy, in Advanced Breast Cancer: A Randomized Study Conducted by the Hellenic Cooperative Oncology Group. JCO 2001;19:2232-9. [DOI: 10.1200/jco.2001.19.8.2232] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
195 Robins HI, Longo WL, Steeves RA, Cohen JD, Schmitt CL, Neville AJ, O'Keefe S, Lagoni R, Riggs C. Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations. Int J Radiat Oncol Biol Phys 1990;18:909-20. [PMID: 2182581 DOI: 10.1016/0360-3016(90)90416-h] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
196 Österborg A, Udvardy M, Zaritskey A, Andersson P, Grosicki S, Mazur G, Kaplan P, Steurer M, Schuh A, Montillo M, Kryachok I, Middeke JM, Kulyaba Y, Rekhtman G, Gorczyca M, Daly S, Chang C, Lisby S, Gupta I. Phase III, randomized study of ofatumumab versus physicians’ choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemia. Leukemia & Lymphoma 2015;57:2037-46. [DOI: 10.3109/10428194.2015.1122783] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
197 Katagiri H, Takahashi M, Wakai K, Sugiura H, Kataoka T, Nakanishi K. Prognostic factors and a scoring system for patients with skeletal metastasis. The Journal of Bone and Joint Surgery British volume 2005;87-B:698-703. [DOI: 10.1302/0301-620x.87b5.15185] [Cited by in Crossref: 153] [Cited by in F6Publishing: 50] [Article Influence: 9.6] [Reference Citation Analysis]
198 Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto H, Morinaga S, Kainuma O, Imai K, Sata N, Hishinuma S, Ojima H, Yamaguchi R, Hirano S, Sudo T, Ohashi Y; JASPAC 01 Study Group. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet. 2016;388:248-257. [PMID: 27265347 DOI: 10.1016/s0140-6736(16)30583-9] [Cited by in Crossref: 460] [Cited by in F6Publishing: 153] [Article Influence: 92.0] [Reference Citation Analysis]
199 Takahashi H, Ohigashi H, Gotoh K, Marubashi S, Yamada T, Murata M, Ioka T, Uehara H, Yano M, Ishikawa O. Preoperative gemcitabine-based chemoradiation therapy for resectable and borderline resectable pancreatic cancer. Ann Surg. 2013;258:1040-1050. [PMID: 23799421 DOI: 10.1097/sla.0b013e31829b3ce4] [Cited by in Crossref: 100] [Cited by in F6Publishing: 33] [Article Influence: 14.3] [Reference Citation Analysis]
200 Steven A, Leisz S, Fussek S, Nowroozizadeh B, Huang J, Branstetter D, Dougall WC, Burchardt M, Belldegrun AS, Seliger B, Pantuck A, Kroeger N. Receptor activator of NF-κB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinoma. Urol Oncol 2018;36:502.e15-24. [PMID: 30170981 DOI: 10.1016/j.urolonc.2018.07.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
201 Javier NS, Montagnini ML. Rehabilitation of the hospice and palliative care patient. J Palliat Med. 2011;14:638-648. [PMID: 21592031 DOI: 10.1089/jpm.2010.0125] [Cited by in Crossref: 59] [Cited by in F6Publishing: 25] [Article Influence: 5.9] [Reference Citation Analysis]
202 Caplan A, Bateman-House A, Waldstreicher J, Fedor L, Sonty R, Roccia T, Ukropec J, Jansson R. A Pilot Experiment in Responding to Individual Patient Requests for Compassionate Use of an Unapproved Drug: The Compassionate Use Advisory Committee (CompAC). Ther Innov Regul Sci 2019;53:243-8. [PMID: 29714573 DOI: 10.1177/2168479018759659] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
203 Gómez-aguirre N, Fuertes-ruiz D, Gracia-tello B, Clemente-sarasa C, Artajona-rodrigo E, Cabrerizo-garcía J, de Escalante-yangüela B, Bueno-castel M, Velilla-marco J, Díez-manglano J; the researchers of the PALIARAGON Study. External validation of the PALIAR index for patients with advanced, nononcologic chronic diseases. Aging Clin Exp Res 2019;31:393-402. [DOI: 10.1007/s40520-018-0980-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
204 Green D, de Leon SP, Leon-rodriguez E, Sosa-sanchez R. Adenocarcinoma of the Stomach: Univariate and Multivariate Analysis of Factors Associated With Survival: . American Journal of Clinical Oncology 2002;25:84-9. [DOI: 10.1097/00000421-200202000-00018] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
205 Tomoda T, Kato H, Ueki T, Akimoto Y, Hata H, Fujii M, Harada R, Ogawa T, Wato M, Takatani M, Matsubara M, Kawai Y, Okada H. Combination of Diclofenac and Sublingual Nitrates Is Superior to Diclofenac Alone in Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography. Gastroenterology 2019; 156: 1753-1760. e1. [PMID: 30772342 DOI: 10.1053/j.gastro.2019.01.267] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
206 Barabasch A, Heinzel A, Bruners P, Kraemer NA, Kuhl CK. Diffusion-weighted MRI Is Superior to PET/CT in Predicting Survival of Patients Undergoing 90Y Radioembolization of Hepatic Metastases. Radiology 2018;288:764-73. [PMID: 29786487 DOI: 10.1148/radiol.2018170408] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
207 Doubek M, Brychtova Y, Panovska A, Sebejova L, Stehlikova O, Chovancova J, Malcikova J, Smardova J, Plevova K, Volfova P, Trbusek M, Mraz M, Bakesova D, Trizuljak J, Hadrabova M, Obrtlikova P, Karban J, Smolej L, Oltova A, Jelinkova E, Pospisilova S, Mayer J. Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study. Am J Hematol 2015;90:417-21. [PMID: 25645263 DOI: 10.1002/ajh.23964] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
208 Novara G, Secco S, Botteri M, De Marco V, Artibani W, Ficarra V. Factors predicting health-related quality of life recovery in patients undergoing surgical treatment for renal tumors: prospective evaluation using the RAND SF-36 Health Survey. Eur Urol 2010;57:112-20. [PMID: 19406562 DOI: 10.1016/j.eururo.2009.04.023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
209 Toyooka S, Soh J, Shien K, Sugimoto S, Yamane M, Oto T, Date H, Miyoshi S. Sacrificing the pulmonary arterial branch to the spared lobe is a risk factor of bronchopleural fistula in sleeve lobectomy after chemoradiotherapy. Eur J Cardiothorac Surg 2013;43:568-72. [PMID: 22659891 DOI: 10.1093/ejcts/ezs323] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
210 Noji T, Tsuchikawa T, Okamura K, Shichinohe T, Tanaka E, Hirano S. Surgical Outcome of Hilar Plate Resection: Extended Hilar Bile Duct Resection Without Hepatectomy. J Gastrointest Surg 2014;18:1131-7. [DOI: 10.1007/s11605-014-2490-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
211 Yeo TP, Burrell SA, Sauter PK, Kennedy EP, Lavu H, Leiby BE, Yeo CJ. A progressive postresection walking program significantly improves fatigue and health-related quality of life in pancreas and periampullary cancer patients. J Am Coll Surg 2012;214:463-75; discussion 475-7. [PMID: 22321518 DOI: 10.1016/j.jamcollsurg.2011.12.017] [Cited by in Crossref: 65] [Cited by in F6Publishing: 46] [Article Influence: 7.2] [Reference Citation Analysis]
212 Piha‐paul SA, Oh D, Ueno M, Malka D, Chung HC, Nagrial A, Kelley RK, Ros W, Italiano A, Nakagawa K, Rugo HS, Braud F, Varga AI, Hansen A, Wang H, Krishnan S, Norwood KG, Doi T. Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE ‐158 and KEYNOTE ‐028 studies. Int J Cancer 2020;147:2190-8. [DOI: 10.1002/ijc.33013] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 55.0] [Reference Citation Analysis]
213 Tobinai K, Igarashi T, Itoh K, Kobayashi Y, Taniwaki M, Ogura M, Kinoshita T, Hotta T, Aikawa K, Tsushita K, Hiraoka A, Matsuno Y, Nakamura S, Mori S, Ohashi Y; IDEC-C2B8 Japan Study Group. Japanese multicenter phase II and pharmacokinetic study of rituximab in relapsed or refractory patients with aggressive B-cell lymphoma. Ann Oncol 2004;15:821-30. [PMID: 15111353 DOI: 10.1093/annonc/mdh176] [Cited by in Crossref: 81] [Cited by in F6Publishing: 65] [Article Influence: 4.8] [Reference Citation Analysis]
214 Purcell SA, Wallengren O, Baracos VE, Lundholm K, Iresjö BM, Chu QSC, Ghosh SS, Prado CM. Determinants of change in resting energy expenditure in patients with stage III/IV colorectal cancer. Clin Nutr 2020;39:134-40. [PMID: 30975554 DOI: 10.1016/j.clnu.2018.12.038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
215 Macé J, Marjanovic N, Faranpour F, Mimoz O, Frerebeau M, Violeau M, Bourry PA, Guénézan J, Thille AW, Frat JP. Early high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure in the ED: A before-after study. Am J Emerg Med 2019;37:2091-6. [PMID: 30857910 DOI: 10.1016/j.ajem.2019.03.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
216 Gately L, Mclachlan S, Philip J, Ruben J, Dowling A. Long-term survivors of glioblastoma: a closer look. J Neurooncol 2018;136:155-62. [DOI: 10.1007/s11060-017-2635-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
217 Jung J, Lavrador J, Patel S, Giamouriadis A, Lam J, Bhangoo R, Ashkan K, Vergani F. First United Kingdom Experience of Navigated Transcranial Magnetic Stimulation in Preoperative Mapping of Brain Tumors. World Neurosurgery 2019;122:e1578-87. [DOI: 10.1016/j.wneu.2018.11.114] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 9.5] [Reference Citation Analysis]
218 Takahashi M, Niitsu H, Sakamoto K, Hinoi T, Hattori M, Goto M, Bando H, Hazama S, Maeda K, Okita K, Horie H, Watanabe M; Japan Society of Laparoscopic Colorectal Surgery. Survival benefit of lymph node dissection in surgery for colon cancer in elderly patients: A multicenter propensity score-matched study in Japan. Asian J Endosc Surg 2018;11:346-54. [PMID: 29601663 DOI: 10.1111/ases.12474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
219 Chen Y, Perng R, Shih J, Tsai C, Whang-peng J. Salvage Therapy for Chinese Non-small Cell Lung Cancer Patients Who Failed Previous Chemotherapy: . Journal of Thoracic Oncology 2006;1:545-50. [DOI: 10.1097/01243894-200607000-00008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
220 Di Blasi R, Cattaneo C, Lewis RE, Tumbarello M, Angelici L, Dragonetti G, Busca A, Cambò B, Candoni A, Cesarini M, Cesaro S, Delia M, Fanci R, Farina F, Garzia M, Giordano A, Martino B, Melillo L, Nadali G, Perriello V, Picardi M, Quinto AM, Salutari P, Spolzino A, Vacca A, Vetro C, Zancanella M, Nosari A, Aversa F, Pagano L; on the behalf of the SEIFEM group (Sorveglianza Epidemiologica Infezioni Fungine in Ematologia). Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL). Ann Hematol 2018;97:791-8. [PMID: 29411126 DOI: 10.1007/s00277-018-3252-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
221 Cavaletti G, Frigeni B, Lanzani F, Mattavelli L, Susani E, Alberti P, Cortinovis D, Bidoli P. Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools. Eur J Cancer 2010;46:479-94. [PMID: 20045310 DOI: 10.1016/j.ejca.2009.12.008] [Cited by in Crossref: 167] [Cited by in F6Publishing: 135] [Article Influence: 15.2] [Reference Citation Analysis]
222 Kim HL, Han KR, Zisman A, Figlin RA, Belldegrun AS. Cachexia-like symptoms predict a worse prognosis in localized t1 renal cell carcinoma. J Urol 2004;171:1810-3. [PMID: 15076282 DOI: 10.1097/01.ju.0000121440.82581.d3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
223 Ha FJ, Spain L, Dowling A, Kwan EM, Pezaro C, Day D, Chia PL, Tran B, Pook D, Weickhardt AJ. Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study. Asia Pac J Clin Oncol 2019;15:e97-e102. [PMID: 30701671 DOI: 10.1111/ajco.13109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
224 West MA, Astin R, Moyses HE, Cave J, White D, Levett DZH, Bates A, Brown G, Grocott MPW, Jack S. Exercise prehabilitation may lead to augmented tumor regression following neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Acta Oncologica 2019;58:588-95. [DOI: 10.1080/0284186x.2019.1566775] [Cited by in Crossref: 22] [Cited by in F6Publishing: 1] [Article Influence: 11.0] [Reference Citation Analysis]
225 Presant CA, Wolf W, Waluch V, Wiseman C, Kennedy P, Blayney D, Brechner RR. Association of intratumoral pharmacokinetics of fluorouracil with clinical response. Lancet 1994;343:1184-7. [PMID: 7909867 DOI: 10.1016/s0140-6736(94)92399-x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
226 Cha BH, Song HH, Kim YN, Jeon WJ, Lee SJ, Kim JD, Lee HH, Lee BS, Lee SH. Percutaneous cholecystostomy is appropriate as definitive treatment for acute cholecystitis in critically ill patients: a single center, cross-sectional study. Korean J Gastroenterol. 2014;63:32-38. [PMID: 24463286 DOI: 10.4166/kjg.2014.63.1.32] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.9] [Reference Citation Analysis]
227 Grose D, Devereux G, Milroy R. Comorbidity in Lung Cancer: Important but Neglected. A Review of the Current Literature. Clinical Lung Cancer 2011;12:207-11. [DOI: 10.1016/j.cllc.2011.03.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
228 Perri G, Prakash L, Qiao W, Varadhachary GR, Wolff R, Fogelman D, Overman M, Pant S, Javle M, Koay EJ, Herman J, Kim M, Ikoma N, Tzeng C, Lee JE, Katz MHG. Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma. Annals of Surgery 2020;271:996-1002. [DOI: 10.1097/sla.0000000000003763] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 5.5] [Reference Citation Analysis]
229 Orphanos G, Alexopoulos A, Malliou S, Ioannidis G, Ardavanis A, Kandylis C, Stavrakakis J, Rigatos G. A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines. J Cancer Res Clin Oncol 2010;136:115-21. [DOI: 10.1007/s00432-009-0642-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
230 Huaringa AJ, Francis WH. Outcome of invasive mechanical ventilation in cancer patients: Intubate or not to intubate a patient with cancer. J Crit Care 2019;50:87-91. [PMID: 30502688 DOI: 10.1016/j.jcrc.2018.11.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
231 Nishi D, Matsuoka Y, Nakajima S, Noguchi H, Kim Y, Kanba S, Schnyder U. Are patients after severe injury who drop out of a longitudinal study at high risk of mental disorder? Comprehensive Psychiatry 2008;49:393-8. [DOI: 10.1016/j.comppsych.2008.02.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
232 Lin T, Chen S, Chen Y, Chang Y, Lin C. Intramucosal variant of nasal natural killer (NK)/T cell lymphoma has a better survival than does invasive variant: implication on loss of E26 transformation-specific sequence 1 (ETS-1) and T-box expressed in T cells (T-bet) with invasion: Intramucosal nasal NK/T cell lymphoma. Histopathology 2012;60:287-95. [DOI: 10.1111/j.1365-2559.2011.04086.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
233 Stuart-harris R, Raghavan D, Fox RH, Peretz G, Crombie C, Teriana N, Young I, Bye P, Tiver K, Green D. CHEMOTHERAPY FOR SMALL CELL LUNG CANCER: INPUCTION AND REINDUCTION WITH VOCA. Australian and New Zealand Journal of Medicine 1987;17:279-82. [DOI: 10.1111/j.1445-5994.1987.tb01225.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
234 Frost JD, Hank JA, Reaman GH, Frierdich S, Seeger RC, Gan J, Anderson PM, Ettinger LJ, Cairo MS, Blazar BR, Krailo MD, Matthay KK, Reisfeld RA, Sondel PM. A Phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: A report of the Children's Cancer Group. Cancer 1997;80:317-33. [DOI: 10.1002/(sici)1097-0142(19970715)80:2<317::aid-cncr21>3.0.co;2-w] [Cited by in Crossref: 109] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
235 Mystakidou K, Parpa E, Tsilika E, Galanos A, Vlahos L. General perceived self-efficacy: validation analysis in Greek cancer patients. Support Care Cancer 2008;16:1317-22. [DOI: 10.1007/s00520-008-0443-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
236 Jo M, Yasui K, Kirishima T, Shima T, Niimi T, Katayama T, Mori T, Funaki J, Sumida Y, Fujii H, Takami S, Kimura H, Mitsumoto Y, Minami M, Yamaguchi K, Yoshinami N, Mizuno M, Sendo R, Tanaka S, Shintani H, Kagawa K, Okanoue T, Itoh Y. Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinoma. Hepatol Res. 2014;44:1329-1338. [PMID: 24528772 DOI: 10.1111/hepr.12308] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
237 Horita N, Koblizek V, Plutinsky M, Novotna B, Hejduk K, Kaneko T. Chronic obstructive pulmonary disease prognostic score: A new index. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2016;160:211-8. [PMID: 27364317 DOI: 10.5507/bp.2016.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
238 Keegan THM, Moy LM, Foran JM, Alizadeh AA, Chang ET, Shema SJ, Schupp CW, Clarke CA, Glaser SL. Rituximab use and survival after diffuse large B-cell or follicular lymphoma: a population-based study. Leukemia & Lymphoma 2012;54:743-51. [DOI: 10.3109/10428194.2012.727415] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
239 Valeberg BT, Grov EK. Symptoms in the cancer patient – Of importance for their caregivers' quality of life and mental health? European Journal of Oncology Nursing 2013;17:46-51. [DOI: 10.1016/j.ejon.2012.01.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
240 Borden EC, Kim K, Ryan L, Blum RH, Shiraki M, Tormey DC, Comis RL, Hahn RG, Parkinson DR. Phase II trials of interferons-alpha and -beta in advanced sarcomas. J Interferon Res 1992;12:455-8. [PMID: 1289413 DOI: 10.1089/jir.1992.12.455] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
241 Chen C, Puvvada S. Prognostic Factors for Chronic Lymphocytic Leukemia. Curr Hematol Malig Rep 2016;11:37-42. [DOI: 10.1007/s11899-015-0294-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
242 Yoon JY, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH. Outcomes of secondary self-expandable metal stents versus surgery after delayed initial palliative stent failure in malignant colorectal obstruction. Digestion. 2013;88:46-55. [PMID: 23880524 DOI: 10.1159/000351208] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
243 Badgwell B, Krouse R, Cormier J, Guevara C, Klimberg VS, Ferrell B. Frequent and early death limits quality of life assessment in patients with advanced malignancies evaluated for palliative surgical intervention. Ann Surg Oncol 2012;19:3651-8. [PMID: 22669450 DOI: 10.1245/s10434-012-2420-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
244 Robenshtok E, Paul M, Leibovici L, Fraser A, Pitlik S, Ostfeld I, Samra Z, Perez S, Lev B, Weinberger M. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes. J Hosp Infect 2006;64:282-7. [PMID: 16930770 DOI: 10.1016/j.jhin.2006.06.025] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
245 Chua TC, Baker B, Yan TD, Zhao J, Morris DL. Palliative effects of an incomplete cytoreduction combined with perioperative intraperitoneal chemotherapy. Am J Clin Oncol. 2010;33:568-571. [PMID: 20019578 DOI: 10.1097/coc.0b013e3181b9cf47] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
246 Moth EB, Kiely BE, Stefanic N, Naganathan V, Martin A, Grimison P, Stockler MR, Beale P, Blinman P. Oncologists' perceptions on the usefulness of geriatric assessment measures and the CARG toxicity score when prescribing chemotherapy for older patients with cancer. Journal of Geriatric Oncology 2019;10:210-5. [DOI: 10.1016/j.jgo.2018.11.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
247 Pietrosi G, Miraglia R, Luca A, Vizzini GB, Fili' D, Riccardo V, D'Antoni A, Petridis I, Maruzzelli L, Biondo D, Gridelli B. Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis. J Vasc Interv Radiol. 2009;20:896-902. [PMID: 19497762 DOI: 10.1016/j.jvir.2009.03.032] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
248 Falkson G, Gelman RS, Tormey DC, Cummings FJ, Carbone PP, Falkson HC. The eastern cooperative oncology group experience with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer. Cancer 1985;56:219-24. [DOI: 10.1002/1097-0142(19850715)56:2<219::aid-cncr2820560202>3.0.co;2-q] [Cited by in Crossref: 25] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
249 Duletić-načinović A, Štifter S, Marijić B, Lučin K, Valković T, Petranović D, Jonjić N. Serum IL-6, IL-8, IL-10 and Beta 2 -Microglobulin in Association with International Prognostic Index in Diffuse Large B Cell Lymphoma. Tumori 2008;94:511-7. [DOI: 10.1177/030089160809400412] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 5.7] [Reference Citation Analysis]
250 Benson DM Jr, Smith MK. Effectiveness of lenalidomide (Revlimid) for the treatment of plasma cell leukemia. Leuk Lymphoma 2007;48:1423-5. [PMID: 17613775 DOI: 10.1080/10428190701361851] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
251 Edbrooke L, Denehy L, Patrick C, Tuffaha H. Cost-effectiveness analysis of home-based rehabilitation compared to usual care for people with inoperable lung cancer. Eur J Cancer Care (Engl) 2021. [PMID: 34396615 DOI: 10.1111/ecc.13501] [Reference Citation Analysis]
252 Reponen E, Tuominen H, Hernesniemi J, Korja M. Modified Rankin Scale and Short-Term Outcome in Cranial Neurosurgery: A Prospective and Unselected Cohort Study. World Neurosurg 2016;91:567-573.e7. [PMID: 27060513 DOI: 10.1016/j.wneu.2016.03.102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
253 Mcmahon JD, Maciver C, Smith M, Stathopoulos P, Wales C, Mcnulty R, Handley TP, Devine JC. Postoperative complications after major head and neck surgery with free flap repair—prevalence, patterns, and determinants: a prospective cohort study. British Journal of Oral and Maxillofacial Surgery 2013;51:689-95. [DOI: 10.1016/j.bjoms.2013.04.015] [Cited by in Crossref: 54] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
254 Aye PS, McKeage MJ, Tin Tin S, Khwaounjoo P, Elwood JM. Factors associated with overall survival in a population-based cohort of non- squamous NSCLC patients from northern New Zealand: A comparative analysis by EGFR mutation status. Cancer Epidemiol 2020;69:101847. [PMID: 33126040 DOI: 10.1016/j.canep.2020.101847] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
255 Carlson K, Ocean AJ. Peripheral neuropathy with microtubule-targeting agents: occurrence and management approach. Clin Breast Cancer 2011;11:73-81. [PMID: 21569993 DOI: 10.1016/j.clbc.2011.03.006] [Cited by in Crossref: 96] [Cited by in F6Publishing: 71] [Article Influence: 9.6] [Reference Citation Analysis]
256 Opstelten JL, de Wijkerslooth LR, Leenders M, Bac DJ, Brink MA, Loffeld BC, Meijnen-Bult MJ, Minderhoud IM, Verhagen MA, van Oijen MG, Siersema PD. Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions. Dis Esophagus. 2017;30:1-7. [PMID: 26919349 DOI: 10.1111/dote.12478] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
257 Cowan AJ, Altemeier WA, Johnston C, Gernsheimer T, Becker PS. Management of Acute Myeloid Leukemia in the Intensive Care Setting. J Intensive Care Med 2015;30:375-84. [DOI: 10.1177/0885066614530959] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
258 Chang AY, Tu ZN, Bryan GT, Kirkwood JM, Oken MM, Trump DL. Phase II study of echinomycin in the treatment of renal cell carcinoma ECOG study E2885. Invest New Drugs 1994;12:151-3. [DOI: 10.1007/bf00874447] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
259 Zaitsu J, Yamasaki T, Saeki I, Harima Y, Iwamoto T, Harima Y, Matsumoto T, Urata Y, Hidaka I, Marumoto Y. Serum transferrin as a predictor of prognosis for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma. Hepatol Res. 2014;44:481-490. [PMID: 23607437 DOI: 10.1111/hepr.12141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
260 Romito F, Cormio C, De Padova S, Lorusso V, Berio MA, Fimiani F, Piattelli A, Palazzo S, Abram G, Dudine L, Guglielmi A, Galise I, Romito S, Mattioli V. Patients attitudes towards sleep disturbances during chemotherapy. Eur J Cancer Care (Engl) 2014;23:385-93. [PMID: 23947497 DOI: 10.1111/ecc.12106] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
261 Adelstein DJ. Clinical trial design in head and neck cancer: what has the oncologist learned? Lancet Oncol 2012;13:e318-23. [PMID: 22748271 DOI: 10.1016/S1470-2045(12)70119-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
262 Argyriou AA, Polychronopoulos P, Koutras A, Iconomou G, Iconomou A, Kalofonos HP, Chroni E. Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted? Support Care Cancer 2005;13:647-51. [DOI: 10.1007/s00520-005-0776-9] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
263 Mohammadi S, Malek Mohammadi A, Norooznezhad AH, Heshmati F, Alimoghaddam K, Ghavamzadeh A. Extra corporeal photochemotherapy in steroid refractory graft versus host disease: A review of guidelines and recommendations. Transfus Apher Sci 2017;56:376-84. [PMID: 28359604 DOI: 10.1016/j.transci.2017.01.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
264 Ni XF, Wu P, Wu CP, Ji M, Wu J, Gu XF, Jiang ZX. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer. Asia Pac J Clin Oncol 2015;11:e22-30. [PMID: 24889374 DOI: 10.1111/ajco.12091] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
265 Shin J, Cho SJ, Lee J, Choi YS. Validation of the Korean Version of the Breakthrough Pain Assessment Tool in Cancer Patients. Journal of Pain and Symptom Management 2017;54:361-7. [DOI: 10.1016/j.jpainsymman.2017.07.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
266 Yennurajalingam S, Astolfi A, Indio V, Beccaro M, Schipani A, Yu R, Shete S, Reyes-Gibby C, Lu Z, Williams JL, Yeun SC, Anderson AE, Biasco G, Bruera E. Genetic Factors Associated With Pain Severity, Daily Opioid Dose Requirement, and Pain Response Among Advanced Cancer Patients Receiving Supportive Care. J Pain Symptom Manage 2021:S0885-3924(21)00278-5. [PMID: 33848569 DOI: 10.1016/j.jpainsymman.2021.03.024] [Reference Citation Analysis]
267 Nakano M, Kawanishi Y, Kuriya Y, Iwase O, Miyazawa K, Aizawa S, Yamasawa I. Spontaneous reduction of leukemic lymphoma cells possibly by anti-tumor antibody-mediated phagocytosis; a κ λ-dual-positive B cell lymphoma. Leukemia 2000;14:278-84. [DOI: 10.1038/sj.leu.2401667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
268 Rhondali W, Perceau E, Berthiller J, Saltel P, Trillet-lenoir V, Tredan O, Coulon J, Bruera E, Filbet M. Frequency of depression among oncology outpatients and association with other symptoms. Support Care Cancer 2012;20:2795-802. [DOI: 10.1007/s00520-012-1401-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
269 Yokoyama H, Morishima Y, Fuji S, Uchida N, Takahashi S, Onizuka M, Tanaka M, Yuju O, Eto T, Ozawa Y, Takada S, Takanashi M, Kato K, Kanda Y, Ichinohe T, Atsuta Y, Kanda J. Impact of HLA Allele Mismatch at HLA-A, -B, -C, and -DRB1 in Single Cord Blood Transplantation. Biology of Blood and Marrow Transplantation 2020;26:519-28. [DOI: 10.1016/j.bbmt.2019.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
270 Hansen MJ, Enright RD, Klatt J, Baskin TW. A Palliative Care Intervention in Forgiveness Therapy for Elderly Terminally Ill Cancer Patients. J Palliat Care 2009;25:51-60. [DOI: 10.1177/082585970902500106] [Cited by in Crossref: 48] [Cited by in F6Publishing: 25] [Article Influence: 16.0] [Reference Citation Analysis]
271 Zhang W, Tanaka M, Sugimoto Y, Takigawa T, Ozaki T. Carbon-ion radiotherapy of spinal osteosarcoma with long-term follow. Eur Spine J 2016;25:113-7. [DOI: 10.1007/s00586-015-4202-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
272 Langer CJ, Li Y, Jennings T, DeConti RC, Nair S, Cohen RB, Forastiere AA; Eastern Cooperative Oncology Group. Phase II evaluation of 96-hour paclitaxel infusion in advanced (recurrent or metastatic) squamous cell carcinoma of the head and neck (E3395): a trial of the Eastern Cooperative Oncology Group. Cancer Invest 2004;22:823-31. [PMID: 15641479 DOI: 10.1081/cnv-200039628] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
273 Kabbinavar F, Hurwitz HI, Fehrenbacher L, Meropol NJ, Novotny WF, Lieberman G, Griffing S, Bergsland E. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol. 2003;21:60-65. [PMID: 12506171 DOI: 10.1200/jco.2003.10.066] [Cited by in Crossref: 1199] [Cited by in F6Publishing: 307] [Article Influence: 66.6] [Reference Citation Analysis]
274 van Dalen EC, Caron HN, Dickinson HO, Kremer LC, van Dalen EC. Cardioprotective interventions for cancer patients receiving anthracyclines. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd003917.pub3] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
275 Amer ME, El-Sayed SZ, El-Kheir WA, Gabr H, Gomaa AA, El-Noomani N, Hegazy M. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells. Eur J Gastroenterol Hepatol. 2011;23:936-941. [PMID: 21900788 DOI: 10.1097/meg.0b013e3283488b00] [Cited by in Crossref: 92] [Cited by in F6Publishing: 50] [Article Influence: 9.2] [Reference Citation Analysis]
276 Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, De La Taille A, Tostain J, Artibani W, Abbou CC. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2005;23:2763-2771. [PMID: 15837991 DOI: 10.1200/jco.2005.07.055] [Cited by in Crossref: 487] [Cited by in F6Publishing: 146] [Article Influence: 30.4] [Reference Citation Analysis]
277 Yoon JH, Cho BS, Kim HJ, Kim JH, Shin SH, Yahng SA, Lee SE, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW. Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status. Am J Hematol 2013;88:1074-81. [PMID: 23983148 DOI: 10.1002/ajh.23576] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
278 Rayar M, Sulpice L, Edeline J, Garin E, Levi Sandri GB, Meunier B, Boucher E, Boudjema K. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment. Ann Surg Oncol. 2015;22:3102-3108. [PMID: 25623598 DOI: 10.1245/s10434-014-4365-3] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
279 Mielke S, Sparreboom A, Mross K. Peripheral neuropathy: A persisting challenge in paclitaxel-based regimes. European Journal of Cancer 2006;42:24-30. [DOI: 10.1016/j.ejca.2005.06.030] [Cited by in Crossref: 128] [Cited by in F6Publishing: 103] [Article Influence: 8.5] [Reference Citation Analysis]
280 Bryant AS, Cerfolio RJ, Minnich DJ. Survival and quality of life at least 1 year after pneumonectomy. The Journal of Thoracic and Cardiovascular Surgery 2012;144:1139-45. [DOI: 10.1016/j.jtcvs.2012.07.083] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
281 Bierman P, Bagin R, Jagannath S, Vose J, Spitzer G, Kessinger A, Dicke K, Armitage J. High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: Long term follow-up in 128 patients. Annals of Oncology 1993;4:767-73. [DOI: 10.1093/oxfordjournals.annonc.a058662] [Cited by in Crossref: 120] [Cited by in F6Publishing: 94] [Article Influence: 4.3] [Reference Citation Analysis]
282 Sok M, Zavrl M, Greif B, Srpčič M. Objective assessment of WHO/ECOG performance status. Support Care Cancer 2019;27:3793-8. [DOI: 10.1007/s00520-018-4597-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
283 Yanada M, Fukuda T, Tanaka M, Ota S, Toya T, Mori T, Uchida N, Ozawa Y, Nakamae H, Kanda Y, Ichinohe T, Atsuta Y, Yano S. Long-term results of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemia: a retrospective analysis of 10-year follow-up data. Bone Marrow Transplant 2020;55:2008-16. [PMID: 32203266 DOI: 10.1038/s41409-020-0868-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
284 Gade G, Venohr I, Conner D, McGrady K, Beane J, Richardson RH, Williams MP, Liberson M, Blum M, Della Penna R. Impact of an inpatient palliative care team: a randomized control trial. J Palliat Med 2008;11:180-90. [PMID: 18333732 DOI: 10.1089/jpm.2007.0055] [Cited by in Crossref: 363] [Cited by in F6Publishing: 266] [Article Influence: 27.9] [Reference Citation Analysis]
285 Coucke PA, Notter M, Stamm B, Matter M, Fasolini F, Schlumpf R, Matzinger O, Bouzourene H; All Surgeons From Public Hospitals And Private Clinics. Preoperative hyper-fractionated accelerated radiotherapy (HART) in locally advanced rectal cancer (LARC) immediately followed by surgery. A prospective phase II trial. Radiother Oncol 2006;79:52-8. [PMID: 16564590 DOI: 10.1016/j.radonc.2006.02.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
286 Han K, Bleumer I, Pantuck AJ, Kim HL, Dorey FJ, Janzen NK, Zisman A, Dinney CP, Wood CG, Swanson DA, Said JW, Figlin RA, Mulders PF, Belldegrun AS. Validation of an Integrated Staging System Toward Improved Prognostication of Patients With Localized Renal Cell Carcinoma in an International Population. Journal of Urology 2003;170:2221-4. [DOI: 10.1097/01.ju.0000096049.64863.a1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
287 Ford HER, Marshall A, Bridgewater JA, Janowitz T, Coxon FY, Wadsley J, Mansoor W, Fyfe D, Madhusudan S, Middleton GW, Swinson D, Falk S, Chau I, Cunningham D, Kareclas P, Cook N, Blazeby JM, Dunn JA. Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial. The Lancet Oncology 2014;15:78-86. [DOI: 10.1016/s1470-2045(13)70549-7] [Cited by in Crossref: 326] [Cited by in F6Publishing: 159] [Article Influence: 46.6] [Reference Citation Analysis]
288 Davies AN, Patel SD, Gregory A, Lee B. Observational study of sleep disturbances in advanced cancer. BMJ Support Palliat Care 2017;7:435-40. [DOI: 10.1136/bmjspcare-2017-001363] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
289 Hara T, Omura K, Hirano M, Asada Y, Munemoto Y, Sakamoto J. A phase I study of paclitaxel, cisplatin, and fluorouracil (TCF) for advanced gastric cancer. Cancer Chemother Pharmacol 2007;59:631-6. [PMID: 16924496 DOI: 10.1007/s00280-006-0305-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
290 Zhang L, Wang N, Zhang J, Liu J, Luo Z, Sun W, Woo SM, Chen C, Zhang K, Miller AR, Guo H, Zhang X, Wang C. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China. Palliat Med 2016;30:401-8. [PMID: 26121985 DOI: 10.1177/0269216315593671] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
291 Berger AK, Abel U, Komander C, Harig S, Jäger D, Springfeld C. Chemotherapy for advanced pancreatic adenocarcinoma in elderly patients (≥70 years of age): a retrospective cohort study at the National Center for Tumor Diseases Heidelberg. Pancreatology. 2014;14:211-215. [PMID: 24854617 DOI: 10.1016/j.pan.2014.03.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
292 Jackson RS, Stepan K, Bollig C, Sharma RK, Patel M, Massa S, Puram SV, Zevallos JP, Pipkorn P, Zenga J. Outcomes of HPV-Negative Oropharyngeal Cancer Treated With Transoral Robotic Surgery. Otolaryngol Head Neck Surg 2021;:194599821996647. [PMID: 33752484 DOI: 10.1177/0194599821996647] [Reference Citation Analysis]
293 Rantala ES, Kivelä TT, Hernberg MM. Impact of staging on survival outcomes: a nationwide real-world cohort study of metastatic uveal melanoma. Melanoma Res 2021;31:224-31. [PMID: 33595243 DOI: 10.1097/CMR.0000000000000728] [Reference Citation Analysis]
294 von Roemeling R, Rabatin JT, Fraley EE, Hrushesky WJ. Progressive Metastatic Renal Cell Carcinoma Controlled by Continuous 5-Fluoro-2-Deoxyuridine Infusion. Journal of Urology 1988;139:259-62. [DOI: 10.1016/s0022-5347(17)42381-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
295 Tseng S, Chiou Y, Lee Y, Perng R, Jacqueline W, Chen Y. Number of liver metastatic nodules affects treatment options for pulmonary adenocarcinoma patients with liver metastases. Lung Cancer 2014;86:225-30. [DOI: 10.1016/j.lungcan.2014.09.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
296 Marín-conde F, Castellanos-cosano L, Pachón-ibañez J, Serrera-figallo M, Gutiérrez-pérez J, Torres-lagares D. Photobiomodulation with low-level laser therapy reduces oral mucositis caused by head and neck radio-chemotherapy: prospective randomized controlled trial. International Journal of Oral and Maxillofacial Surgery 2019;48:917-23. [DOI: 10.1016/j.ijom.2018.12.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
297 Elkin EB, Kim SH, Casper ES, Kissane DW, Schrag D. Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions. J Clin Oncol 2007;25:5275-80. [PMID: 18024875 DOI: 10.1200/JCO.2007.11.1922] [Cited by in Crossref: 225] [Cited by in F6Publishing: 70] [Article Influence: 16.1] [Reference Citation Analysis]
298 Mystakidou K, Tsilika E, Parpa E, Galanos A, Vlahos L. Caregivers of Advanced Cancer Patients: Feelings of Hopelessness and Depression. Cancer Nursing 2007;30:412-8. [DOI: 10.1097/01.ncc.0000290807.84076.73] [Cited by in Crossref: 41] [Cited by in F6Publishing: 7] [Article Influence: 2.9] [Reference Citation Analysis]
299 Mizumoto M, Harada H, Asakura H, Hashimoto T, Furutani K, Hashii H, Murata H, Takagi T, Katagiri H, Takahashi M, Nishimura T. Radiotherapy for Patients With Metastases to the Spinal Column: A Review of 603 Patients at Shizuoka Cancer Center Hospital. International Journal of Radiation Oncology*Biology*Physics 2011;79:208-13. [DOI: 10.1016/j.ijrobp.2009.10.056] [Cited by in Crossref: 66] [Cited by in F6Publishing: 43] [Article Influence: 6.6] [Reference Citation Analysis]
300 Avisar N, Adar L, Bock J, Müller U, Shen D, Barash S, Pukac L. First-in-human, phase I/IIa dose-escalation and safety study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy. Cancer Chemother Pharmacol 2015;75:929-39. [DOI: 10.1007/s00280-015-2703-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
301 Søreide JA, Tholfsen T, Karlsen LN, Kvaløy JT, Kørner H. Palliative surgical outcome score (PSOS) in patients treated palliatively with self-expanding metal stent (SEMS) for malignant incurable colorectal obstruction. Surg Oncol 2019;29:134-9. [PMID: 31196477 DOI: 10.1016/j.suronc.2019.04.006] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
302 Shitara T, Shimada A, Hanada R, Matsunaga T, Kawa K, Mugishima H, Sugimoto T, Mimaya J, Manabe A, Tsurusawa M, Tsuchida Y. Irinotecan for children with relapsed solid tumors. Pediatr Hematol Oncol 2006;23:103-10. [PMID: 16651238 DOI: 10.1080/08880010500457152] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
303 Filosso PL, Guerrera F, Evangelista A, Welter S, Thomas P, Casado PM, Rendina EA, Venuta F, Ampollini L, Brunelli A, Stella F, Nosotti M, Raveglia F, Larocca V, Rena O, Margaritora S, Ardissone F, Travis WD, Sarkaria I, Sagan D. Prognostic model of survival for typical bronchial carcinoid tumours: analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group. Eur J Cardiothorac Surg 2015;48:441-7. [DOI: 10.1093/ejcts/ezu495] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
304 de la Torre-montero J, Montealegre-sanz M, Faraldo-cabana A, Oliva-pellicer B, García-real I, Fenwick M, Cáceres EM, Rivas-eguía B, Vila-borrajo C, Valles-andrés J, Alonso-gordoa T, García-carrión C, García ED, Beneit-montesinos J. Venous International Assessment, VIA Scale, Validated Classification Procedure for the Peripheral Venous System. J Vasc Access 2014;15:45-50. [DOI: 10.5301/jva.5000173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
305 Ryan DA, Gallagher P, Wright S, Cassidy EM. Sensitivity and specificity of the Distress Thermometer and a two-item depression screen (Patient Health Questionnaire-2) with a 'help' question for psychological distress and psychiatric morbidity in patients with advanced cancer. Psychooncology 2012;21:1275-84. [PMID: 21919118 DOI: 10.1002/pon.2042] [Cited by in Crossref: 47] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
306 Murphy RA, Bureyko TF, Mourtzakis M, Chu QS, Clandinin MT, Reiman T, Mazurak VC. Aberrations in Plasma Phospholipid Fatty Acids in Lung Cancer Patients. Lipids 2012;47:363-9. [DOI: 10.1007/s11745-011-3641-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
307 Chang P, Lai Y, Shun S, Lin L, Chen M, Yang Y, Tsai J, Huang G, Cheng S. Effects of a Walking Intervention on Fatigue-Related Experiences of Hospitalized Acute Myelogenous Leukemia Patients Undergoing Chemotherapy: A Randomized Controlled Trial. Journal of Pain and Symptom Management 2008;35:524-34. [DOI: 10.1016/j.jpainsymman.2007.06.013] [Cited by in Crossref: 80] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
308 Helseth R, Helseth E, Johannesen TB, Langberg CW, Lote K, Rønning P, Scheie D, Vik A, Meling TR. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme: Survival, prognostic factors, and repeat surgery in GBM patients. Acta Neurologica Scandinavica 2010;122:159-67. [DOI: 10.1111/j.1600-0404.2010.01350.x] [Cited by in Crossref: 127] [Cited by in F6Publishing: 106] [Article Influence: 11.5] [Reference Citation Analysis]
309 Cereda E, Pedrazzoli P, Lobascio F, Masi S, Crotti S, Klersy C, Turri A, Stobäus N, Tank M, Franz K, Cutti S, Giaquinto E, Filippi AR, Norman K, Caccialanza R. The prognostic impact of BIA-derived fat-free mass index in patients with cancer. Clin Nutr 2021;40:3901-7. [PMID: 34134007 DOI: 10.1016/j.clnu.2021.04.024] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
310 Bliziotis IA, Michalopoulos A, Kasiakou SK, Samonis G, Christodoulou C, Chrysanthopoulou S, Falagas ME. Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials. Mayo Clin Proc 2005;80:1146-56. [PMID: 16178494 DOI: 10.4065/80.9.1146] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
311 Mystakidou K, Tsilika E, Parpa E, Smyrnioti M, Vlahos L. Assessing Spirituality and Religiousness in Advanced Cancer Patients. Am J Hosp Palliat Care 2007;23:457-63. [DOI: 10.1177/1049909106294880] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
312 Tomoda T, Kato H, Ueki T, Ogawa T, Hirao K, Akimoto Y, Matsumoto K, Horiguchi S, Tsutsumi K, Okada H. Efficacy of double-balloon enteroscopy-assisted endoscopic balloon dilatation combined with stent deployment for hepaticojejunostomy anastomotic stricture. Dig Endosc 2021. [PMID: 34324732 DOI: 10.1111/den.14097] [Reference Citation Analysis]
313 Nelson RP Jr, Cornetta K, Ward KE, Ramanuja S, Fausel C, Cripe LD. Desensitization to imatinib in patients with leukemia. Ann Allergy Asthma Immunol 2006;97:216-22. [PMID: 16937754 DOI: 10.1016/S1081-1206(10)60016-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
314 Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Nigudgi S. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy—a randomized controlled trial. Support Care Cancer 2013;21:1421-8. [DOI: 10.1007/s00520-012-1684-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
315 Yennurajalingam S, Edwards T, Arthur J, Lu Z, Erdogan E, Malik JS, Naqvi SMA, Wu J, Liu DD, Williams JL, Hui D, Reddy SK, Bruera E. The development of a nomogram to determine the frequency of elevated risk for non-medical opioid use in cancer patients. Palliat Support Care 2021;19:3-10. [PMID: 32729447 DOI: 10.1017/S1478951520000322] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
316 Koreth R, Weinert C, Weisdorf DJ, Key NS. Measurement of bleeding severity: a critical review: MEASUREMENT OF BLEEDING SEVERITY. Transfusion 2004;44:605-17. [DOI: 10.1111/j.1537-2995.2004.03153.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
317 Healy JM, Patel T, Lee S, Sanchez-Reilly S. Do symptoms matter when considering patients for phase I clinical trials?: a pilot study of older adults with advanced cancer. Am J Hosp Palliat Care 2011;28:463-6. [PMID: 21398266 DOI: 10.1177/1049909111400723] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
318 Bowden JCS, Williams LJ, Simms A, Price A, Campbell S, Fallon MT, Fearon KCH. Prediction of 90 Day and Overall Survival after Chemoradiotherapy for Lung Cancer: Role of Performance Status and Body Composition. Clin Oncol (R Coll Radiol) 2017;29:576-84. [PMID: 28652093 DOI: 10.1016/j.clon.2017.06.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
319 Annunziata MA, Muzzatti B, Mella S, Bidoli E. Fatigue, Quality of Life, and Mood States during Chemotherapy in Italian Cancer Patients. Tumori 2013;99:e28-33. [DOI: 10.1177/030089161309900129] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
320 Radzikowska E, Roszkowski-Sliz K, Chabowski M, Glaz P. Influence of delays in diagnosis and treatment on survival in small cell lung cancer patients. Adv Exp Med Biol 2013;788:355-62. [PMID: 23835998 DOI: 10.1007/978-94-007-6627-3_48] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
321 Homsi J, Bedikian AY, Papadopoulos NE, Kim KB, Hwu WJ, Mahoney SL, Hwu P. Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanoma. Melanoma Res 2010;20:507-10. [PMID: 20881508 DOI: 10.1097/CMR.0b013e3283403ce9] [Cited by in Crossref: 46] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
322 Sjölander H, Strømsnes T, Gerke O, Hess S. Value of FDG-PET/CT for treatment response in tuberculosis: a systematic review and meta-analysis. Clin Transl Imaging 2018;6:19-29. [DOI: 10.1007/s40336-017-0259-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
323 Deliberato RO, Escudero GG, Bulgarelli L, Neto AS, Ko SQ, Campos NS, Saat B, Amaro E Júnior, Lopes FS, Johnson AE. SEVERITAS: An externally validated mortality prediction for critically ill patients in low and middle-income countries. Int J Med Inform 2019;131:103959. [PMID: 31539837 DOI: 10.1016/j.ijmedinf.2019.103959] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
324 Naito K, Furuya H, Han C, Orita H, Sato K, Kaneko K, Obayashi O. Gastric cancer with metastases to the scaphoid: a case report. J Orthop Sci. 2015;20:213-216. [PMID: 23892427 DOI: 10.1007/s00776-013-0441-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
325 Takahashi H, Yamada D, Asukai K, Wada H, Hasegawa S, Hara H, Shinno N, Ushigome H, Haraguchi N, Sugimura K, Yamamoto K, Nishimura J, Yasui M, Omori T, Miyata H, Ohue M, Yano M, Sakon M, Ishikawa O. Clinical implications of the serum CA19-9 level in "biological borderline resectability" and "biological downstaging" in the setting of preoperative chemoradiation therapy for pancreatic cancer. Pancreatology 2020;20:919-28. [PMID: 32563596 DOI: 10.1016/j.pan.2020.05.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
326 Ludbrook JJ, Truong PT, MacNeil MV, Lesperance M, Webber A, Joe H, Martins H, Lim J. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? a community-based population analysis. Int J Radiat Oncol Biol Phys 2003;55:1321-30. [PMID: 12654444 DOI: 10.1016/s0360-3016(02)04576-5] [Cited by in Crossref: 97] [Cited by in F6Publishing: 18] [Article Influence: 5.4] [Reference Citation Analysis]
327 Sakamoto H, Kitano M, Suetomi Y, Takeyama Y, Ohyanagi H, Nakai T, Yasuda C, Kudo M. Comparison of standard-dose and low-dose gemcitabine regimens in pancreatic adenocarcinoma patients: a prospective randomized trial. J Gastroenterol 2006;41:70-6. [DOI: 10.1007/s00535-005-1724-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
328 Onishi T, Oishi Y, Suzuki Y, Asano K. Prognostic evaluation of transcatheter arterial embolization for unresectable renal cell carcinoma with distant metastasis. BJU Int 2001;87:312-5. [PMID: 11251521 DOI: 10.1046/j.1464-410x.2001.00070.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
329 Irie M, Nakanishi R, Yasuda M, Fujino Y, Hamada K, Hyodo M. Risk factors for short-term outcomes after thoracoscopic lobectomy for lung cancer. Eur Respir J 2016;48:495-503. [DOI: 10.1183/13993003.01939-2015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
330 Shen J, Dong X, Liu Z, Wang G, Yang J, Zhou F, Lu M, Ma X, Li Y, Tang C, Luo X, Zhao Q, Zhang J. Modularized laparoscopic regional en bloc mesogastrium excision (rEME) based on membrane anatomy for distal gastric cancer. Surg Endosc. 2018;32:4698-4705. [PMID: 30054740 DOI: 10.1007/s00464-018-6375-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
331 Récher C, Coiffier B, Haioun C, Molina TJ, Fermé C, Casasnovas O, Thiéblemont C, Bosly A, Laurent G, Morschhauser F, Ghesquières H, Jardin F, Bologna S, Fruchart C, Corront B, Gabarre J, Bonnet C, Janvier M, Canioni D, Jais J, Salles G, Tilly H. Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial. The Lancet 2011;378:1858-67. [DOI: 10.1016/s0140-6736(11)61040-4] [Cited by in Crossref: 229] [Cited by in F6Publishing: 64] [Article Influence: 22.9] [Reference Citation Analysis]
332 Webert KE, Arnold DM, Lui Y, Carruthers J, Arnold E, Heddle NM. A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia. Transfusion 2012;52:2466-74; quiz 2465. [PMID: 22486274 DOI: 10.1111/j.1537-2995.2012.03634.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
333 Yau JC, Dimopoulos MA, Huan SD, Tarrand JJ, Spencer V, Spitzer G, Meneghetti CM, Wallerstein RO, Andersson BS, LeMaistre CF. Prophylaxis of cytomegalovirus infection with ganciclovir in allogeneic marrow transplantation. Eur J Haematol 1991;47:371-6. [PMID: 1662140 DOI: 10.1111/j.1600-0609.1991.tb01863.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
334 Cocconi G, Passalacqua R, Foladore S, Carlini P, Acito L, Maiello E, Marchi M, Gebbia V, Di Sarra S, Beretta M, Bacchi M. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized study. Melanoma Res 2003;13:73-9. [PMID: 12569288 DOI: 10.1097/00008390-200302000-00012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
335 Galsky MD, Chen GJ, Oh WK, Bellmunt J, Roth BJ, Petrioli R, Dogliotti L, Dreicer R, Sonpavde G. Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma. Ann Oncol 2012;23:406-10. [PMID: 21543626 DOI: 10.1093/annonc/mdr156] [Cited by in Crossref: 127] [Cited by in F6Publishing: 88] [Article Influence: 12.7] [Reference Citation Analysis]
336 Dotti G, Fiocchi R, Motta T, Mammana C, Gotti E, Riva S, Cornelli P, Gridelli B, Viero P, Oldani E, Ferrazzi P, Remuzzi G, Barbui T, Rambaldi A. Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome. Transplantation 2002;74:1095-102. [PMID: 12438953 DOI: 10.1097/00007890-200210270-00007] [Cited by in Crossref: 108] [Cited by in F6Publishing: 83] [Article Influence: 5.7] [Reference Citation Analysis]
337 Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet 2001;358:1772-7. [PMID: 11734235 DOI: 10.1016/S0140-6736(01)06805-2] [Cited by in Crossref: 429] [Cited by in F6Publishing: 123] [Article Influence: 21.5] [Reference Citation Analysis]
338 Tseng CK, Lin CH, Hsu HS, Ho CT, Huang HY, Liu CS, Lin CC, Huang KC, Lin WY. In addition to malnutrition and renal function impairment, anemia is associated with hyponatremia in the elderly. Arch Gerontol Geriatr 2012;55:77-81. [PMID: 21763015 DOI: 10.1016/j.archger.2011.06.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
339 Gad KT, Johansen C, Duun-henriksen AK, Krøyer A, Olsen MH, Lassen U, Mau-sørensen M, Oksberg Dalton S. Socioeconomic Differences in Referral to Phase I Cancer Clinical Trials: A Danish Matched Cancer Case-Control Study. JCO 2019;37:1111-9. [DOI: 10.1200/jco.18.01983] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
340 Santoso AMM, Jansen F, Lissenberg-Witte BI, Baatenburg de Jong RJ, Langendijk JA, Leemans CR, Smit JH, Takes RP, Terhaard CHJ, van Straten A, Verdonck-de Leeuw IM. Sleep quality trajectories from head and neck cancer diagnosis to six months after treatment. Oral Oncol 2021;115:105211. [PMID: 33581506 DOI: 10.1016/j.oraloncology.2021.105211] [Reference Citation Analysis]
341 Graziano SL, Herndon JE, Richards F, Difino S, Modeas C, Duggan DB, Green MR. A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer a cancer and leukemia group B study. Cancer 1993;72:62-8. [DOI: 10.1002/1097-0142(19930701)72:1<62::aid-cncr2820720114>3.0.co;2-e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
342 Homma A, Sakashita T, Oridate N, Suzuki F, Suzuki S, Hatakeyama H, Mizumachi T, Taki S, Fukuda S. Importance of comorbidity in hypopharyngeal cancer. Head Neck 2010;32:148-53. [PMID: 19536763 DOI: 10.1002/hed.21158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
343 Díaz-díaz D, Villanova Martínez M, Palencia Herrejón E. Pacientes oncológicos ingresados en Unidad de Cuidados Intensivos. Análisis de factores predictivos de mortalidad. Medicina Intensiva 2018;42:346-53. [DOI: 10.1016/j.medin.2018.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
344 Lee J, Park HY, Jung D, Moon M, Keam B, Hahm B. Effect of brief psychoeducation using a tablet PC on distress and quality of life in cancer patients undergoing chemotherapy: a pilot study: Tablet PC-based psychoeducation on cancer patients' distress. Psycho-Oncology 2014;23:928-35. [DOI: 10.1002/pon.3503] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
345 Toffart A, Pizarro CA, Schwebel C, Sakhri L, Minet C, Duruisseaux M, Azoulay E, Moro-sibilot D, Timsit J. Selection criteria for intensive care unit referral of lung cancer patients: a pilot study. Eur Respir J 2015;45:491-500. [DOI: 10.1183/09031936.00118114] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
346 Sun CY, Huang CC, Tsai YS, Chang YT, Ou CH, Su WC, Fan SY, Wang ST, Yang DC, Huang CC, Chang CM. Clinical Frailty Scale in Predicting Postoperative Outcomes in Older Patients Undergoing Curative Surgery for Urologic Malignancies: A Prospective Observational Cohort Study. Urology 2020;144:38-45. [PMID: 32711011 DOI: 10.1016/j.urology.2020.06.069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
347 Takeda H, Nishikawa H, Osaki Y, Tsuchiya K, Joko K, Ogawa C, Taniguchi H, Orito E, Uchida Y, Izumi N; Japanese Red Cross Liver Study Group. Proposal of Japan Red Cross score for sorafenib therapy in hepatocellular carcinoma. Hepatol Res 2015;45:E130-40. [PMID: 25581351 DOI: 10.1111/hepr.12480] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
348 Hwang IC, Keam B, Yun YH, Ahn HY, Kim Y. Quality of life changes and intensive care preferences in terminal cancer patients. Pall Supp Care 2015;13:1309-16. [DOI: 10.1017/s147895151400131x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
349 Son KY, Lee CH, Park SM, Lee CH, Oh SI, Oh B, Tak SH, Cho B, Lee K, Lee SH. The Factors Associated with the Quality of Life of the Spouse Caregivers of Patients with Cancer: A Cross-Sectional Study. Journal of Palliative Medicine 2012;15:216-24. [DOI: 10.1089/jpm.2011.0305] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
350 Abe S, Kanaya K, Kikukawa M, Sakai M, Akai T, Takata Y, Sakurai H, Shin K, Mori M, Iwamoto T. Clinical results and issues of acute myeloid leukemia in elderly patients aged 75 years and older. Geriatr Gerontol Int 2011;11:290-6. [PMID: 21303435 DOI: 10.1111/j.1447-0594.2010.00682.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
351 Cruz-jentoft AJ, González B, de la Rubia J, Hernández Rivas JÁ, Soler JA, Fernández Lago C, Arnao M, Gironella M, Pérez Persona E, Zudaire MT, Olivier C, Altés A, García Guiñón A, Nomdedeu B, Arnan M, Ramírez Payer Á, Sánchez-godoy P, Pajuelo N, Vilanova D, Monjil DF, Bonanad S. Further psychometric validation of the GAH scale: Responsiveness and effect size. Journal of Geriatric Oncology 2017;8:211-5. [DOI: 10.1016/j.jgo.2016.12.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
352 Vorobiof DA, Falkson G. Phase II study of high-dose 4'-epidoxorubicin in the treatment of advanced gastrointestinal cancer. Eur J Cancer Clin Oncol 1989;25:563-4. [PMID: 2703009 DOI: 10.1016/0277-5379(89)90271-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
353 Yang JC, Hirsh V, Schuler M, Yamamoto N, O’Byrne KJ, Mok TS, Zazulina V, Shahidi M, Lungershausen J, Massey D. Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations. J Clin Oncol. 2013;31:3342-3350. [PMID: 23816967 DOI: 10.1200/jco.2012.46.1764] [Cited by in Crossref: 189] [Cited by in F6Publishing: 87] [Article Influence: 23.6] [Reference Citation Analysis]
354 Helbekkmo N, Strøm HH, Sundstrøm SH, Aasebø U, Von Plessen C, Bremnes RM; For The Norwegian Lung Cancer Study Group. Chemotherapy and quality of life in NSCLC PS 2 patients. Acta Oncologica 2009;48:1019-25. [DOI: 10.1080/02841860902795240] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
355 Mielcarek P, Nowicka-Sauer K, Kozaka J. Anxiety and depression in patients with advanced ovarian cancer: a prospective study. J Psychosom Obstet Gynaecol 2016;37:57-67. [PMID: 26939616 DOI: 10.3109/0167482X.2016.1141891] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 4.4] [Reference Citation Analysis]
356 Pellerin O, Medioni J, Vulser C, Déan C, Oudard S, Sapoval M. Management of painful pelvic bone metastasis of renal cell carcinoma using embolization, radio-frequency ablation, and cementoplasty: a prospective evaluation of efficacy and safety. Cardiovasc Intervent Radiol 2014;37:730-6. [PMID: 24091753 DOI: 10.1007/s00270-013-0740-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
357 Zannetti BA, Zamagni E, Santostefano M, De Sanctis LB, Tacchetti P, Mancini E, Pantani L, Brioli A, Rizzo R, Mancuso K, Rocchi S, Pezzi A, Borsi E, Terragna C, Marzocchi G, Santoro A, Cavo M. Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment. Am J Hematol 2015;90:647-52. [PMID: 25858483 DOI: 10.1002/ajh.24035] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
358 Kako S, Kanda Y, Onizuka M, Aotsuka N, Usuki K, Tachibana T, Kobayashi T, Kato J, Yano S, Shimizu H, Shono K, Tanaka M, Tsukamoto S, Mori T, Yamazaki E, Najima Y, Hangaishi A, Hoshino T, Watanabe R, Matsumoto K, Okamoto S; for Kanto Study Group for Cell Therapy (KSGCT). Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: A KSGCT prospective study. Am J Hematol 2020;95:251-7. [PMID: 31804748 DOI: 10.1002/ajh.25693] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
359 Gadzinski AJ, Psutka SP. Risk stratification metrics for bladder cancer: Comprehensive Geriatric Assessments. Urol Oncol 2020;38:725-33. [PMID: 32037198 DOI: 10.1016/j.urolonc.2020.01.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
360 Oldenmenger WH, Echteld MA, de Wit R, Sillevis Smitt PA, Stronks DL, Stoter G, van der Rijt CC. Analgesic adherence measurement in cancer patients: comparison between electronic monitoring and diary. J Pain Symptom Manage 2007;34:639-47. [PMID: 17703909 DOI: 10.1016/j.jpainsymman.2007.01.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
361 Colloca G. Performance status as prognostic factor in phase III trials of first-line chemotherapy of unresectable or metastatic pancreatic cancer: A trial-level meta-analysis. Asia Pac J Clin Oncol 2021. [PMID: 34161667 DOI: 10.1111/ajco.13598] [Reference Citation Analysis]
362 Karakiewicz PI, Trinh Q, de la Taille A, Abbou CC, Salomon L, Tostain J, Cindolo L, Artibani W, Ficarra V, Patard J. ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survival. European Journal of Cancer 2007;43:1023-9. [DOI: 10.1016/j.ejca.2007.01.020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
363 Annunziata MA, Muzzatti B, Mella S, Narciso D, Giacalone A, Fratino L, Tirelli U. The Revised Piper Fatigue Scale (PFS-R) for Italian Cancer Patients: A Validation Study. Tumori 2010;96:276-81. [DOI: 10.1177/030089161009600215] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
364 Tsang RY, Santos C, Ghosh S, Dabbagh L, King K, Young J, Cass CE, Mackey JR, Lai R. Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts fludarabine sensitivity in chronic lymphocytic leukemia. Mod Pathol 2008;21:1387-93. [DOI: 10.1038/modpathol.2008.110] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
365 Saphner T, Tormey DC, Albertini M. Continuous infusion 5-fluorouracil with escalating doses of intermittent cisplatin and etoposide. A phase I study. Cancer 1991;68:2359-62. [DOI: 10.1002/1097-0142(19911201)68:11<2359::aid-cncr2820681105>3.0.co;2-a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
366 Yoshiyama A, Morii T, Susa M, Morioka H, Kobayashi E, Asano N, Mori T, Anazawa U, Watanabe I, Takeuchi K, Kushima Y, Aoyagi T, Ichimura S. Preoperative evaluation of renal cell carcinoma patients with bone metastases on risks for blood loss, performance status and lethal event. Journal of Orthopaedic Science 2017;22:924-30. [DOI: 10.1016/j.jos.2017.07.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
367 Murton AJ, Maddocks M, Stephens FB, Marimuthu K, England R, Wilcock A. Consequences of Late-Stage Non-Small-Cell Lung Cancer Cachexia on Muscle Metabolic Processes. Clin Lung Cancer 2017;18:e1-e11. [PMID: 27461772 DOI: 10.1016/j.cllc.2016.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
368 Kim G, Yoo M, Hong MH, Lee BW, Kang ES, Cha BS, Kim HR, Lee YH, Cho BC. Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors. Cancer Chemother Pharmacol 2019;84:405-14. [PMID: 31250153 DOI: 10.1007/s00280-019-03889-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
369 Morgan JL, Shrestha A, Reed MWR, Herbert E, Bradburn M, Walters SJ, Martin C, Collins K, Ward S, Holmes G, Burton M, Lifford K, Edwards A, Ring A, Robinson T, Chater T, Pemberton K, Brennan A, Cheung KL, Todd A, Audisio R, Wright J, Simcock R, Thomson AM, Gosney M, Hatton M, Green T, Revill D, Gath J, Horgan K, Holcombe C, Winter MC, Naik J, Parmeschwar R, Wyld L. Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomes. Br J Surg 2021;108:315-25. [PMID: 33760065 DOI: 10.1093/bjs/znaa125] [Reference Citation Analysis]
370 Kuo WK, Hua CC, Yu CC, Liu YC, Huang CY. The cancer control status and APACHE II score are prognostic factors for critically ill patients with cancer and sepsis. J Formos Med Assoc 2020;119:276-81. [PMID: 31153724 DOI: 10.1016/j.jfma.2019.05.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
371 Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U, Digumarti R, Zukin M, Lee JS, Mellemgaard A, Park K, Patil S, Rolski J, Goksel T, de Marinis F, Simms L, Sugarman KP, Gandara D. Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer. JCO 2008;26:3543-51. [DOI: 10.1200/jco.2007.15.0375] [Cited by in Crossref: 2249] [Cited by in F6Publishing: 782] [Article Influence: 173.0] [Reference Citation Analysis]
372 Roemeling RV, Hrushesky WJM. Advanced transitional cell bladder cancer: A treatable disease. Semin Surg Oncol 1986;2:76-89. [DOI: 10.1002/ssu.2980020204] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
373 Perera M, Krishnananthan N, Lindner U, Lawrentschuk N. An update on focal therapy for prostate cancer. Nat Rev Urol 2016;13:641-53. [DOI: 10.1038/nrurol.2016.177] [Cited by in Crossref: 49] [Cited by in F6Publishing: 30] [Article Influence: 9.8] [Reference Citation Analysis]
374 Dedeciusova M, Majovsky M, Pecen L, Benes V, Netuka D. Long-term outcome of Simpson IV meningioma resection: Would it improve with adjuvant SRS? Clin Neurol Neurosurg 2021;207:106766. [PMID: 34166979 DOI: 10.1016/j.clineuro.2021.106766] [Reference Citation Analysis]
375 Rueda A, Olmos D, Villareal V, Torres E, Pajares BI, Alba E. Elevated Vascular Endothelial Growth Factor Pretreatment Levels Are Correlated with the Tumor Burden in Hodgkin Lymphoma and Continue to Be Elevated in Prolonged Complete Remission. Clinical Lymphoma and Myeloma 2007;7:400-5. [DOI: 10.3816/clm.2007.n.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
376 Henry M, Alias A, Cherba M, Woronko C, Rosberger Z, Hier M, Zeitouni A, Kost K, Mlynarek A, Richardson K, Black M, MacDonald C, Chartier G, Frenkiel S. Immediate post-treatment supportive care needs of patients newly diagnosed with head and neck cancer. Support Care Cancer 2020;28:5557-67. [PMID: 32189100 DOI: 10.1007/s00520-020-05368-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
377 Iihara N, Kurosaki Y, Miyoshi C, Takabatake K, Morita S, Hori K. Comparison of individual perceptions of medication costs and benefits between intentional and unintentional medication non-adherence among Japanese patients. Patient Educ Couns 2008;70:292-9. [PMID: 18068938 DOI: 10.1016/j.pec.2007.10.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
378 Cocconi G, Bisagni G, Bella M, Acito L, Anastasi P, Carpi A, Di Costanzo F, Frassoldati A, Mosconi A, Borrini A, Buzzi P. Comparison of CMF (Cyclophosphamide, Methotrexate, and 5-Fluorouracil) With a Rotational Crossing and a Sequential Intensification Regimen in Advanced Breast Cancer: A Prospective Randomized Study. American Journal of Clinical Oncology: Cancer Clinical Trials 1999;22:593. [DOI: 10.1097/00000421-199912000-00010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
379 Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kies MS, Weber RS, Lewin JS, Garden AS, Ang KK, S. Wang X, Cleeland CS. Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck 2007;29:923-31. [DOI: 10.1002/hed.20602] [Cited by in Crossref: 150] [Cited by in F6Publishing: 99] [Article Influence: 10.7] [Reference Citation Analysis]
380 Garg P, Rana F, Gupta R, Buzaianu EM, Guthrie TH. Predictors of toxicity and toxicity profile of adjuvant chemotherapy in elderly breast cancer patients. Breast J 2009;15:404-8. [PMID: 19508671 DOI: 10.1111/j.1524-4741.2009.00745.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
381 Fagard K, Casaer J, Wolthuis A, Flamaing J, Milisen K, Lobelle J, Wildiers H, Kenis C. Value of geriatric screening and assessment in predicting postoperative complications in patients older than 70 years undergoing surgery for colorectal cancer. Journal of Geriatric Oncology 2017;8:320-7. [DOI: 10.1016/j.jgo.2017.07.008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 8.5] [Reference Citation Analysis]
382 Dahele M, Skipworth RJ, Wall L, Voss A, Preston T, Fearon KC. Objective Physical Activity and Self-Reported Quality of Life in Patients Receiving Palliative Chemotherapy. Journal of Pain and Symptom Management 2007;33:676-85. [DOI: 10.1016/j.jpainsymman.2006.09.024] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 4.1] [Reference Citation Analysis]
383 Latagliata R, Breccia M, Carmosino I, Cannella L, De Cuia R, Diverio D, Frustaci A, Loglisci G, Mancini M, Santopietro M, Stefanizzi C, Volpicelli P, Vozella F, Alimena G. "Real-life" results of front-line treatment with Imatinib in older patients (≥ 65 years) with newly diagnosed chronic myelogenous leukemia. Leuk Res 2010;34:1472-5. [PMID: 20708799 DOI: 10.1016/j.leukres.2010.07.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
384 Pectasides D, Aspropotamitis A, Halikia A, Visvikis A, Antoniou F, Kalantaridou A, Karvounis N, Batzios S, Athanassiou A. Combination Chemotherapy With Carboplatin, Docetaxel, and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: A Phase II Study. JCO 1999;17:3816-21. [DOI: 10.1200/jco.1999.17.12.3816] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
385 Schmitz N, Nickelsen M, Ziepert M, Haenel M, Borchmann P, Schmidt C, Viardot A, Bentz M, Peter N, Ehninger G, Doelken G, Ruebe C, Truemper L, Rosenwald A, Pfreundschuh M, Loeffler M, Glass B; German High-Grade Lymphoma Study Group (DSHNHL). Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1). Lancet Oncol 2012;13:1250-9. [PMID: 23168367 DOI: 10.1016/S1470-2045(12)70481-3] [Cited by in Crossref: 153] [Cited by in F6Publishing: 45] [Article Influence: 17.0] [Reference Citation Analysis]
386 Marinello R, Marenco D, Roglia D, Stasi MF, Ferrando A, Ceccarelli M, Bertetto O, Molaschi M, Ciccone G. Predictors of treatment failures during chemotherapy: A prospective study on 110 older cancer patients. Archives of Gerontology and Geriatrics 2009;48:222-6. [DOI: 10.1016/j.archger.2008.01.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
387 Paz-Ares L, de Marinis F, Dediu M, Thomas M, Pujol JL, Bidoli P, Molinier O, Sahoo TP, Laack E, Reck M. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial. Lancet Oncol. 2012;13:247-255. [PMID: 22341744 DOI: 10.1016/s1470-2045(12)70063-3] [Cited by in Crossref: 385] [Cited by in F6Publishing: 147] [Article Influence: 42.8] [Reference Citation Analysis]
388 Lorimer C, Hanna C, Saran F, Chalmers A, Brock J. Challenges to Treating Older Glioblastoma Patients: the Influence of Clinical and Tumour Characteristics on Survival Outcomes. Clinical Oncology 2017;29:739-47. [DOI: 10.1016/j.clon.2017.05.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
389 Bernabeu-wittel M, Murcia-zaragoza J, Hernández-quiles C, Escolano-fernández B, Jarava-rol G, Oliver M, Díez-manglano J, Ruiz-cantero A, Ollero-baturone M. Development of a Six-Month Prognostic Index in Patients With Advanced Chronic Medical Conditions: The PALIAR Score. Journal of Pain and Symptom Management 2014;47:551-65. [DOI: 10.1016/j.jpainsymman.2013.04.011] [Cited by in Crossref: 42] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
390 Broun ER, Nichols CR, Gize G, Cornetta K, Hromas RA, Schacht B, Einhorn LH. Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer. Cancer 1997;79:1605-10. [DOI: 10.1002/(sici)1097-0142(19970415)79:8<1605::aid-cncr25>3.0.co;2-0] [Cited by in Crossref: 58] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
391 Schmid S, Omlin A, Blum D, Strasser F, Gillessen S, Rothermundt C. Assessment of anticancer-treatment outcome in patients with metastatic castration-resistant prostate cancer-going beyond PSA and imaging, a systematic literature review. Ann Oncol 2015;26:2221-47. [PMID: 26216388 DOI: 10.1093/annonc/mdv326] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
392 Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2008;15:526-534. [PMID: 18043976 DOI: 10.1245/s10434-007-9691-2] [Cited by in Crossref: 116] [Cited by in F6Publishing: 100] [Article Influence: 8.3] [Reference Citation Analysis]
393 Carrington C, Stone L, Koczwara B, Searle C, Siderov J, Stevenson B, Michael M, Hyde S, Booth A, Rushton S; Clinical Oncological Society of Australia. The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy. Asia Pac J Clin Oncol 2010;6:220-37. [PMID: 20887505 DOI: 10.1111/j.1743-7563.2010.01321.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
394 Wadhwa D, Burman D, Swami N, Rodin G, Lo C, Zimmermann C. Quality of life and mental health in caregivers of outpatients with advanced cancer. Psychooncology 2013;22:403-10. [PMID: 22135229 DOI: 10.1002/pon.2104] [Cited by in Crossref: 99] [Cited by in F6Publishing: 74] [Article Influence: 9.9] [Reference Citation Analysis]
395 Cabelguenne A, Loriot MA, Stucker I, Blons H, Koum-Besson E, Brasnu D, Beaune P, Laccourreye O, Laurent-Puig P, De Waziers I. Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy. Int J Cancer 2001;93:725-30. [PMID: 11477586 DOI: 10.1002/ijc.1392] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
396 Ciani O, Buyse M, Garside R, Peters J, Saad ED, Stein K, Taylor RS. Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancer. Journal of Clinical Epidemiology 2015;68:833-42. [DOI: 10.1016/j.jclinepi.2015.02.016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 5.7] [Reference Citation Analysis]
397 Strassels SA, Blough DK, Veenstra DL, Hazlet TK, Sullivan SD. Clinical and Demographic Characteristics Help Explain Variations in Pain at the End of Life. Journal of Pain and Symptom Management 2008;35:10-9. [DOI: 10.1016/j.jpainsymman.2007.02.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
398 Blanchon F, Grivaux M, Asselain B, Lebas F, Orlando J, Piquet J, Zureik M. 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index. The Lancet Oncology 2006;7:829-36. [DOI: 10.1016/s1470-2045(06)70868-3] [Cited by in Crossref: 78] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
399 Heckman JT, Devera MB, Marsh JW, Fontes P, Amesur NB, Holloway SE, Nalesnik M, Geller DA, Steel JL, Gamblin TC. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann Surg Oncol. 2008;15:3169-3177. [PMID: 18696158 DOI: 10.1245/s10434-008-0071-3] [Cited by in Crossref: 93] [Cited by in F6Publishing: 76] [Article Influence: 7.2] [Reference Citation Analysis]
400 Kroeger N, Rampersaud EN, Patard J, Klatte T, Birkhäuser FD, Shariat SF, Lang H, Rioux-leclerq N, Remzi M, Zomorodian N, Kabbinavar FF, Belldegrun AS, Pantuck AJ. Prognostic Value of Microvascular Invasion in Predicting the Cancer Specific Survival and Risk of Metastatic Disease in Renal Cell Carcinoma: A Multicenter Investigation. Journal of Urology 2012;187:418-23. [DOI: 10.1016/j.juro.2011.10.024] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
401 Ito A, Ishida T, Tokumasu H, Yamazaki A, Washio Y. Evaluation of pneumonia severity scoring systems in nursing and healthcare-associated pneumonia for predicting prognosis: A prospective, cohort study. J Infect Chemother 2020;26:372-8. [PMID: 31787528 DOI: 10.1016/j.jiac.2019.11.001] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
402 Frost N, Kollmeier J, Misch D, Vollbrecht C, Grah C, Matthes B, Pultermann D, Olive E, Raspe M, Ochsenreither S, von Laffert M, Suttorp N, Witzenrath M, Grohé C. Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (≥ 50%) NSCLC: Real-world Results with Special Focus on PS ≥ 2, Brain Metastases, and Steroids. Clin Lung Cancer 2021:S1525-7304(21)00024-3. [PMID: 33648877 DOI: 10.1016/j.cllc.2021.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
403 Tu S, Millikan RE, Mengistu B, Delpassand ES, Amato RJ, Pagliaro LC, Daliani D, Papandreou CN, Smith TL, Kim J, Podoloff DA, Logothetis CJ. Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial. The Lancet 2001;357:336-41. [DOI: 10.1016/s0140-6736(00)03639-4] [Cited by in Crossref: 300] [Cited by in F6Publishing: 54] [Article Influence: 15.0] [Reference Citation Analysis]
404 Zampieri FG, Ladeira JP, Park M, Haib D, Pastore CL, Santoro CM, Colombari F. Admission factors associated with prolonged (>14 days) intensive care unit stay. J Crit Care 2014;29:60-5. [PMID: 24268622 DOI: 10.1016/j.jcrc.2013.09.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
405 Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hütterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Mühlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC. ESPEN guidelines on nutrition in cancer patients. Clin Nutr 2017;36:11-48. [PMID: 27637832 DOI: 10.1016/j.clnu.2016.07.015] [Cited by in Crossref: 937] [Cited by in F6Publishing: 603] [Article Influence: 187.4] [Reference Citation Analysis]
406 Woldu SL, Sanli O, Clinton TN, Lotan Y. Validating the predictors of outcomes after radical cystectomy for bladder cancer: Predicting Radical Cystectomy Outcomes. Cancer 2019;125:223-31. [DOI: 10.1002/cncr.31799] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
407 Palakshappa JA, Meyer NJ. Which patients with ARDS benefit from lung biopsy? Chest 2015;148:1073-82. [PMID: 25950989 DOI: 10.1378/chest.15-0076] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
408 Gascón P, Almenárez J, Artal Á, Camps C, Fírvida JL, Garrido P, González Larriba JL, Montalar J. Management of lung cancer-associated anaemia: the Spanish Lung Cancer Anaemia Survey (SLCAS). Clin Transl Oncol 2011;13:328-34. [DOI: 10.1007/s12094-011-0662-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
409 Marotta V, Ramundo V, Camera L, Del Prete M, Fonti R, Esposito R, Palmieri G, Salvatore M, Vitale M, Colao A, Faggiano A. Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET. Clin Endocrinol (Oxf) 2013;78:760-7. [PMID: 23009688 DOI: 10.1111/cen.12057] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 6.9] [Reference Citation Analysis]
410 Allen OS, Kim N, Morillo J, Smith CB. Assessment of prognostic understanding, perceived goals of care, and quality of life in hospitalized patients with leukemia or multiple myeloma. Cancer 2021. [PMID: 33891716 DOI: 10.1002/cncr.33599] [Reference Citation Analysis]
411 Liu G, Gurubhagavatula S, Zhou W, Wang Z, Yeap BY, Asomaning K, Su L, Heist R, Lynch TJ, Christiani DC. Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib. Pharmacogenomics J 2008;8:129-38. [PMID: 17375033 DOI: 10.1038/sj.tpj.6500444] [Cited by in Crossref: 76] [Cited by in F6Publishing: 61] [Article Influence: 5.4] [Reference Citation Analysis]
412 Shuch B, La Rochelle JC, Wu J, Klatte T, Riggs SB, Kabbinavar F, Belldegrun AS, Pantuck AJ. Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance. Cancer 2008;113:1324-31. [PMID: 18661529 DOI: 10.1002/cncr.23708] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
413 Cerqua R, Balestrini S, Perozzi C, Cameriere V, Renzi S, Lagalla G, Mancini G, Montanari M, Leoni P, Scerrati M, Iacoangeli M, Silvestrini M, Luzzi S, Provinciali L. Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme. Neurol Sci 2016;37:23-9. [DOI: 10.1007/s10072-015-2353-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
414 Zhao Y, Qiao G, Wang X, Song Y, Zhou X, Jiang N, Zhou L, Huang H, Zhao J, Morse MA, Hobeika A, Ren J, Lyerly HK. Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients’ preference-based study (PPPS). Clin Transl Oncol 2019;21:721-8. [DOI: 10.1007/s12094-018-1968-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
415 Jager-wittenaar H, Dijkstra PU, Dijkstra G, Bijzet J, Langendijk JA, van der Laan BF, Roodenburg JL. High prevalence of cachexia in newly diagnosed head and neck cancer patients: An exploratory study. Nutrition 2017;35:114-8. [DOI: 10.1016/j.nut.2016.11.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
416 Arbea L, Martínez-Monge R, Díaz-González JA, Moreno M, Rodríguez J, Hernández JL, Sola JJ, Ramos LI, Subtil JC, Nuñez J, Chopitea A, Cambeiro M, Gaztañaga M, García-Foncillas J, Aristu J. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial. Int J Radiat Oncol Biol Phys 2012;83:587-93. [PMID: 22079731 DOI: 10.1016/j.ijrobp.2011.06.2008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
417 James K, Eisenhauer E, Christian M, Terenziani M, Vena D, Muldal A, Therasse P. Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst. 1999;91:523-528. [PMID: 10088622 DOI: 10.1093/jnci/91.6.523] [Cited by in Crossref: 299] [Cited by in F6Publishing: 238] [Article Influence: 13.6] [Reference Citation Analysis]
418 Huang C, Kuo H, Lin Y, Chen S. Effects of a Web-based Health Education Program on Quality of Life and Symptom Distress of Initially Diagnosed Advanced Non-Small Cell Lung Cancer Patients: A Randomized Controlled Trial. J Canc Educ 2019;34:41-9. [DOI: 10.1007/s13187-017-1263-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
419 Nair SC, Hassen WA, Sreedharan J, Qawasmeh K, Ibrahim H. Comparison of perceptions of unmet supportive care needs between cancer patients and their oncologists. Support Care Cancer 2019;27:4229-35. [PMID: 30847701 DOI: 10.1007/s00520-019-04705-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
420 Niell HB, Griffin JP, Hunter RF, Meredith CA, Somes G. Combination versus sequential single-agent chemotherapy in the treatment of patients with advanced non-small cell lung cancer. Med Pediatr Oncol 1989;17:69-75. [DOI: 10.1002/mpo.2950170115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
421 Merli F, Luminari S, Gobbi PG, Cascavilla N, Mammi C, Ilariucci F, Stelitano C, Musso M, Baldini L, Galimberti S, Angrilli F, Polimeno G, Scalzulli PR, Ferrari A, Marcheselli L, Federico M. Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi. JCO 2016;34:1175-81. [DOI: 10.1200/jco.2015.62.4817] [Cited by in Crossref: 64] [Cited by in F6Publishing: 24] [Article Influence: 12.8] [Reference Citation Analysis]
422 Kefeli U, Kaya S, Ustaalioglu BO, Bilici A, Kefeli AU, Yildirim ME, Seker M, Yilmaz B, Salepci T, Uygun K, Gumus M. Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience. Med Oncol 2011;28:661-6. [DOI: 10.1007/s12032-010-9504-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
423 Masi G, Vasile E, Loupakis F, Cupini S, Fornaro L, Baldi G, Salvatore L, Cremolini C, Stasi I, Brunetti I. Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis. J Natl Cancer Inst. 2011;103:21-30. [PMID: 21123833 DOI: 10.1093/jnci/djq456] [Cited by in Crossref: 105] [Cited by in F6Publishing: 80] [Article Influence: 9.5] [Reference Citation Analysis]
424 Aynehchi BB, Obourn C, Sundaram K, Bentsianov BL, Rosenfeld RM. Validation of the Modified Brief Fatigue Inventory in Head and Neck Cancer Patients. Otolaryngol Head Neck Surg 2013;148:69-74. [DOI: 10.1177/0194599812460985] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
425 Zhao L, Li X, Zhang Z, Song C, Guo C, Zhang Y, Zhang Y, Li L, Lu G, Zheng G, Wang K, Pei W, Han L. Prevalence, correlates and recognition of depression in Chinese inpatients with cancer. Gen Hosp Psychiatry 2014;36:477-82. [PMID: 24961793 DOI: 10.1016/j.genhosppsych.2014.05.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
426 Schröder C, Ivo M, Buchali A. Does high-dose radiotherapy benefit palliative lung cancer patients?: An intradepartmental comparison of two dose regimens. Strahlenther Onkol 2013;189:771-6. [DOI: 10.1007/s00066-013-0360-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
427 Finlay E, Lu HL, Henderson H, O'dwyer PJ, Casarett DJ. Do phase 1 patients have greater needs for palliative care compared with other cancer patients? Cancer 2009;115:446-53. [DOI: 10.1002/cncr.24025] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
428 Kim S, Kim S, Kim J, Shin I, Bae K, Shim H, Bae W, Cho S, Chung I, Yoon J. Differential Associations Between Delirium and Mortality According to Delirium Subtype and Age: A Prospective Cohort Study. Psychosomatic Medicine 2015;77:903-10. [DOI: 10.1097/psy.0000000000000239] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
429 Akiyama N, Miyazawa K, Kanda Y, Tohyama K, Omine M, Mitani K, Ohyashiki K. Multicenter phase II trial of vitamin K(2) monotherapy and vitamin K(2) plus 1alpha-hydroxyvitamin D(3) combination therapy for low-risk myelodysplastic syndromes. Leuk Res 2010;34:1151-7. [PMID: 20569983 DOI: 10.1016/j.leukres.2010.04.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
430 Kodani T, Ueoka H, Kiura K, Tabata M, Takigawa N, Segawa Y, Moritaka T, Hiraki S, Harada M, Tanimoto M. A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors. Lung Cancer 2002;36:313-9. [PMID: 12009244 DOI: 10.1016/s0169-5002(02)00008-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
431 Kishimoto K, Kobayashi R, Sano H, Suzuki D, Yasuda K, Kobayashi K. Analysis of Risk Factors for Hyponatremia During or Following Chemotherapy in Children With Cancer: A Hospital-based, Retrospective Cohort Study. Journal of Pediatric Hematology/Oncology 2016;38:443-8. [DOI: 10.1097/mph.0000000000000478] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
432 Kilton LJ, Benson AB, Greenberg A, Johnson P, Shapiro C, Blough R, French S, Weidner L. Phase II trial of fludarabine phosphate for adenocarcinoma of the pancreas: An Illinois Cancer Center study. Invest New Drugs 1992;10:201-4. [DOI: 10.1007/bf00877246] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
433 Johnston S, Puhalla S, Wheatley D, Ring A, Barry P, Holcombe C, Boileau JF, Provencher L, Robidoux A, Rimawi M, McIntosh SA, Shalaby I, Stein RC, Thirlwell M, Dolling D, Morden J, Snowdon C, Perry S, Cornman C, Batten LM, Jeffs LK, Dodson A, Martins V, Modi A, Osborne CK, Pogue-Geile KL, Cheang MCU, Wolmark N, Julian TB, Fisher K, MacKenzie M, Wilcox M, Huang Bartlett C, Koehler M, Dowsett M, Bliss JM, Jacobs SA. Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial. J Clin Oncol. 2019;37:178-189. [PMID: 30523750 DOI: 10.1200/jco.18.01624] [Cited by in Crossref: 61] [Cited by in F6Publishing: 32] [Article Influence: 20.3] [Reference Citation Analysis]
434 Lloyd-williams M, Cobb M, O'connor C, Dunn L, Shiels C. A pilot randomised controlled trial to reduce suffering and emotional distress in patients with advanced cancer. Journal of Affective Disorders 2013;148:141-5. [DOI: 10.1016/j.jad.2012.11.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
435 Picardi V, Deodato F, Guido A, Giaccherini L, Macchia G, Frazzoni L, Farioli A, Cuicchi D, Cilla S, Cellini F, Uddin AK, Gambacorta MA, Buwenge M, Ardizzoni A, Poggioli G, Valentini V, Fuccio L, Morganti AG. Palliative Short-Course Radiation Therapy in Rectal Cancer: A Phase 2 Study. International Journal of Radiation Oncology*Biology*Physics 2016;95:1184-90. [DOI: 10.1016/j.ijrobp.2016.03.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
436 Urba S, van Herpen CML, Sahoo TP, Shin DM, Licitra L, Mezei K, Reuter C, Hitt R, Russo F, Chang S, Hossain AM, Frimodt-moller B, Koustenis A, Hong R. Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: Final results of a randomized, double-blind, placebo-controlled, phase 3 study. Cancer 2012;118:4694-705. [DOI: 10.1002/cncr.27449] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
437 Ransom S, Jacobsen PB, Booth-Jones M. Validation of the Distress Thermometer with bone marrow transplant patients. Psychooncology 2006;15:604-12. [PMID: 16208733 DOI: 10.1002/pon.993] [Cited by in Crossref: 155] [Cited by in F6Publishing: 120] [Article Influence: 10.3] [Reference Citation Analysis]
438 Molinari M, El-Tawil K, Swaid F, Fiorentini G, Bou-Samra P, Sharma C, Liu H, Rahman SH, Hurton S, Tsung A. Patients' treatment preferences for potentially resectable tumors of the head of the pancreas. HPB (Oxford) 2020;22:265-74. [PMID: 31501009 DOI: 10.1016/j.hpb.2019.06.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
439 Romano A, Chiarenza A, Conticello C, Cavalli M, Vetro C, Di Raimondo C, Cunsolo R, Palumbo GA, Di Raimondo F. Salvage therapy with pegylated liposomal doxorubicin, bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory myeloma patients. Eur J Haematol 2014;93:207-13. [PMID: 24673398 DOI: 10.1111/ejh.12325] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
440 Kim CG, Choi IJ, Lee JY, Cho SJ, Park SR, Lee JH, Ryu KW, Kim YW, Park YI. Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study. Gastrointest Endosc. 2010;72:25-32. [PMID: 20381802 DOI: 10.1016/j.gie.2010.01.039] [Cited by in Crossref: 83] [Cited by in F6Publishing: 71] [Article Influence: 7.5] [Reference Citation Analysis]
441 Gershanovich M, Garin A, Baltina D, Kurvet A, Kangas L, Ellmén J, Eastern European Study Group. A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer. Breast Cancer Res Treat 1997;45:251-62. [DOI: 10.1023/a:1005891506092] [Cited by in Crossref: 60] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
442 Rao RD, Michalak JC, Sloan JA, Loprinzi CL, Soori GS, Nikcevich DA, Warner DO, Novotny P, Kutteh LA, Wong GY; North Central Cancer Treatment Group. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer 2007;110:2110-8. [PMID: 17853395 DOI: 10.1002/cncr.23008] [Cited by in Crossref: 225] [Cited by in F6Publishing: 183] [Article Influence: 16.1] [Reference Citation Analysis]
443 McFarland DC, Miller AH, Nelson C. A Longitudinal Analysis of Inflammation and Depression in Patients With Metastatic Lung Cancer: Associations With Survival. Biol Res Nurs 2021;23:301-10. [PMID: 32959680 DOI: 10.1177/1099800420959721] [Reference Citation Analysis]
444 Quigley MR, Bello N, Jho D, Fuhrer R, Karlovits S, Buchinsky FJ. Estimating the Additive Benefit of Surgical Excision to Stereotactic Radiosurgery in the Management of Metastatic Brain Disease. Neurosurgery 2015;76:707-13. [DOI: 10.1227/neu.0000000000000707] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
445 Baratti D, Kusamura S, Martinetti A, Seregni E, Laterza B, Oliva DG, Deraco M. Prognostic Value of Circulating Tumor Markers in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol 2007;14:2300-8. [DOI: 10.1245/s10434-007-9393-9] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
446 Robak T, Błasińska-morawiec M, Błasiński J, Hellmann A, Hałaburda K, Konopka L, Kotlarek-haus S, Potoczek S, Hansz J, Dmoszyn̊ska A, Urasiński I, Zdziarska B, Dwilewicz-trojaczek J, Hołowiecki J, Skotnicki AB. 2-Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland. European Journal of Haematology 1999;62:49-56. [DOI: 10.1111/j.1600-0609.1999.tb01114.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
447 Jiménez-fonseca P, Carmona-bayonas A, Martín-pérez E, Crespo G, Serrano R, Llanos M, Villabona C, García-carbonero R, Aller J, Capdevila J, Grande E; On behalf of the Spanish Neuroendocrine Tumor Group (GETNE). Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors. Cancer Metastasis Rev 2015;34:381-400. [DOI: 10.1007/s10555-015-9573-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
448 Mazzaferro V, Sposito C, Bhoori S, Romito R, Chiesa C, Morosi C, Maccauro M, Marchianò A, Bongini M, Lanocita R, Civelli E, Bombardieri E, Camerini T, Spreafico C. Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study. Hepatology 2013;57:1826-37. [DOI: 10.1002/hep.26014] [Cited by in Crossref: 290] [Cited by in F6Publishing: 226] [Article Influence: 36.3] [Reference Citation Analysis]
449 Hata M, Koike I, Miyagi E, Numazaki R, Asai-sato M, Kasuya T, Kaizu H, Matsui T, Hirahara F, Inoue T. Radiation therapy for pelvic lymph node metastasis from uterine cervical cancer. Gynecologic Oncology 2013;131:99-102. [DOI: 10.1016/j.ygyno.2013.07.085] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
450 Atkins MB, Lotze MT, Dutcher JP, Fisher RI, Weiss G, Margolin K, Abrams J, Sznol M, Parkinson D, Hawkins M, Paradise C, Kunkel L, Rosenberg SA. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol. 1999;17:2105-2116. [PMID: 10561265 DOI: 10.1200/jco.1999.17.7.2105] [Cited by in Crossref: 1360] [Cited by in F6Publishing: 494] [Article Influence: 64.8] [Reference Citation Analysis]
451 Macchia G, Morganti AG, Cilla S, Ippolito E, Massaccesi M, Picardi V, Mattiucci GC, Bonomo P, Tambaro R, Pacelli F. Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series. Cancer Invest. 2012;30:149-155. [PMID: 22250589 DOI: 10.3109/07357907.2011.640649] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
452 Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383:1721-1730. [PMID: 24559581 DOI: 10.1016/s0140-6736(13)62416-2] [Cited by in Crossref: 880] [Cited by in F6Publishing: 292] [Article Influence: 125.7] [Reference Citation Analysis]
453 Reis-pina P, Acharya A, Lawlor PG. Cancer Pain With a Neuropathic Component: A Cross-sectional Study of Its Clinical Characteristics, Associated Psychological Distress, Treatments, and Predictors at Referral to a Cancer Pain Clinic. Journal of Pain and Symptom Management 2018;55:297-306. [DOI: 10.1016/j.jpainsymman.2017.08.028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
454 Khammari A, Nguyen JM, Leccia MT, Guillot B, Saiagh S, Pandolfino MC, Knol AC, Quéreux G, Chiffolettau A, Labarrière N, Dréno B. Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial. Cancer Immunol Immunother 2020;69:1663-72. [PMID: 32306076 DOI: 10.1007/s00262-020-02572-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
455 Goodman HM, Dottino PR, Kredenster D, Mark M, Runowicz C, Cohen CJ. Continuous infusion fluoropyrimidines as salvage therapy for patients with advanced ovarian carcinoma. Gynecologic Oncology 1988;29:348-55. [DOI: 10.1016/0090-8258(88)90234-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
456 Al-Batran SE, Hofheinz RD, Reichart A, Pauligk C, Schönherr C, Schlag R, Siegler G, Dörfel S, Koenigsmann M, Zahn MO, Schubert J, Aldaoud A, Höffkes HG, Schulz H, Hahn L, Uhlig J, Blau W, Stauch M, Weniger J, Wolf M, Jacobasch L, Bildat S, Wehmeyer J, Homann N, Trojan J, Waidmann O, Fietz T, Feustel HP, Groschek M, Wierecky J, Waibel K, Mahlmann S, Schwindel U, Peters U, Schuch G, Pink D, Eschenburg H, Wörns MA, Harich HD, von Weikersthal LF, Däßler KU, Behringer DM, Messmann H, Kretzschmar A, Gallmeier E, Forstbauer H, Kunzmann V, Papke J, Büchner-Steudel P, Vehling-Kaiser U, Springfeld C, Vogel A, Ettrich TJ, Schaaf M, Hausen GZ, Götze TO; Arbeitsgemeinschaft Internistische Onkologie (AIO). Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry. Int J Cancer 2021;148:1478-88. [PMID: 33038277 DOI: 10.1002/ijc.33336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
457 Obermair A, Crandon A, Perrin L, Walsh T, Carrazo M, Nicklin J. RANDOMIZED TRIAL OF SKIN CLOSURE AFTER LAPAROTOMY FOR GYNAECOLOGICAL SURGERY. ANZ J Surg 2007;77:460-3. [DOI: 10.1111/j.1445-2197.2007.04095.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
458 Interval ET, Whitenack N, Panwar A. Role of Frailty and Comorbidity in Determination of Operability for Patients With Oral and Oropharyngeal Squamous Cell Carcinoma. Curr Otorhinolaryngol Rep 2019;7:39-48. [DOI: 10.1007/s40136-019-00225-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
459 Spaner DE, Astsaturov I, Vogel T, Petrella T, Elias I, Burdett-Radoux S, Verma S, Iscoe N, Hamilton P, Berinstein NL. Enhanced viral and tumor immunity with intranodal injection of canary pox viruses expressing the melanoma antigen, gp100. Cancer 2006;106:890-9. [PMID: 16404742 DOI: 10.1002/cncr.21669] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
460 Kwon M, Kim RB, Roh JL, Lee SW, Kim SB, Choi SH, Nam SY, Kim SY. Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma. Head Neck 2017;39:716-23. [PMID: 28000343 DOI: 10.1002/hed.24672] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
461 Roulin D, Melloul E, Wellg BE, Izbicki J, Vrochides D, Adham M, Hübner M, Demartines N. Feasibility of an Enhanced Recovery Protocol for Elective Pancreatoduodenectomy: A Multicenter International Cohort Study. World J Surg 2020;44:2761-9. [DOI: 10.1007/s00268-020-05499-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
462 Hata M, Koike I, Wada H, Minagawa Y, Kasuya T, Matsui T, Suzuki R, Takano S, Inoue T. Radiation therapy for lymph node metastasis from extramammary Paget's disease. J Eur Acad Dermatol Venereol 2014;28:873-7. [DOI: 10.1111/jdv.12185] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
463 Vasson MP, Talvas J, Perche O, Dillies AF, Bachmann P, Pezet D, Achim AC, Pommier P, Racadot S, Weber A. Immunonutrition improves functional capacities in head and neck and esophageal cancer patients undergoing radiochemotherapy: a randomized clinical trial. Clin Nutr. 2014;33:204-210. [PMID: 23849811 DOI: 10.1016/j.clnu.2013.06.008] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
464 Kelly CM, Shahrokni A. From Shelf to Bedside—Wearable Electronic Activity Monitoring Technologies Might Assist Oncologists in Functional Performance Status Assessment of Older Cancer Patients. Clinical Colorectal Cancer 2017;16:e115-8. [DOI: 10.1016/j.clcc.2016.11.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
465 Fujisawa D, Temel JS, Greer JA, El-Jawahri A, Traeger L, Jacobs JM, Cutrono S, Pirl WF. Actigraphy as an assessment of performance status in patients with advanced lung cancer. Palliat Support Care 2019;17:574-8. [PMID: 30739635 DOI: 10.1017/S1478951518001074] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
466 Wentlandt K, Burman D, Swami N, Hales S, Rydall A, Rodin G, Lo C, Zimmermann C. Preparation for the end of life in patients with advanced cancer and association with communication with professional caregivers: Preparation for the end of life in advanced cancer. Psycho-Oncology 2012;21:868-76. [DOI: 10.1002/pon.1995] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
467 Olmos D, Arkenau HT, Ang JE, Ledaki I, Attard G, Carden CP, Reid AH, A'Hern R, Fong PC, Oomen NB. Circulating tumour cell (CTC) counts as intermediate end points in castration- resistant prostate cancer (CRPC): a single-centre experience. Ann Oncol. 2009;20:27-33. [PMID: 18695026 DOI: 10.1093/annonc/mdn544] [Cited by in Crossref: 178] [Cited by in F6Publishing: 151] [Article Influence: 13.7] [Reference Citation Analysis]
468 Schultz MZ, Sandier AB, Durivage HJ, Cooper DL. A Phase I Pilot Study of BCNU plus Thymidine in Patients with Refractory Cancer. Cancer Investigation 2009;14:218-24. [DOI: 10.3109/07357909609012142] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
469 Wilks S, Puhalla S, O'shaughnessy J, Schwartzberg L, Berrak E, Song J, Cox D, Vahdat L. Phase 2, Multicenter, Single-Arm Study of Eribulin Mesylate With Trastuzumab as First-Line Therapy for Locally Recurrent or Metastatic HER2-Positive Breast Cancer. Clinical Breast Cancer 2014;14:405-12. [DOI: 10.1016/j.clbc.2014.04.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
470 Endo S, Takiguchi S, Miyazaki Y, Nishikawa K, Imamura H, Takachi K, Kimura Y, Takeno A, Tamura S, Mori M, Doki Y; on behalf of the CLINICAL STUDY GROUP OF OSAKA UNIVERSITY (CSGO), UPPER GI GROUP. Efficacy of endoscopic gastroduodenal stenting for gastric outlet obstruction due to unresectable advanced gastric cancer: A prospective multicenter study: Gastroduodenal Stent for Gastric Cancer. J Surg Oncol 2014;109:208-12. [DOI: 10.1002/jso.23486] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
471 . Adverse drug reaction criteria of the Japan Society of clinical oncology: Japan society of clinical oncology committee on criteria for efficacy of cancer therapy. Int J Clin Oncol 1997;2:177-9. [DOI: 10.1007/bf02490132] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
472 Santana MJ, Au HJ, Dharma-Wardene M, Hewitt JD, Dupere D, Hanson J, Ghosh S, Feeny D. Health-related quality of life measures in routine clinical care: can FACT-fatigue help to assess the management of fatigue in cancer patients? Int J Technol Assess Health Care 2009;25:90-6. [PMID: 19126256 DOI: 10.1017/S0266462309090126] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
473 Coyle T, Bushunow P, Winfield J, Wright J, Graziano S. Hypersensitivity reactions to procarbazine with mechlorethamine, vincristine, and procarbazine chemotherapy in the treatment of glioma. Cancer 1992;69:2532-40. [DOI: 10.1002/1097-0142(19920515)69:10<2532::aid-cncr2820691024>3.0.co;2-i] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
474 Tardy B, Picard S, Guirimand F, Chapelle C, Danel Delerue M, Celarier T, Ciais JF, Vassal P, Salas S, Filbet M, Gomas JM, Guillot A, Gaultier JB, Merah A, Richard A, Laporte S, Bertoletti L. Bleeding risk of terminally ill patients hospitalized in palliative care units: the RHESO study. J Thromb Haemost 2017;15:420-8. [PMID: 28035750 DOI: 10.1111/jth.13606] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 4.8] [Reference Citation Analysis]
475 Kojima T, Shah MA, Muro K, Francois E, Adenis A, Hsu CH, Doi T, Moriwaki T, Kim SB, Lee SH, Bennouna J, Kato K, Shen L, Enzinger P, Qin SK, Ferreira P, Chen J, Girotto G, de la Fouchardiere C, Senellart H, Al-Rajabi R, Lordick F, Wang R, Suryawanshi S, Bhagia P, Kang SP, Metges JP;  KEYNOTE-181 Investigators. Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer. J Clin Oncol. 2020;38:4138-4148. [PMID: 33026938 DOI: 10.1200/jco.20.01888] [Cited by in Crossref: 73] [Cited by in F6Publishing: 31] [Article Influence: 73.0] [Reference Citation Analysis]
476 Crippa S, Partelli S, Bassi C, Berardi R, Capelli P, Scarpa A, Zamboni G, Falconi M. Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters. Surgery. 2016;159:862-871. [PMID: 26602841 DOI: 10.1016/j.surg.2015.09.012] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
477 Honoré C, Souadka A, Goéré D, Dumont F, Deschamps F, Elias D. HIPEC for peritoneal carcinomatosis: does an associated urologic procedure increase morbidity? Ann Surg Oncol 2012;19:104-9. [PMID: 21638092 DOI: 10.1245/s10434-011-1820-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
478 Granger CL, Irving L, Antippa P, Edbrooke L, Parry SM, Krishnasamy M, Denehy L. CAPACITY: A physical activity self-management program for patients undergoing surgery for lung cancer, a phase I feasibility study. Lung Cancer 2018;124:102-9. [DOI: 10.1016/j.lungcan.2018.07.034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
479 Girre V, Falcou M, Gisselbrecht M, Gridel G, Mosseri V, Bouleuc C, Poinsot R, Vedrine L, Ollivier L, Garabige V, Pierga J, Dieras V, Mignot L. Does a Geriatric Oncology Consultation Modify the Cancer Treatment Plan for Elderly Patients? The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2008;63:724-30. [DOI: 10.1093/gerona/63.7.724] [Cited by in Crossref: 137] [Cited by in F6Publishing: 92] [Article Influence: 10.5] [Reference Citation Analysis]
480 Souza-dantas V, Salluh J, Soares M. Impact of neutropenia on the outcomes of critically ill patients with cancer: a matched case–control study. Annals of Oncology 2011;22:2094-100. [DOI: 10.1093/annonc/mdq711] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
481 Morshaeuser L, May M, Burger M, Otto W, Hutterer GC, Pichler M, Klatte T, Wild P, Buser L, Brookman-May S. p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models. Urol Oncol 2018;36:94.e15-21. [PMID: 29221641 DOI: 10.1016/j.urolonc.2017.11.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
482 Batra A, Rigo R, Hannouf MB, Cheung WY. Real-world Safety and Efficacy of Raltitrexed in Patients With Metastatic Colorectal Cancer. Clin Colorectal Cancer 2021;20:e75-81. [PMID: 33268287 DOI: 10.1016/j.clcc.2020.09.006] [Reference Citation Analysis]
483 Pronzato P, Ardizzoni A, Lionetto R, Conte P, Rosso R. Aminoglutethimide as Second-Line Endocrine Treatment in Metastatic Breast Cancer. Tumori 1985;71:297-300. [DOI: 10.1177/030089168507100313] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
484 Sepucha KR, Ozanne EM, Partridge AH, Moy B. Is There a Role for Decision Aids in Advanced Breast Cancer? Med Decis Making 2009;29:475-82. [DOI: 10.1177/0272989x09333124] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
485 Li M, Macedo A, Crawford S, Bagha S, Leung YW, Zimmermann C, Fitzgerald B, Wyatt M, Stuart-mcewan T, Rodin G. Easier Said Than Done: Keys to Successful Implementation of the Distress Assessment and Response Tool (DART) Program. JOP 2016;12:e513-26. [DOI: 10.1200/jop.2015.010066] [Cited by in Crossref: 38] [Cited by in F6Publishing: 10] [Article Influence: 7.6] [Reference Citation Analysis]
486 Takaki-Hamabe S, Yamasaki T, Saeki I, Harima Y, Okita K, Terai S, Sakaida I. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: Is the addition of subcutaneous interferon-alpha-2b beneficial? Hepatol Res. 2009;39:223-230. [PMID: 19054152 DOI: 10.1111/j.1872-034x.2008.00458.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
487 Park HY, Lee B, Kim J, Bae J, Hahm B. Rapid improvement of depression and quality of life with escitalopram treatment in outpatients with breast cancer: A 12-week, open-label prospective trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012;36:318-23. [DOI: 10.1016/j.pnpbp.2011.11.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
488 Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, Pfreundschuh M, Reiser M, Metzner B, Einsele H, Peter N, Jung W, Wörmann B, Ludwig WD, Dührsen U, Eimermacher H, Wandt H, Hasford J, Hiddemann W, Unterhalt M; German Low Grade Lymphoma Study Group (GLSG)., European Mantle Cell Lymphoma Network. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 2008;111:558-65. [PMID: 17962512 DOI: 10.1182/blood-2007-06-095331] [Cited by in Crossref: 584] [Cited by in F6Publishing: 429] [Article Influence: 41.7] [Reference Citation Analysis]
489 Antonelli A, Minervini A, Mari A, Bertolo R, Bianchi G, Lapini A, Longo N, Martorana G, Mirone V, Morgia G, Novara G, Porpiglia F, Rocco B, Rovereto B, Schiavina R, Simeone C, Sodano M, Terrone C, Ficarra V, Carini M, Serni S; RECORd Project-LUNA Foundation. TriMatch comparison of the efficacy of FloSeal versus TachoSil versus no hemostatic agents for partial nephrectomy: Results from a large multicenter dataset: Efficacy of hemostatics for partial nephrectomy. Int J Urol 2015;22:47-52. [DOI: 10.1111/iju.12603] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
490 Robak T, Gora-tybor J, Krykowski E, Walewski JA, Borawska A, Plubańska A, Potemski P, Hellmann A, Zaucha JM, Konopka L, Ceglarek B, Durýński T, Sikorska A, Michalak K, Urasiński J, Opalińska J, Dmoszyńska A, Adamczyk-cioch MB, Kuratowska Z, Dwilewicz-trojaczek J, Boguradzki P, Dere M, May S, Grieb P. Activity of 2-chlorodeoxyadenosine (cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-hodgkin's lymphoma. Leukemia & Lymphoma 2009;26:99-105. [DOI: 10.3109/10428199709109163] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
491 Mystakidou K, Tsilika E, Parpa E, Galanos A, Vlahos L. Post-traumatic growth in advanced cancer patients receiving palliative care. Br J Health Psychol 2008;13:633-46. [PMID: 17919355 DOI: 10.1348/135910707X246177] [Cited by in Crossref: 21] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
492 Yu J, Wang C, Yang Y, Wang R, Chang K, Hwang W, Teng CJ. Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution. Ann Hematol 2013;92:1529-36. [DOI: 10.1007/s00277-013-1784-3] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 6.5] [Reference Citation Analysis]
493 Gkika E, Gauler T, Eberhardt W, Stahl M, Stuschke M, Pöttgen C. Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus. Dis Esophagus 2014;27:678-84. [PMID: 24147973 DOI: 10.1111/dote.12146] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 5.1] [Reference Citation Analysis]
494 Ho SY, Hsu CY, Liu PH, Lee RC, Ko CC, Huang YH, Su CW, Hou MC, Huo TI. Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Dig Dis Sci 2021;66:1730-8. [PMID: 32548811 DOI: 10.1007/s10620-020-06384-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
495 Rossi CR, Vecchiato A, Foletto M, Nitti D, Ninfo V, Fornasiero A, Sotti G, Tregnaghi A, Melanotte P, Lise M. Phase II study on neoadjuvant hyperthermic-antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomas. Cancer 1994;73:2140-6. [PMID: 8156518 DOI: 10.1002/1097-0142(19940415)73:8<2140::aid-cncr2820730819>3.0.co;2-0] [Cited by in Crossref: 61] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
496 Han KH, Hwang IC, Kim S, Bae JM, Kim YW, Ryu KW, Lee JH, Noh JH, Sohn TS, Shin DW, Yun YH. Factors associated with depression in disease-free stomach cancer survivors. J Pain Symptom Manage 2013;46:511-22. [PMID: 23489829 DOI: 10.1016/j.jpainsymman.2012.10.234] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
497 Bradbury P, Seymour L. Tumor shrinkage and objective response rates: gold standard for oncology efficacy screening trials, or an outdated end point? Cancer J 2009;15:354-60. [PMID: 19826353 DOI: 10.1097/PPO.0b013e3181b9c506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
498 Chen W, Fernandes ML, Lin C, Lin S. Delay in treatment of early-stage hepatocellular carcinoma using radiofrequency ablation may impact survival of cirrhotic patients in a surveillance program: Delay in RFA for HCC Impacts Survival. J Surg Oncol 2011;103:133-9. [DOI: 10.1002/jso.21797] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
499 Mantovani G, Macciò A, Madeddu C, Gramignano G, Serpe R, Massa E, Dessì M, Tanca FM, Sanna E, Deiana L, Panzone F, Contu P, Floris C. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results. Nutrition 2008;24:305-13. [DOI: 10.1016/j.nut.2007.12.010] [Cited by in Crossref: 64] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
500 Holch P, Warrington L, Potrata B, Ziegler L, Hector C, Keding A, Harley C, Absolom K, Morris C, Bamforth L, Velikova G. Asking the right questions to get the right answers: using cognitive interviews to review the acceptability, comprehension and clinical meaningfulness of patient self-report adverse event items in oncology patients. Acta Oncologica 2016;55:1220-6. [DOI: 10.1080/0284186x.2016.1213878] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 3.6] [Reference Citation Analysis]
501 Young J, Badgery-Parker T, Dobbins T, Jorgensen M, Gibbs P, Faragher I, Jones I, Currow D. Comparison of ECOG/WHO performance status and ASA score as a measure of functional status. J Pain Symptom Manage. 2015;49:258-264. [PMID: 24996034 DOI: 10.1016/j.jpainsymman.2014.06.006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 39] [Article Influence: 8.1] [Reference Citation Analysis]
502 Rossi M, Dastidar P, Pertovaara H, Järvenpää R, Luukkaala T, Kellokumpu-lehtinen P, Rautakunnas S, Heinonen T, Soimakallio S, Eskola H. Response Analysis of Non-Hodgkin Lymphoma Using Magnetic Resonance Imaging-Based Volumes: . Journal of Computer Assisted Tomography 2009;33:466-74. [DOI: 10.1097/rct.0b013e31818337d3] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
503 West MA, Dimitrov BD, Moyses HE, Kemp GJ, Loughney L, White D, Grocott MP, Jack S, Brown G. Timing of surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer - A comparison of magnetic resonance imaging at two time points and histopathological responses. Eur J Surg Oncol 2016;42:1350-8. [PMID: 27160356 DOI: 10.1016/j.ejso.2016.04.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
504 Forde JC, Daly PJ, White S, Morrin M, Smyth GP, O’neill BDP, Power RE. A single centre experience of active surveillance as management strategy for low-risk prostate cancer in Ireland. Ir J Med Sci 2014;183:377-82. [DOI: 10.1007/s11845-013-1024-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
505 Takuma Y, Takabatake H, Morimoto Y, Toshikuni N, Kayahara T, Makino Y, Yamamoto H. Comparison of Combined Transcatheter Arterial Chemoembolization and Radiofrequency Ablation with Surgical Resection by Using Propensity Score Matching in Patients with Hepatocellular Carcinoma within Milan Criteria. Radiology 2013;269:927-37. [DOI: 10.1148/radiol.13130387] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 7.4] [Reference Citation Analysis]
506 Zhang Y, Li Y, Cai Y, Wang K, Li H. Efficacy of sorafenib correlates with Memorial Sloan-Kettering Cancer Center (MSKCC) risk classification and bone metastasis in Chinese patients with metastatic renal cell carcinoma. Cell Oncol 2016;39:15-21. [DOI: 10.1007/s13402-015-0245-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
507 Baratti D, Kusamura S, Nonaka D, Cabras AD, Laterza B, Deraco M. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2009;249:243-249. [PMID: 19212177 DOI: 10.1097/sla.0b013e31818eec64] [Cited by in Crossref: 67] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
508 Duan ZY, Liu JQ, Yin P, Li JJ, Cai GY, Chen XM. Impact of aging on the risk of platinum-related renal toxicity: A systematic review and meta-analysis. Cancer Treat Rev 2018;69:243-53. [PMID: 30121504 DOI: 10.1016/j.ctrv.2018.07.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
509 Huang C, Lin Z, Su I, Chao T, Tien H, Chang M, Huang M, Kao W, Tang J, Yeh K, Wang C, Hsu C, Liu M, Cheng A. Combination of 13-cis Retinoic Acid and Interferon-α in the Treatment of Recurrent or Refractory Peripheral T-cell Lymphoma. Leukemia & Lymphoma 2009;43:1415-20. [DOI: 10.1080/1042819022386806] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
510 Anderson KO, Mendoza TR, Payne R, Valero V, Palos GR, Nazario A, Richman SP, Hurley J, Gning I, Lynch GR, Kalish D, Cleeland CS. Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol. 2004;22:4918-4925. [PMID: 15611506 DOI: 10.1200/jco.2004.06.115] [Cited by in Crossref: 71] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
511 Caccialanza R, Palladini G, Klersy C, Cena H, Vagia C, Cameletti B, Russo P, Lavatelli F, Merlini G. Nutritional status of outpatients with systemic immunoglobulin light-chain amyloidosis 1. Am J Clin Nutr 2006;83:350-4. [PMID: 16469994 DOI: 10.1093/ajcn/83.2.350] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
512 Eskander MF, Bliss LA, Tseng JF. Pancreatic adenocarcinoma. Current Problems in Surgery 2016;53:107-54. [DOI: 10.1067/j.cpsurg.2016.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
513 Roghmann M, Wallin MT, Gorman PH, Johnson JA. Prevalence and Natural History of Colonization With Fluoroquinolone-Resistant Gram-Negative Bacilli in Community-Dwelling People With Spinal Cord Dysfunction. Archives of Physical Medicine and Rehabilitation 2006;87:1305-9. [DOI: 10.1016/j.apmr.2006.07.260] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
514 Liu WP, Wang XP, Zheng W, Ping LY, Zhang C, Wang GQ, Song YQ, Zhu J. Hepatitis B virus reactivation after withdrawal of prophylactic antiviral therapy in patients with diffuse large B cell lymphoma. Leuk Lymphoma. 2016;57:1355-1362. [PMID: 26727044 DOI: 10.3109/10428194.2015.1116121] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
515 Liu ES, Burian C, Miller WE, Saven A. Bolus administration of cladribine in the treatment of Waldenström macroglobulinaemia: Bolus Cladribine in WM. British Journal of Haematology 1998;103:690-5. [DOI: 10.1046/j.1365-2141.1998.01069.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
516 Hernberg M, Mattila PS, Rissanen M, Hansson J, Aamdal S, Bastholt L, von der Maase H, Schmidt H, Stierner U, Tarkkanen J. The prognostic role of blood lymphocyte subset distribution in patients with resected high-risk primary or regionally metastatic melanoma. J Immunother 2007;30:773-9. [PMID: 17893569 DOI: 10.1097/CJI.0b013e31814e0898] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
517 Laribi K, Tempescul A, Ghnaya H, Denizon N, Besançon A, Anghel A, Farhi J, Truong C, Lemaire P, Poulain S, Bolle D, Ianotto JC, Baugier de Materre A. The bendamustine plus rituximab regimen is active against primary nodal marginal zone B-cell lymphoma. Hematol Oncol 2017;35:536-41. [PMID: 27443419 DOI: 10.1002/hon.2334] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
518 Kasai K, Ushio A, Kasai Y, Sawara K, Miyamoto Y, Oikawa K, Kuroda H, Takikawa Y, Suzuki K. Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion. Cancer. 2012;118:3302-3310. [PMID: 22072099 DOI: 10.1002/cncr.26648] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
519 Secord AA, Coleman RL, Havrilesky LJ, Abernethy AP, Samsa GP, Cella D. Patient-reported outcomes as end points and outcome indicators in solid tumours. Nat Rev Clin Oncol 2015;12:358-70. [DOI: 10.1038/nrclinonc.2015.29] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
520 Verhoef MJ, de Nijs EJM, Fiocco M, Heringhaus C, Horeweg N, van der Linden YM. Surprise Question and Performance Status Indicate Urgency of Palliative Care Needs in Patients with Advanced Cancer at the Emergency Department: An Observational Cohort Study. J Palliat Med 2020;23:801-8. [PMID: 31880489 DOI: 10.1089/jpm.2019.0413] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
521 Sadikov E, Bezjak A, Yi QL, Wells W, Dawson L, Millar BA, Laperriere N. Value of whole brain re-irradiation for brain metastases--single centre experience. Clin Oncol (R Coll Radiol) 2007;19:532-8. [PMID: 17662582 DOI: 10.1016/j.clon.2007.06.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
522 Kinnane N, Stuart E, Thompson L, Evans K, Schneider-kolsky M. Evaluation of the addition of video-based education for patients receiving standard pre-chemotherapy education. European Journal of Cancer Care 2008;17:328-39. [DOI: 10.1111/j.1365-2354.2007.00846.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
523 Tateishi U, Kawai A, Chuman H, Nakatani F, Beppu Y, Seki K, Miyake M, Terauchi T, Moriyama N, Kim EE. PET/CT allows stratification of responders to neoadjuvant chemotherapy for high-grade sarcoma: a prospective study. Clin Nucl Med 2011;36:526-32. [PMID: 21637052 DOI: 10.1097/RLU.0b013e3182175856] [Cited by in Crossref: 30] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
524 Hua Y, Ma S, Fu Z, Hu Q, Wang L, Piao Y. Intracavity hyperthermia in nasopharyngeal cancer: A phase III clinical study. International Journal of Hyperthermia 2011;27:180-6. [DOI: 10.3109/02656736.2010.503982] [Cited by in Crossref: 57] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
525 Ger LP, Ho ST, Wang JJ, Cherng CH. The prevalence and severity of cancer pain: a study of newly-diagnosed cancer patients in Taiwan. J Pain Symptom Manage 1998;15:285-93. [PMID: 9654833 DOI: 10.1016/s0885-3924(98)00017-7] [Cited by in Crossref: 60] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
526 Kavanagh B, Anscher M, Leopold K, Deutsch M, Gaydica E, Dodge R, Allen K, Allen D, Staub W, Montana G. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990. Int J Radiat Oncol Biol Phys. 1992;24:633-642. [PMID: 1429085 DOI: 10.1016/0360-3016(92)90708-P] [Cited by in Crossref: 63] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
527 Saven A, Burian C, Koziol JA, Piro LD. Long-Term Follow-Up of Patients With Hairy Cell Leukemia After Cladribine Treatment. Blood 1998;92:1918-26. [DOI: 10.1182/blood.v92.6.1918.418k33_1918_1926] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
528 Seiwert TY, Burtness B, Mehra R, Weiss J, Berger R, Eder JP, Heath K, McClanahan T, Lunceford J, Gause C, Cheng JD, Chow LQ. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. Lancet Oncol. 2016;17:956-965. [PMID: 27247226 DOI: 10.1016/S1470-2045(16)30066-3] [Cited by in Crossref: 832] [Cited by in F6Publishing: 438] [Article Influence: 166.4] [Reference Citation Analysis]
529 Martin RC, Scoggins CR, Mc Masters KM. A phase II study of radiofrequency ablation of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy. J Surg Oncol 2006;93:387-93. [DOI: 10.1002/jso.20463] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
530 Castagneto B, Stevani I, Giorcelli L, Montefiore F, Bigatti GL, Pisacco P, Cosimi MF. Sustained response following sorafenib therapy in an older adult patient with advanced renal cancer on hemodialysis: a case report. Med Oncol 2011;28:1384-8. [DOI: 10.1007/s12032-010-9595-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
531 Ibrahim E, Ezzat A, Raja M, Rahal M, Ajarim D, Mann B, Baloush A, Stuart R, Bazarbashi S. Primary gastric non-Hodgkin's lymphoma: Clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma. Annals of Oncology 1999;10:1441-9. [DOI: 10.1023/a:1008325823967] [Cited by in Crossref: 24] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
532 Bentley R, Hussain A, Maddocks M, Wilcock A. Occupational therapy needs of patients with thoracic cancer at the time of diagnosis: findings of a dedicated rehabilitation service. Support Care Cancer 2013;21:1519-24. [DOI: 10.1007/s00520-012-1687-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
533 Dorman S, Jolley C, Abernethy A, Currow D, Johnson M, Farquhar M, Griffiths G, Peel T, Moosavi S, Byrne A, Wilcock A, Alloway L, Bausewein C, Higginson I, Booth S. Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup. Palliat Med 2009;23:213-27. [PMID: 19251835 DOI: 10.1177/0269216309102520] [Cited by in Crossref: 69] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]
534 Oliveira PD, Farre L, Bittencourt AL. Adult T-cell leukemia/lymphoma. Rev Assoc Med Bras 2016;62:691-700. [DOI: 10.1590/1806-9282.62.07.691] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
535 Colleoni M, Buzzoni R, Bajetta E, Bochicchio AM, Bartoli C, Audisio R, Bonfanti G, Nolè F. A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinoma. Cancer 1993;72:3196-201. [DOI: 10.1002/1097-0142(19931201)72:11<3196::aid-cncr2820721111>3.0.co;2-q] [Cited by in Crossref: 33] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
536 Uster A, Ruehlin M, Mey S, Gisi D, Knols R, Imoberdorf R, Pless M, Ballmer PE. Effects of nutrition and physical exercise intervention in palliative cancer patients: A randomized controlled trial. Clin Nutr. 2017;pii: S0261-5614(17)30201-7. [PMID: 28651827 DOI: 10.1016/j.clnu.2017.05.027] [Cited by in Crossref: 42] [Cited by in F6Publishing: 25] [Article Influence: 10.5] [Reference Citation Analysis]
537 Barbosa BJ, Dimostheni A, Teixeira MJ, Tatagiba M, Lepski G. Insular gliomas and the role of intraoperative assistive technologies: Results from a volumetry-based retrospective cohort. Clin Neurol Neurosurg 2016;149:104-10. [PMID: 27509592 DOI: 10.1016/j.clineuro.2016.08.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
538 Bruggeman AR, Kamal AH, LeBlanc TW, Ma JD, Baracos VE, Roeland EJ. Cancer Cachexia: Beyond Weight Loss. J Oncol Pract 2016;12:1163-71. [PMID: 27858548 DOI: 10.1200/JOP.2016.016832] [Cited by in Crossref: 85] [Cited by in F6Publishing: 37] [Article Influence: 21.3] [Reference Citation Analysis]
539 Gills J, Parker WP, Pate S, Niu S, Van Veldhuizen P, Mirza M, Holzbeierlein JM, Lee EK. The Role of High Dose Interleukin-2 in the Era of Targeted Therapy. J Urol 2017;198:538-45. [PMID: 28288839 DOI: 10.1016/j.juro.2017.03.076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
540 Boulanger E, Gérard L, Gabarre J, Molina J, Rapp C, Abino J, Cadranel J, Chevret S, Oksenhendler E. Prognostic Factors and Outcome of Human Herpesvirus 8–Associated Primary Effusion Lymphoma in Patients With AIDS. JCO 2005;23:4372-80. [DOI: 10.1200/jco.2005.07.084] [Cited by in Crossref: 211] [Cited by in F6Publishing: 76] [Article Influence: 13.2] [Reference Citation Analysis]
541 Mathieu R, Pignot G, Ingles A, Crepel M, Bigot P, Bernhard JC, Joly F, Guy L, Ravaud A, Azzouzi AR, Gravis G, Chevreau C, Zini L, Lang H, Pfister C, Lechevallier E, Fais PO, Berger J, Vayleux B, Roupret M, Audenet F, Descazeaud A, Rigaud J, Machiels JP, Staehler M, Salomon L, Ferriere JM, Kleinclauss F, Bensalah K, Patard JJ. Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features. Urol Oncol 2015;33:339.e9-15. [PMID: 26087971 DOI: 10.1016/j.urolonc.2015.05.014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 6.3] [Reference Citation Analysis]
542 Belch A, Kouroukis CT, Crump M, Sehn L, Gascoyne RD, Klasa R, Powers J, Wright J, Eisenhauer EA. A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150. Ann Oncol 2007;18:116-21. [PMID: 16971665 DOI: 10.1093/annonc/mdl316] [Cited by in Crossref: 120] [Cited by in F6Publishing: 97] [Article Influence: 8.0] [Reference Citation Analysis]
543 Butt Z, Wagner LI, Beaumont JL, Paice JA, Peterman AH, Shevrin D, Von Roenn JH, Carro G, Straus JL, Muir JC, Cella D. Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage 2008;35:20-30. [PMID: 17959345 DOI: 10.1016/j.jpainsymman.2007.02.040] [Cited by in Crossref: 117] [Cited by in F6Publishing: 83] [Article Influence: 8.4] [Reference Citation Analysis]
544 Al-Ali HK, Jaekel N, Niederwieser D. The role of hypomethylating agents in the treatment of elderly patients with AML. J Geriatr Oncol 2014;5:89-105. [PMID: 24484723 DOI: 10.1016/j.jgo.2013.08.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
545 Sparano JA, Bernardo P, Stephenson P, Gradishar WJ, Ingle JN, Zucker S, Davidson NE. Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196. J Clin Oncol 2004;22:4683-90. [PMID: 15570070 DOI: 10.1200/JCO.2004.08.054] [Cited by in Crossref: 144] [Cited by in F6Publishing: 66] [Article Influence: 9.0] [Reference Citation Analysis]
546 Moreau A, Lengline E, Seguin A, Lemiale V, Canet E, Raffoux E, Schlemmer B, Azoulay E. Respiratory events at the earliest phase of acute myeloid leukemia. Leukemia & Lymphoma 2014;55:2556-63. [DOI: 10.3109/10428194.2014.887709] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
547 Buzio C, Andrulli S, Santi R, Pavone L, Passalacqua R, Potenzoni D, Ferrozzi F, Giacosa R, Vaglio A. Long-term immunotherapy with low-dose interleukin-2 and interferon-? in the treatment of patients with advanced renal cell carcinoma. Cancer 2001;92:2286-96. [DOI: 10.1002/1097-0142(20011101)92:9<2286::aid-cncr1575>3.0.co;2-i] [Cited by in Crossref: 40] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
548 Okabayashi T, Shima Y, Iwata J, Morita S, Sumiyoshi T, Kozuki A, Iiyama T, Nishioka A, Matsumoto M. Is a surgical approach justified for octogenarians with pancreatic carcinoma? Projecting surgical decision making for octogenarian patients. The American Journal of Surgery 2016;212:896-902. [DOI: 10.1016/j.amjsurg.2015.12.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
549 Caccialanza R, Palladini G, Klersy C, Cereda E, Bonardi C, Cameletti B, Quarleri L, Montagna E, Foli A, Milani P, Lavatelli F, Marena C, Merlini G. Malnutrition at diagnosis predicts mortality in patients with systemic immunoglobulin light-chain amyloidosis independently of cardiac stage and response to treatment. JPEN J Parenter Enteral Nutr 2014;38:891-4. [PMID: 24072737 DOI: 10.1177/0148607113501328] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
550 Ando M, Morita T, Akechi T. Factors in the Short-term Life Review That Affect Spiritual Well-being in Terminally Ill Cancer Patients: . Journal of Hospice & Palliative Nursing 2010;12:305-11. [DOI: 10.1097/njh.0b013e3181e53ae8] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
551 Luo J, Peng ZW, Guo RP, Zhang YQ, Li JQ, Chen MS, Shi M. Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis. Radiology. 2011;259:286-295. [PMID: 21330557 DOI: 10.1148/radiol.10101072] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
552 Pardon K, Deschepper R, Vander Stichele R, Bernheim J, Mortier F, Schallier D, Germonpré P, Galdermans D, Van Kerckhoven W, Deliens L. Are patients' preferences for information and participation in medical decision-making being met? Interview study with lung cancer patients. Palliat Med 2011;25:62-70. [PMID: 20621948 DOI: 10.1177/0269216310373169] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
553 Seki H, Shiina M. Placement of a long tapered side-hole catheter in the hepatic artery: technical advantages, catheter stability, and arterial patency. AJR Am J Roentgenol 2006;187:1312-20. [PMID: 17056922 DOI: 10.2214/AJR.05.0741] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
554 Colussi O, Voron T, Pozet A, Hammel P, Sauvanet A, Bachet J, Vaillant J, Rougier P, Nordlinger B, Berger A, Coriat R, Dousset B, Malka D, André T, Paye F, Aparicio T, Locher C, Cojean Zeleck D, Tchinou L, Bonnetain F, Taieb J. Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort. European Journal of Surgical Oncology (EJSO) 2015;41:520-6. [DOI: 10.1016/j.ejso.2015.01.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
555 Vigano A, Piccioni M, Trutschnigg B, Hornby L, Chaudhury P, Kilgour R. Male hypogonadism associated with advanced cancer: a systematic review. The Lancet Oncology 2010;11:679-84. [DOI: 10.1016/s1470-2045(10)70021-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
556 Boukovinas I, Kosmidis P. Treatment of non-small cell lung cancer patients with performance status2 (PS2). Lung Cancer 2009;63:10-5. [DOI: 10.1016/j.lungcan.2008.05.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
557 Harle ASM, Blackhall FH, Molassiotis A, Yorke J, Dockry R, Holt KJ, Yuill D, Baker K, Smith JA. Cough in Patients With Lung Cancer: A Longitudinal Observational Study of Characterization and Clinical Associations. Chest 2019;155:103-13. [PMID: 30321508 DOI: 10.1016/j.chest.2018.10.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
558 Mazza P, Zinzani PL, Martelli M, Fiacchini M, Bocchia M, Pileri S, Falini B, Martelli MF, Amadori S, Papa G. MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas. Leuk Lymphoma 1995;16:457-63. [PMID: 7540460 DOI: 10.3109/10428199509054434] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
559 Devriese LA, Witteveen PO, Marchetti S, Mergui-roelvink M, Reyderman L, Wanders J, Jenner A, Edwards G, Beijnen JH, Voest EE, Schellens JHM. Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment. Cancer Chemother Pharmacol 2012;70:823-32. [DOI: 10.1007/s00280-012-1976-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
560 Filicko J, Lazarus HM, Flomenberg N. Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment. Bone Marrow Transplant 2003;31:1-10. [DOI: 10.1038/sj.bmt.1703776] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
561 Quaglino P, Knobler R, Fierro MT, Savoia P, Marra E, Fava P, Bernengo MG. Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature. Int J Dermatol 2013;52:1308-18. [PMID: 23786842 DOI: 10.1111/ijd.12121] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
562 Tomimaru Y, Fukuchi N, Yokoyama S, Mori T, Tanemura M, Sakai K, Takeda Y, Tsujie M, Yamada T, Miyamoto A, Hashimoto Y, Hatano H, Shimizu J, Sugimoto K, Kashiwazaki M, Kobayashi S, Doki Y, Eguchi H. Optimal timing of laparoscopic cholecystectomy after gallbladder drainage for acute cholecystitis: A multi‐institutional retrospective study. J Hepatobiliary Pancreat Sci 2020;27:451-60. [DOI: 10.1002/jhbp.768] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
563 Gauden AJ, Hunn A, Erasmus A, Waites P, Dubey A, Gauden SJ. Combined modality treatment of newly diagnosed glioblastoma multiforme in a regional neurosurgical centre. Journal of Clinical Neuroscience 2009;16:1174-9. [DOI: 10.1016/j.jocn.2008.12.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
564 Ochiai K, Sasaki H, Terashima Y, Fukushima M. Prognostic Factor Analysis and Treatment Results of Ovarian Cancer in Japan. Int J Technol Assess Health Care 1994;10:406-25. [DOI: 10.1017/s0266462300006644] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
565 Tateiwa D, Oshima K, Nakai T, Imura Y, Tanaka T, Outani H, Tamiya H, Araki N, Naka N. Clinical outcomes and significant factors in the survival rate after decompression surgery for patients who were non-ambulatory due to spinal metastases. J Orthop Sci. 2019;24:347-352. [PMID: 30482604 DOI: 10.1016/j.jos.2018.10.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
566 Martin L, Watanabe S, Fainsinger R, Lau F, Ghosh S, Quan H, Atkins M, Fassbender K, Downing GM, Baracos V. Prognostic Factors in Patients With Advanced Cancer: Use of the Patient-Generated Subjective Global Assessment in Survival Prediction. JCO 2010;28:4376-83. [DOI: 10.1200/jco.2009.27.1916] [Cited by in Crossref: 86] [Cited by in F6Publishing: 21] [Article Influence: 7.8] [Reference Citation Analysis]
567 Kayama T, Sato S, Sakurada K, Mizusawa J, Nishikawa R, Narita Y, Sumi M, Miyakita Y, Kumabe T, Sonoda Y, Arakawa Y, Miyamoto S, Beppu T, Sugiyama K, Nakamura H, Nagane M, Nakasu Y, Hashimoto N, Terasaki M, Matsumura A, Ishikawa E, Wakabayashi T, Iwadate Y, Ohue S, Kobayashi H, Kinoshita M, Asano K, Mukasa A, Tanaka K, Asai A, Nakamura H, Abe T, Muragaki Y, Iwasaki K, Aoki T, Watanabe T, Sasaki H, Izumoto S, Mizoguchi M, Matsuo T, Takeshima H, Hayashi M, Jokura H, Mizowaki T, Shimizu E, Shirato H, Tago M, Katayama H, Fukuda H, Shibui S; Japan Clinical Oncology Group. Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial. J Clin Oncol 2018;:JCO2018786186. [PMID: 29924704 DOI: 10.1200/JCO.2018.78.6186] [Cited by in Crossref: 42] [Cited by in F6Publishing: 18] [Article Influence: 14.0] [Reference Citation Analysis]
568 Peters S, Voelter V, Zografos L, Pampallona S, Popescu R, Gillet M, Bosshard W, Fiorentini G, Lotem M, Weitzen R, Keilholz U, Humblet Y, Piperno-neumann S, Stupp R, Leyvraz S. Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients. Annals of Oncology 2006;17:578-83. [DOI: 10.1093/annonc/mdl009] [Cited by in Crossref: 79] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
569 Rha SY, Park Y, Song SK, Lee CE, Lee J. Caregiving burden and the quality of life of family caregivers of cancer patients: the relationship and correlates. European Journal of Oncology Nursing 2015;19:376-82. [DOI: 10.1016/j.ejon.2015.01.004] [Cited by in Crossref: 66] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
570 Nicholls L, Keir GJ, Murphy MA, Mai T, Lehman M. Prophylactic cranial irradiation in small cell lung cancer: A single institution experience. Asia Pac J Clin Oncol 2016;12:415-20. [PMID: 27453519 DOI: 10.1111/ajco.12564] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
571 Enting RH, Oldenmenger WH, Van Gool AR, van der Rijt CC, Sillevis Smitt PA. The Effects of Analgesic Prescription and Patient Adherence on Pain in a Dutch Outpatient Cancer Population. Journal of Pain and Symptom Management 2007;34:523-31. [DOI: 10.1016/j.jpainsymman.2007.01.007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
572 Lo C, Burman D, Swami N, Gagliese L, Rodin G, Zimmermann C. Validation of the QUAL-EC for assessing quality of life in patients with advanced cancer. European Journal of Cancer 2011;47:554-60. [DOI: 10.1016/j.ejca.2010.10.027] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
573 Schofield P, Ugalde A, Gough K, Reece J, Krishnasamy M, Carey M, Ball D, Aranda S. A tailored, supportive care intervention using systematic assessment designed for people with inoperable lung cancer: a randomised controlled trial. Psychooncology 2013;22:2445-53. [PMID: 23733720 DOI: 10.1002/pon.3306] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
574 Wong DJ, Smee RI. Sinonasal carcinomas - A single-centre experience at Prince of Wales Hospital, Sydney, Australia, from 1994 to 2016. J Med Imaging Radiat Oncol 2020;64:450-9. [PMID: 32307914 DOI: 10.1111/1754-9485.13034] [Reference Citation Analysis]
575 Mystakidou K, Parpa E, Tsilika E, Panagiotou I, Zygogianni A, Giannikaki E, Gouliamos A. Geriatric depression in advanced cancer patients: the effect of cognitive and physical functioning. Geriatr Gerontol Int 2013;13:281-8. [PMID: 22694340 DOI: 10.1111/j.1447-0594.2012.00891.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
576 Deraco M, Virzì S, Iusco DR, Puccio F, Macrì A, Famulari C, Solazzo M, Bonomi S, Grassi A, Baratti D. Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study. BJOG. 2012;119:800-809. [PMID: 22571746 DOI: 10.1111/j.1471-0528.2011.03207.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
577 Zujewski JA, Eng-wong J, O'shaughnessy J, Venzon D, Chow C, Danforth D, Kohler DR, Cusack G, Riseberg D, Cowan KH. A Pilot Study of Dose Intense Doxorubicin and Cyclophosphamide Followed by Infusional Paclitaxel in High-Risk Primary Breast Cancer. Breast Cancer Res Treat 2003;81:41-51. [DOI: 10.1023/a:1025421416674] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
578 Schiavina R, Serni S, Mari A, Antonelli A, Bertolo R, Bianchi G, Brunocilla E, Borghesi M, Carini M, Longo N, Martorana G, Mirone V, Morgia G, Porpiglia F, Rocco B, Rovereto B, Simeone C, Sodano M, Terrone C, Ficarra V, Minervini A. A Prospective, Multicenter Evaluation of Predictive Factors for Positive Surgical Margins After Nephron-Sparing Surgery for Renal Cell Carcinoma: The RECORd1 Italian Project. Clinical Genitourinary Cancer 2015;13:165-70. [DOI: 10.1016/j.clgc.2014.08.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
579 Tamburini M, Casali PG, Miccinesi G. Outcome assessment in cancer management. Surg Clin North Am 2000;80:471-86, viii. [PMID: 10836002 DOI: 10.1016/s0039-6109(05)70196-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
580 Falkson G, Macintyre JM, Moertel CG. Eastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer 1984;54:965-9. [DOI: 10.1002/1097-0142(19840915)54:6<965::aid-cncr2820540603>3.0.co;2-x] [Cited by in Crossref: 153] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
581 Paquette M, Truong PT, Hart J, Jones SO, Martens B, Christie JL, Alexander C, Joe H. Primary Sarcoma of the Mediastinum: A Report of 16 Cases Referred to the British Columbia Cancer Agency. Journal of Thoracic Oncology 2010;5:898-906. [DOI: 10.1097/jto.0b013e3181d8fe80] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
582 Araujo LH, Baldotto CS, Zukin M, Vieira FM, Victorino AP, Rocha VR, Helal RC, Salem JH, Teich N, Ferreira CG. Survival and prognostic factors in patients with non-small cell lung cancer treated in private health care. Rev Bras Epidemiol 2014;17:1001-14. [PMID: 25388498 DOI: 10.1590/1809-4503201400040017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
583 Tsilika E, Parpa E, Panagiotou I, Roumeliotou A, Kouloulias V, Gennimata V, Galanos A, Mystakidou K. Reliability and Validity of the Greek Version of Patient Generated-Subjective Global Assessment in Cancer Patients. Nutrition and Cancer 2015;67:899-905. [DOI: 10.1080/01635581.2015.1055364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
584 Waziry R, Gomaa A, Waked I, Dore GJ. Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era. Arab J Gastroenterol 2018;19:26-32. [PMID: 29506913 DOI: 10.1016/j.ajg.2018.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
585 Roque DM, Ratner ES, Silasi DA, Azodi M, Rutherford TJ, Schwartz PE, Nelson WK, Santin AD. Weekly ixabepilone with or without biweekly bevacizumab in the treatment of recurrent or persistent uterine and ovarian/primary peritoneal/fallopian tube cancers: A retrospective review. Gynecol Oncol 2015;137:392-400. [PMID: 25792179 DOI: 10.1016/j.ygyno.2015.03.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
586 Hurwitz HI, Fehrenbacher L, Hainsworth JD, Heim W, Berlin J, Holmgren E, Hambleton J, Novotny WF, Kabbinavar F. Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. J Clin Oncol. 2005;23:3502-3508. [PMID: 15908660 DOI: 10.1200/jco.2005.10.017] [Cited by in Crossref: 484] [Cited by in F6Publishing: 142] [Article Influence: 30.3] [Reference Citation Analysis]
587 Spiliotis J, Iavazzo C, Fotiou A, Kopanakis N, Terra A, Efstathiou E, Margari C, Tsiatas M. Upfront or intermediate treatment of advanced ovarian cancer patients with cytoreduction plus HIPEC: Results of a retrospective study. J Surg Oncol 2021;123:630-7. [PMID: 33125733 DOI: 10.1002/jso.26280] [Reference Citation Analysis]
588 Conte PF, Guarneri V, Bruzzi P, Prochilo T, Salvadori B, Bolognesi A, Aldrighetti D, Venturini M, Rosso R, Mammoliti S, Carnino F, Giannessi P, Costantini M, Moyano A, Baldini E; on behalf of the Gruppo Oncologico Nord Ovest. Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: Results from the Gruppo Oncologico Nord Ovest Randomized Trial. Cancer 2004;101:704-12. [DOI: 10.1002/cncr.20400] [Cited by in Crossref: 55] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
589 Williams J, Heppel NH, Britt-compton B, Grimstead JW, Jones RE, Tauro S, Bowen DT, Knapper S, Groves M, Hills RK, Pepper C, Baird DM, Fegan C. Telomere length is an independent prognostic marker in MDS but not in de novo AML. Br J Haematol 2017;178:240-9. [DOI: 10.1111/bjh.14666] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
590 Seki H, Ozaki T, Ooi H. Dual-phase CT angiography through the port-catheter system for hepatic arterial infusion chemotherapy using multislice CT: assessment of system dysfunction and impact on predicting clinical problems. Acta Radiol 2012;53:1026-34. [DOI: 10.1258/ar.2012.120174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
591 Zinzani PL, Gherlinzoni F, Bendandi M, Zaccaria A, Aitini E, Salvucci M, Tura S. Fludarabine treatment in resistant Waldenstrom's macroglobulinemia. European Journal of Haematology 1995;54:120-3. [DOI: 10.1111/j.1600-0609.1995.tb01779.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
592 Wheelwright SJ, Hopkinson JB, Darlington A, Fitzsimmons DF, Fayers P, Balstad TR, Bredart A, Hammerlid E, Kaasa S, Nicolatou-galitis O, Pinto M, Schmidt H, Solheim TS, Strasser F, Tomaszewska IM, Johnson CD. Development of the EORTC QLQ-CAX24, A Questionnaire for Cancer Patients With Cachexia. Journal of Pain and Symptom Management 2017;53:232-42. [DOI: 10.1016/j.jpainsymman.2016.09.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
593 Tanasale B, Kits J, Kluin PM, Trip A, Kluin-nelemans HC. Pain and Anxiety During Bone Marrow Biopsy. Pain Management Nursing 2013;14:310-7. [DOI: 10.1016/j.pmn.2011.06.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
594 Koch KM, Im YH, Kim SB, Urruticoechea Ribate A, Stephenson J, Botbyl J, Cartee L, Holshouser J, Ridgway D. Effects of Esomeprazole on the Pharmacokinetics of Lapatinib in Breast Cancer Patients. Clin Pharmacol Drug Dev 2013;2:336-41. [PMID: 27121938 DOI: 10.1002/cpdd.45] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
595 Hsu CY, Lee YH, Hsia CY, Huang YH, Su CW, Lin HC, Chiou YY, Lee FY, Huo TI. Performance status enhances the selection of treatment for patients with hepatocellular carcinoma within the milan criteria. Ann Surg Oncol 2013;20:2035-42. [PMID: 23306955 DOI: 10.1245/s10434-012-2847-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
596 Francini G, Petrioli R, Aquino A, Gonnelli S. Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mitomycin C. Cancer Chemother Pharmacol 1993;32:359-64. [DOI: 10.1007/bf00735919] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
597 Raper SE, Wilson JM, Yudkoff M, Robinson MB, Ye X, Batshaw ML. Developing adenoviral-mediated in vivo gene therapy for ornithine transcarbamylase deficiency. J Inherit Metab Dis 1998;21:119-37. [DOI: 10.1023/a:1005369926784] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
598 Waki F, Masuoka K, Fukuda T, Kanda Y, Nakamae M, Yakushijin K, Togami K, Nishiwaki K, Ueda Y, Kawano F, Kasai M, Nagafuji K, Hagihara M, Hatanaka K, Taniwaki M, Maeda Y, Shirafuji N, Mori T, Utsunomiya A, Eto T, Nakagawa H, Murata M, Uchida T, Iida H, Yakushiji K, Yamashita T, Wake A, Takahashi S, Takaue Y, Taniguchi S. Feasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of adult patients. Biol Blood Marrow Transplant 2011;17:841-51. [PMID: 20849969 DOI: 10.1016/j.bbmt.2010.09.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
599 Peng M, Liu C, Hung Y, Kao C, Chang P, Yeh K, Wang H, Lin Y, Chou W. Sequential Assessments of the Eastern Cooperative Oncology Group Performance Scale Enhance Prognostic Value in Patients With Terminally Ill Cancer Receiving Palliative Care. Am J Hosp Palliat Care 2016;33:471-6. [DOI: 10.1177/1049909114566226] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
600 Ueda K, Kaneda Y, Sudoh M, Mitsutaka J, Tanaka N, Suga K, Hamano K. Role of Quantitative CT in Predicting Hypoxemia and Complications After Lung Lobectomy for Cancer, With Special Reference to Area of Emphysema. Chest 2005;128:3500-6. [DOI: 10.1378/chest.128.5.3500] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
601 Suzuki M, Mizoi K, Yoshimoto T. Should meningiomas involving the cavernous sinus be totally resected? Surgical Neurology 1995;44:3-13. [DOI: 10.1016/0090-3019(95)00129-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
602 Robertson G, Greenlaw N, Bray CA, Morrison DS. Explaining the effects of socio-economic deprivation on survival in a national prospective cohort study of 1909 patients with head and neck cancers. Cancer Epidemiology 2010;34:682-8. [DOI: 10.1016/j.canep.2010.05.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
603 Pardon K, Deschepper R, Stichele RV, Bernheim J, Mortier F, Deliens L; EOLIC-consortium. Preferences of advanced lung cancer patients for patient-centred information and decision-making: a prospective multicentre study in 13 hospitals in Belgium. Patient Educ Couns 2009;77:421-9. [PMID: 19828279 DOI: 10.1016/j.pec.2009.09.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
604 Guarneri V, Bengala C, Orlandini C, Gennari A, Donati S, Campani D, Collecchi P, Maur M, Conte PF. HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support. Bone Marrow Transplant 2004;34:413-7. [DOI: 10.1038/sj.bmt.1704619] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
605 Ito H, Inoue H, Hasegawa K, Hasegawa Y, Shimizu T, Kimura S, Onimaru M, Ikeda H, Kudo SE. Use of surface-enhanced Raman scattering for detection of cancer-related serum-constituents in gastrointestinal cancer patients. Nanomedicine. 2014;10:599-608. [PMID: 24103303 DOI: 10.1016/j.nano.2013.09.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
606 Shi Q, Mendoza TR, Dueck AC, Ma H, Zhang J, Qian Y, Bhowmik D, Cleeland CS. Determination of mild, moderate, and severe pain interference in patients with cancer. Pain 2017;158:1108-12. [DOI: 10.1097/j.pain.0000000000000890] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
607 Tomimaru Y, Eguchi H, Nagano H, Wada H, Kobayashi S, Marubashi S, Tanemura M, Tomokuni A, Takemasa I, Umeshita K, Kanto T, Doki Y, Mori M. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. Journal of Hepatology 2012;56:167-75. [DOI: 10.1016/j.jhep.2011.04.026] [Cited by in Crossref: 228] [Cited by in F6Publishing: 213] [Article Influence: 25.3] [Reference Citation Analysis]
608 Goerling U, Faller H, Hornemann B, Hönig K, Bergelt C, Maatouk I, Stein B, Teufel M, Erim Y, Geiser F, Niecke A, Senf B, Wickert M, Büttner-teleaga A, Weis J. Information needs in cancer patients across the disease trajectory. A prospective study. Patient Education and Counseling 2020;103:120-6. [DOI: 10.1016/j.pec.2019.08.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
609 Wiernik PH, Dutcher JP, Todd M, Caliendo G, Benson L. Polyethylene glycolated interleukin-2 as maintenance therapy for acute myelogenous leukemia in second remission. Am J Hematol 1994;47:41-4. [DOI: 10.1002/ajh.2830470109] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
610 Kaku N, Nagashima S, Fukuda M, Takatani H, Fukuda M, Hashiguchi K, Kaku N, Yanagihara K, Morinaga Y, Izumikawa K, Kakeya H, Yamamoto Y, Kohno S, Yanagihara K, Morinaga Y. The definition of healthcare-associated pneumonia (HCAP) is insufficient for the medical environment in Japan: a comparison of HCAP and nursing and healthcare-associated pneumonia (NHCAP). Journal of Infection and Chemotherapy 2013;19:70-6. [DOI: 10.1007/s10156-012-0454-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
611 Stovell MG, Jenkinson MD. Neurosurgery in octogenarians. British Journal of Neurosurgery 2014;28:611-5. [DOI: 10.3109/02688697.2014.889809] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
612 Flöther L, Pötzsch B, Jung M, Jung R, Bucher M, Glowka A, Medenwald D. Treatment effects of palliative care consultation and patient contentment: A monocentric observational study. Medicine (Baltimore) 2021;100:e24320. [PMID: 33761631 DOI: 10.1097/MD.0000000000024320] [Reference Citation Analysis]
613 Kodama Y, Takita M, Kawagoe S, Hirahara S, Kimura Y, Onozawa S, Wada T, Nakano K, Kami M, Matsumura T, Yuji K. Retrospective Study on Home Care for Patients with Hematologic Malignancies. Japanese Journal of Clinical Oncology 2009;39:606-11. [DOI: 10.1093/jjco/hyp064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
614 Halvorsen CM, Kolstad F, Hald J, Johannesen TB, Krossnes BK, Langmoen IA, Lied B, Rønning P, Skaar S, Spetalen S, Helseth E. Long-term outcome after resection of intraspinal ependymomas: report of 86 consecutive cases. Neurosurgery 2010;67:1622-31; discussion 1631. [PMID: 21107192 DOI: 10.1227/NEU.0b013e3181f96d41] [Cited by in Crossref: 41] [Cited by in F6Publishing: 14] [Article Influence: 4.1] [Reference Citation Analysis]
615 Lee JJ, Low JA, Croarkin E, Parks R, Berman AW, Mannan N, Steinberg SM, Swain SM. Changes in Neurologic Function Tests May Predict Neurotoxicity Caused by Ixabepilone. JCO 2006;24:2084-91. [DOI: 10.1200/jco.2005.04.2820] [Cited by in Crossref: 35] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
616 Kirwan CC, Mccollum CN, Mcdowell G, Byrne GJ. Investigation of Proposed Mechanisms of Chemotherapy-Induced Venous Thromboembolism: Endothelial Cell Activation and Procoagulant Release Due to Apoptosis. Clin Appl Thromb Hemost 2015;21:420-7. [DOI: 10.1177/1076029615575071] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
617 Armstrong DK, White AJ, Weil SC, Phillips M, Coleman RL. Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer. Gynecol Oncol 2013;129:452-8. [PMID: 23474348 DOI: 10.1016/j.ygyno.2013.03.002] [Cited by in Crossref: 86] [Cited by in F6Publishing: 72] [Article Influence: 10.8] [Reference Citation Analysis]
618 Fan S, Eiser C. Illness experience in patients with hepatocellular carcinoma: an interpretative phenomenological analysis study. European Journal of Gastroenterology & Hepatology 2012;24:203-8. [DOI: 10.1097/meg.0b013e32834ec184] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
619 Ripamonti C, Fulfaro F, Ticozzi C, Casuccio A, De Conno F. Role of Pamidronate Disodium in the Treatment of Metastatic Bone Disease. Tumori 1998;84:442-55. [DOI: 10.1177/030089169808400403] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
620 Abrão RA, de Andrade JM, Tiezzi DG, Marana HRC, dos Reis FJC, Clagnan WS. Treatment for low-risk gestational trophoblastic disease: Comparison of single-agent methotrexate, dactinomycin and combination regimens. Gynecologic Oncology 2008;108:149-53. [DOI: 10.1016/j.ygyno.2007.09.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
621 Novara G, Ficarra V, D’elia C, Secco S, Cavalleri S, Artibani W. Prospective Evaluation With Standardised Criteria for Postoperative Complications After Robotic-Assisted Laparoscopic Radical Prostatectomy. European Urology 2010;57:363-70. [DOI: 10.1016/j.eururo.2009.11.032] [Cited by in Crossref: 100] [Cited by in F6Publishing: 60] [Article Influence: 9.1] [Reference Citation Analysis]
622 Kataoka Y, Yamamoto Y, Otsuki T, Shinomiya M, Terada T, Fukuma S, Yamazaki S, Hirabayashi M, Nakano T, Fukuhara S. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index. Jpn J Clin Oncol 2015;45:562-8. [PMID: 25838292 DOI: 10.1093/jjco/hyv039] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
623 Miyashita N, Kawai Y, Tanaka T, Akaike H, Teranishi H, Wakabayashi T, Nakano T, Ouchi K, Okimoto N. Detection failure rate of chest radiography for the identification of nursing and healthcare-associated pneumonia. J Infect Chemother 2015;21:492-6. [PMID: 25842163 DOI: 10.1016/j.jiac.2015.03.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
624 Meunier J, Rouïc LL, Dendale R, Vincent-salomon A, Asselain B, Arnaud P, Némati F, Fourquet A, Desjardins L, Plancher C, Levy C, Chaoui D, Validire P, Decaudin D. Conjunctival low-grade non-Hodgkin's lymphoma: a large single-center study of initial characteristics, natural history and prognostic factors. Leukemia & Lymphoma 2009;47:1295-305. [DOI: 10.1080/10428190500518966] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
625 Chu TL, Yu WP, Chen SC, Peng HL, Wu MJ. Comparison of differences and determinants between presence and absence of sleep disturbance in hepatocellular carcinoma patients. Cancer Nurs 2011;34:354-60. [PMID: 21242769 DOI: 10.1097/NCC.0b013e3182037bf3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
626 Loree JM, Javaheri KR, Lefresne SV, Speers CH, Ruan JY, Chang JT, Brown CJ, Kennecke HF, Olson RA, Cheung WY. Impact of Travel Distance and Urban-Rural Status on the Multidisciplinary Management of Rectal Cancer. J Rural Health 2017;33:393-401. [PMID: 27717002 DOI: 10.1111/jrh.12219] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
627 Wadler S, Burk RD, Neuberg D, Rameau R, Runowicz CD, Goldberg G, Mcgill F, Tachezy R, Comis R, Edmonson J, Wiernik PH. Lack of Efficacy of Interferon-α Therapy in Recurrent, Advanced Cervical Cancer. Journal of Interferon & Cytokine Research 1995;15:1011-6. [DOI: 10.1089/jir.1995.15.1011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
628 Phillips A, Singh K, Pounds R, Sundar S, Kehoe S, Nevin J, Elattar A, Balega J. Predictive value of the age-adjusted Charlston co-morbidity index on peri-operative complications, adjuvant chemotherapy usage and survival in patients undergoing debulking surgery after neo-adjuvant chemotherapy for advanced epithelial ovarian cancer. J Obstet Gynaecol 2017;37:1070-5. [PMID: 28741395 DOI: 10.1080/01443615.2017.1324413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
629 Mancuso A, Mazzola A, Cabibbo G, Perricone G, Enea M, Galvano A, Zavaglia C, Belli L, Cammà C. Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: a systematic review and meta-analysis. Dig Liver Dis 2015;47:324-30. [PMID: 25641331 DOI: 10.1016/j.dld.2015.01.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
630 Tamaki K, Fukuyama AK, Terukina S, Kamada Y, Uehara K, Arakaki M, Yamashiro K, Miyashita M, Ishida T, McNamara KM, Ohuchi N, Tamaki N, Sasano H. Randomized trial of aromatherapy versus conventional care for breast cancer patients during perioperative periods. Breast Cancer Res Treat 2017;162:523-31. [PMID: 28181131 DOI: 10.1007/s10549-017-4134-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
631 Tobinai K, Uike N, Saburi Y, Chou T, Etoh T, Masuda M, Kawano F, Matsuoka M, Taguchi H, Makino T, Asano Y, Tamura K, Ohashi Y. Phase II Study of Cladribine (2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma. Int J Hematol 2003;77:512-7. [DOI: 10.1007/bf02986621] [Cited by in Crossref: 29] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
632 Rena O, Boldorini R, Papalia E, Mezzapelle R, Baietto G, Roncon A, Casadio C. Persistent lung expansion after pleural talc poudrage in non-surgically resected malignant pleural mesothelioma. Ann Thorac Surg 2015;99:1177-83. [PMID: 25669666 DOI: 10.1016/j.athoracsur.2014.11.050] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
633 Lee SH, Jang DK, Yoo MW, Hwang SH, Ryu SY, Kwon OK, Hur H, Man Yoon H, Eom BW, Ahn HS, Son T, Song KY, Lee HH, Choi MG, An JY, Lee SI, Lee KH, Ahn S, Park YS, Park DJ; Efficacy and Safety of DWJ1319 in the Prevention of Gallstone Formation after Gastrectomy in Patient with Gastric Cancer: A Multicenter, Randomized, Double-blind, Placebo-controlled Study (PEGASUS-D) Group. Efficacy and Safety of Ursodeoxycholic Acid for the Prevention of Gallstone Formation After Gastrectomy in Patients With Gastric Cancer: The PEGASUS-D Randomized Clinical Trial. JAMA Surg 2020;155:703-11. [PMID: 32584935 DOI: 10.1001/jamasurg.2020.1501] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
634 Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, Hoang-Xuan K, Lantéri-Minet M, Grant R, Huddart R, Moynihan C, Maher J, Lucey R; EORTC Quality of Life Group. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer 2005;41:1135-9. [PMID: 15911236 DOI: 10.1016/j.ejca.2005.02.012] [Cited by in Crossref: 267] [Cited by in F6Publishing: 196] [Article Influence: 16.7] [Reference Citation Analysis]
635 Arnold DM, Neame PB, Meyer RM, Soamboonsrup P, Luinstra KE, O'hoski P, Garner J, Foley R. Autologous peripheral blood progenitor cells are a potential source of parvovirus B19 infection. Transfusion 2005;45:394-8. [DOI: 10.1111/j.1537-2995.2005.04267.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
636 Fong DYT, Lee AHK, Tung SY, Wong JYH, Chan YM, Goh CR, Cheung YB. The Functional Living Index-Cancer is a reliable and valid instrument in Chinese cancer patients. Qual Life Res 2014;23:311-6. [DOI: 10.1007/s11136-013-0456-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
637 Postlewait LM, Ethun CG, Baptiste GG, Le N, Mcinnis MR, Cardona K, Russell MC, Sarmiento JM, Kooby DA, Staley CA, Maithel SK. Pancreatic neuroendocrine tumors: Preoperative factors that predict lymph node metastases to guide operative strategy: Pancreatic Neuroendocrine Tumors. J Surg Oncol 2016;114:440-5. [DOI: 10.1002/jso.24338] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
638 Karakiewicz PI, Hutterer GC, Trinh Q, Jeldres C, Perrotte P, Gallina A, Tostain J, Patard J. C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: A European study of 313 patients. Cancer 2007;110:1241-7. [DOI: 10.1002/cncr.22896] [Cited by in Crossref: 126] [Cited by in F6Publishing: 111] [Article Influence: 9.0] [Reference Citation Analysis]
639 Shimomura Y, Hara M, Konuma T, Itonaga H, Doki N, Ozawa Y, Eto T, Uchida N, Aoki J, Kato J, Onishi Y, Takahashi S, Fukushima K, Nakamae H, Kawakita T, Tanaka J, Fukuda T, Atsuta Y, Ishikawa T, Ishiyama K. Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients. Bone Marrow Transplant 2021. [PMID: 33993196 DOI: 10.1038/s41409-021-01324-8] [Reference Citation Analysis]
640 Ludovini V, Bianconi F, Pistola L, Chiari R, Minotti V, Colella R, Giuffrida D, Tofanetti FR, Siggillino A, Flacco A, Baldelli E, Iacono D, Mameli MG, Cavaliere A, Crinò L. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer. J Thorac Oncol 2011;6:707-15. [PMID: 21258250 DOI: 10.1097/JTO.0b013e31820a3a6b] [Cited by in Crossref: 119] [Cited by in F6Publishing: 67] [Article Influence: 11.9] [Reference Citation Analysis]
641 Chen S, Liao C, Lin C, Chang JT, Lai Y. Distress and care needs in newly diagnosed oral cavity cancer patients receiving surgery. Oral Oncology 2009;45:815-20. [DOI: 10.1016/j.oraloncology.2009.01.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
642 Auerbach M, Wampler GL, Lokich JJ, Fryer D, Fryer JG, Ahlgren JD. Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-fluorouracil and weekly carboplatin: a Mid-Atlantic Oncology Program Study. Ann Oncol 1997;8:439-44. [PMID: 9233522 DOI: 10.1023/a:1008299429294] [Cited by in Crossref: 24] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
643 Shi M, Lu LG, Fang WQ, Guo RP, Chen MS, Li Y, Luo J, Xu L, Zou RH, Lin XJ, Zhang YQ. Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial. J Natl Cancer Inst. 2013;105:59-68. [PMID: 23150720 DOI: 10.1093/jnci/djs464] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
644 Podoltsev NA, Stahl M, Zeidan AM, Gore SD. Selecting initial treatment of acute myeloid leukaemia in older adults. Blood Rev 2017;31:43-62. [PMID: 27745715 DOI: 10.1016/j.blre.2016.09.005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 9.6] [Reference Citation Analysis]
645 Uchida T, Ogawa Y, Kobayashi Y, Ishikawa T, Ohashi H, Hata T, Usui N, Taniwaki M, Ohnishi K, Akiyama H, Ozawa K, Ohyashiki K, Okamoto S, Tomita A, Nakao S, Tobinai K, Ogura M, Ando K, Hotta T. Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes. Cancer Sci 2011;102:1680-6. [PMID: 21624006 DOI: 10.1111/j.1349-7006.2011.01993.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
646 Fallenius M, Skrifvars MB, Reinikainen M, Bendel S, Curtze S, Sibolt G, Martinez-Majander N, Raj R. Spontaneous Intracerebral Hemorrhage. Stroke 2019;50:2336-43. [PMID: 31311464 DOI: 10.1161/STROKEAHA.118.024560] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
647 O’malley ME, Chung P, Haider M, Jang H, Jhaveri K, Khalili K, Panzarella T, Warde P. Comparison of low dose with standard dose abdominal/pelvic multidetector CT in patients with stage 1 testicular cancer under surveillance. Eur Radiol 2010;20:1624-30. [DOI: 10.1007/s00330-009-1710-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
648 Chakiba C, Bellera C, Etchepare F, Mathoulin-pelissier S, Rainfray M, Soubeyran P. The prognostic value of G8 for functional decline. Journal of Geriatric Oncology 2019;10:921-5. [DOI: 10.1016/j.jgo.2018.12.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
649 Harji DP, Vallance A, Selgimann J, Bach S, Mohamed F, Brown J, Fearnhead N. A systematic analysis highlighting deficiencies in reported outcomes for patients with stage IV colorectal cancer undergoing palliative resection of the primary tumour. Eur J Surg Oncol 2018;44:1469-78. [PMID: 30007475 DOI: 10.1016/j.ejso.2018.06.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
650 Klarod K, Hongsprabhas P, Khampitak T, Wirasorn K, Kiertiburanakul S, Tangrassameeprasert R, Daduang J, Yongvanit P, Boonsiri P. Serum antioxidant levels and nutritional status in early and advanced stage lung cancer patients. Nutrition 2011;27:1156-60. [DOI: 10.1016/j.nut.2010.12.019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
651 Hochster H, Plimack ER, Runowicz CD, Speyer J, Wallach RC, Sorich J, Mandeli J, Wadler S, Wright J, Muggia FM. Biweekly 72-Hour 9-Aminocamptothecin Infusion As Second-Line Therapy for Ovarian Carcinoma: Phase II Study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group. JCO 2004;22:120-6. [DOI: 10.1200/jco.2004.03.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
652 Toso A, Aluffi P, Capello D, Conconi A, Gaidano G, Pia F. Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands. Head Neck 2009;31:1181-7. [DOI: 10.1002/hed.21087] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
653 Baldewijns MM, van Vlodrop IJ, Schouten LJ, Soetekouw PM, de Bruïne AP, van Engeland M. Genetics and epigenetics of renal cell cancer. Biochim Biophys Acta 2008;1785:133-55. [PMID: 18187049 DOI: 10.1016/j.bbcan.2007.12.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 57] [Article Influence: 1.1] [Reference Citation Analysis]
654 Blake HA, Sharples LD, Harron K, van der Meulen JH, Walker K. Probabilistic linkage without personal information successfully linked national clinical datasets. J Clin Epidemiol 2021;136:136-45. [PMID: 33932483 DOI: 10.1016/j.jclinepi.2021.04.015] [Reference Citation Analysis]
655 Morrison EJ, Novotny PJ, Sloan JA, Yang P, Patten CA, Ruddy KJ, Clark MM. Emotional Problems, Quality of Life, and Symptom Burden in Patients With Lung Cancer. Clin Lung Cancer 2017;18:497-503. [PMID: 28412094 DOI: 10.1016/j.cllc.2017.02.008] [Cited by in Crossref: 47] [Cited by in F6Publishing: 30] [Article Influence: 11.8] [Reference Citation Analysis]
656 Sun J, Kirichenko DA, Chung JL, Carr MJ, Eroglu Z, Khushalani NI, Markowitz J, Messina JL, Sondak VK, Zager JS, Patel SY. Perioperative Outcomes of Melanoma Patients Undergoing Surgery After Receiving Immunotherapy or Targeted Therapy. World J Surg 2020;44:1283-93. [DOI: 10.1007/s00268-019-05314-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
657 Thomas JP, Moore T, Kraut EH, Balcerzak SP, Galloway S, Vandre DD. A Phase II Study of CI-980 in Previously Untreated Extensive Small Cell Lung Cancer: An Ohio State University Phase II Research Consortium Study. Cancer Investigation 2002;20:192-8. [DOI: 10.1081/cnv-120001146] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
658 Noer MC, Sperling CD, Ottesen B, Antonsen SL, Christensen IJ, Høgdall C. Ovarian Cancer and Comorbidity: Is Poor Survival Explained by Choice of Primary Treatment or System Delay? Int J Gynecol Cancer 2017;27:1123-33. [DOI: 10.1097/igc.0000000000001001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
659 Shin SJ, Kim H, Baek JH, Ahn JJ, Jegal Y, Seo KW, Park CR, Shin JK, Jung JP, Kim JW, Cha HJ, Kwon WJ, Jeong AK, Noh YJ, Park JH, Min YJ. Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinoma. Lung Cancer 2008;60:83-91. [PMID: 18006180 DOI: 10.1016/j.lungcan.2007.09.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
660 Bicakli DH, Uslu R, Güney SC, Coker A. The Relationship Between Nutritional Status, Performance Status, and Survival Among Pancreatic Cancer Patients.Nutr Cancer. 2020;72:202-208. [PMID: 31271302 DOI: 10.1080/01635581.2019.1634217] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
661 Mehta M, Petereitg D, Chosy L, Harmon M, Fowler J, Shahabi S, Thomadsen B, Kinsella T. Sequential comparison of low dose rate and hyperfractionated high dose rate endobronchial radiation for malignant airway occlusion. International Journal of Radiation Oncology*Biology*Physics 1992;23:133-9. [DOI: 10.1016/0360-3016(92)90552-s] [Cited by in Crossref: 51] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
662 Chen Y, Perng R, Shih J, Tsai C, Whang-peng J. Salvage Therapy for Chinese Non-small Cell Lung Cancer Patients Who Failed Previous Chemotherapy. Journal of Thoracic Oncology 2006;1:545-50. [DOI: 10.1016/s1556-0864(15)30357-9] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
663 Takayama K, Kawasaki M, Ninomiya K, Motohiro A, Fujita M, Watanabe K, Kajiki A, Iwami F, Miyazaki N, Izumi M, Hara N, Nakanishi Y; FUKUOKA LUNG CANCER STUDY GROUP, JAPAN. Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer: A phase II study of UFT plus CDDP in NSCLC. Respirology 2008;13:103-7. [DOI: 10.1111/j.1440-1843.2007.01190.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [